ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,74/1291,130/10616,9.20595034710691e-35,1.0936669012363e-31,1.03106643887597e-31,VCAM1/CD160/FCGR1A/CD1A/CD1C/SLAMF6/SLAMF7/FCGR3A/FCGR2B/SH2D1B/CD247/SELL/CD8A/CD8B/ITGA4/CD96/CD200R1/HLA-F/HLA-G/HLA-B/MICB/NCR3/TREML1/TREM2/TREML2/TREM1/JAML/CD3E/CD3D/CD3G/CRTAM/KLRG1/KLRB1/CLEC2D/KLRF1/CLEC2B/KLRD1/KLRK1/KLRC1/ITGB7/B2M/CD19/ITGAL/CD300A/CD300LB/CD300E/CD300LF/CD226/MADCAM1/ICAM5/ICAM3/CD22/HCST/TYROBP/SIGLEC9/CD33/SIGLEC10/SIGLEC8/SIGLEC6/SIGLEC5/OSCAR/LILRA4/LAIR1/LAIR2/LILRA2/LILRA1/LILRB1/LILRB4/KIR3DL2/NCR1/ITGB2/SH2D1A/CD40LG/CD300LG,74
R-HSA-500792,GPCR ligand binding,126/1291,467/10616,4.0430683058151e-19,2.40158257365417e-16,2.26411825125646e-16,TAS1R3/UTS2/CNR2/PTAFR/LPAR3/XCL2/XCL1/UCN/OXER1/TACR1/CXCR4/CXCR2/CXCR1/WNT6/WNT10A/CCL20/GPR55/GPR35/WNT7A/CCR4/CX3CR1/CCR8/CCR9/CXCR6/XCR1/CCR2/CCR5/GRM2/PROK2/P2RY13/P2RY12/UTS2B/CXCL9/CXCL10/CXCL11/CXCL13/CCR6/WNT16/TAS2R5/KEL/GNRH1/PNOC/CCL19/NPFFR1/WNT8B/ADRA2A/CXCR5/C3AR1/TAS2R19/TAS2R43/WNT10B/WNT1/PMCH/HCAR2/HCAR3/LPAR6/CYSLTR2/GPR18/GPR183/LTB4R/GNG2/PTGDR/GPR65/GPR68/GPR132/CCL22/CCL17/CCL13/CCR7/CRHR1/GCGR/HRH4/MC4R/KISS1R/S1PR4/ADGRE1/CCL25/S1PR5/ADGRE3/ADGRE2/INSL3/FFAR2/GNG8/C5AR1/FPR3/PROKR2/OPRL1/ADORA2A/CXCR3/CYSLTR1/P2RY10/HCRTR1/AGT/POMC/GPR39/GPBAR1/VIPR1/AGTR1/P2RY14/ECE2/SST/ADRA1B/TAC1/WNT2/GRM8/OPN1SW/TRHR/GABBR2/QRFP/OPN4/ADRB1/CALCA/CHRM4/GAL/DHH/RXFP2/EDNRB/TSHR/BDKRB2/BDKRB1/NMB/WNT9B/GRP/GPR4/GNRH2/EDN3,126
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),99/1291,335/10616,4.08016628869948e-18,1.61574585032499e-15,1.52326208111447e-15,UTS2/CNR2/PTAFR/LPAR3/XCL2/XCL1/OXER1/TACR1/CXCR4/CXCR2/CXCR1/CCL20/GPR55/GPR35/CCR4/CX3CR1/CCR8/CCR9/CXCR6/XCR1/CCR2/CCR5/PROK2/P2RY13/P2RY12/UTS2B/CXCL9/CXCL10/CXCL11/CXCL13/CCR6/KEL/GNRH1/PNOC/CCL19/NPFFR1/ADRA2A/CXCR5/C3AR1/PMCH/HCAR2/HCAR3/LPAR6/CYSLTR2/GPR18/GPR183/LTB4R/PTGDR/GPR65/GPR68/GPR132/CCL22/CCL17/CCL13/CCR7/HRH4/MC4R/KISS1R/S1PR4/CCL25/S1PR5/INSL3/FFAR2/C5AR1/FPR3/PROKR2/OPRL1/ADORA2A/CXCR3/CYSLTR1/P2RY10/HCRTR1/AGT/POMC/GPR39/GPBAR1/AGTR1/P2RY14/ECE2/SST/ADRA1B/TAC1/OPN1SW/TRHR/QRFP/OPN4/ADRB1/CHRM4/GAL/RXFP2/EDNRB/TSHR/BDKRB2/BDKRB1/NMB/GRP/GPR4/GNRH2/EDN3,99
R-HSA-202433,Generation of second messenger molecules,22/1291,33/10616,3.20979377336797e-13,9.53308750690287e-11,8.98742256543032e-11,LCK/CD101/CD247/ZAP70/FYB1/ITK/LCP2/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/CD3E/CD3D/CD3G/CD4/EVL/LAT/GRAP2/WAS,22
R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,17/1291,22/10616,3.65645646138627e-12,8.68774055225379e-10,8.19046247350525e-10,LCK/PTPN22/CD247/PTPRC/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/PAG1/CD3E/CD3D/CD3G/CD4/CSK,17
R-HSA-375276,Peptide ligand-binding receptors,60/1291,201/10616,1.20010063849932e-11,2.10917007089001e-09,1.98844316447543e-09,UTS2/XCL2/XCL1/TACR1/CXCR4/CXCR2/CXCR1/CCL20/CCR4/CX3CR1/CCR8/CCR9/CXCR6/XCR1/CCR2/CCR5/PROK2/UTS2B/CXCL9/CXCL10/CXCL11/CXCL13/CCR6/KEL/PNOC/CCL19/NPFFR1/CXCR5/C3AR1/PMCH/CCL22/CCL17/CCL13/CCR7/MC4R/KISS1R/CCL25/INSL3/C5AR1/FPR3/PROKR2/OPRL1/CXCR3/HCRTR1/AGT/POMC/AGTR1/ECE2/SST/TAC1/TRHR/QRFP/GAL/RXFP2/EDNRB/BDKRB2/BDKRB1/NMB/GRP/EDN3,60
R-HSA-389948,PD-1 signaling,17/1291,23/10616,1.24277697779714e-11,2.10917007089001e-09,1.98844316447543e-09,LCK/CD247/PDCD1/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/CD274/CD3E/CD3D/CD3G/CD4/PTPN6/CSK,17
R-HSA-5669034,TNFs bind their physiological receptors,19/1291,29/10616,2.18782217592765e-11,3.24891593125256e-09,3.06295104629871e-09,TNFRSF18/TNFRSF4/TNFRSF25/TNFRSF9/TNFRSF8/TNFRSF1B/FASLG/TNFSF4/EDAR/LTA/TNFSF8/CD27/TNFSF11/TNFSF13B/TNFRSF17/TNFRSF13B/TNFSF9/CD70/TNFRSF11B,19
R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,15/1291,19/10616,4.20576855729818e-11,5.5516144956336e-09,5.23384531574885e-09,LCK/PTPN22/CD247/ZAP70/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/CD3E/CD3D/CD3G/CD4,15
R-HSA-380108,Chemokine receptors bind chemokines,27/1291,59/10616,1.50484058887378e-10,1.78775061958205e-08,1.68542145953863e-08,XCL2/XCL1/CXCR4/CXCR2/CXCR1/CCL20/CCR4/CX3CR1/CCR8/CCR9/CXCR6/XCR1/CCR2/CCR5/CXCL9/CXCL10/CXCL11/CXCL13/CCR6/CCL19/CXCR5/CCL22/CCL17/CCL13/CCR7/CCL25/CXCR3,27
R-HSA-877300,Interferon gamma signaling,35/1291,92/10616,1.72015963826006e-10,1.85777240932086e-08,1.7514352680466e-08,PTAFR/GBP1/GBP2/GBP4/GBP5/VCAM1/FCGR1A/TRIM46/TRIM17/IRF1/IRF4/HLA-F/HLA-G/HLA-B/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/IRF5/TRIM14/TRIM22/PTPN6/IFNG/OAS1/OAS3/OAS2/OASL/B2M/CIITA/IRF8/IFI30/MT2A,35
R-HSA-418594,G alpha (i) signalling events,93/1291,405/10616,4.55642744379034e-10,4.51086316935244e-08,4.25266561420432e-08,TAS1R3/CNR2/LPAR3/RGS18/RGS1/RGS13/OXER1/CXCR4/DHRS9/CXCR2/CXCR1/CCL20/GPR55/CCR4/CX3CR1/CCR8/CCR9/CXCR6/CCR2/CCR5/GRM2/P2RY13/P2RY12/CXCL9/CXCL10/CXCL11/CXCL13/CAMK4/RGS14/GPSM3/GUCA1B/CCR6/GPC2/TAS2R5/PNOC/ADCY8/CCL19/ADRA2A/GRK2/CXCR5/C3AR1/TAS2R19/TAS2R43/RDH16/PMCH/HCAR2/HCAR3/GPR18/GPR183/GNG2/PLCB2/STRA6/ADCY7/CCL13/CCR7/RGS9/PDE6G/HRH4/S1PR4/PCP2/CCL25/S1PR5/APOC2/GNG8/C5AR1/FPR3/PRKCG/RGS19/OPRL1/CXCR3/DHRS3/LRP8/AGT/POMC/P2RY14/SST/CLPS/GRM8/OPN1SW/AKR1B10/LPL/GABBR2/AKR1C1/AKR1C3/RBP4/PNLIP/CHRM4/GAL/APOA1/RDH12/BDKRB2/BDKRB1/LDLR,93
R-HSA-449147,Signaling by Interleukins,99/1291,460/10616,5.006224072807e-09,4.57491861422671e-07,4.31305458580296e-07,PIK3CD/TNFRSF1B/PTAFR/LCK/CSF3R/IL23R/VCAM1/H3C13/IL6R/FASLG/PTPN7/IL24/IL18R1/IL18RAP/IL1B/STAT4/CCL20/INPP5D/IL5RA/CCR2/CCR5/CD80/CD86/IL12A/CXCL10/IL2/IL7R/LMNB1/CSF2/IL4/CSF1R/HAVCR2/IL12B/IRF4/H3C4/H3C12/TNF/PSMB9/IL22RA2/PTK2B/IL7/CCL19/GATA3/ALOX5/NFKB2/SIGIRR/CASP1/IL18/IL10RA/CD4/PTPN6/IL23A/IFNG/IL26/LCP1/BATF/IL16/IL4R/IL21R/ITGAM/ITGAX/NOD2/CCL22/IL34/IL17C/LGALS9/BIRC5/PSMA8/EBI3/VAV1/FCER2/IL27RA/JAK3/IL12RB1/SNAP25/HCK/MMP9/ITGB2/OSM/CSF2RB/IL2RB/CSF2RA/IL2RG/IL9R/POMC/IL36RN/PSMD14/IRS1/PSMD1/CISH/CEBPD/CNTFR/TALDO1/PTPN5/MMP3/HSP90B1/PSMB5/PTPN9/PSMC4,99
R-HSA-388841,Costimulation by the CD28 family,26/1291,69/10616,4.81524224819395e-08,4.08607699346743e-06,3.85219379855516e-06,LCK/CD247/CD28/CTLA4/ICOS/PDCD1/BTLA/CD80/CD86/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/CD274/CD3E/CD3D/CD3G/CD4/PTPN6/CSK/VAV1/TRIB3/GRAP2,26
R-HSA-416476,G alpha (q) signalling events,55/1291,217/10616,5.66040996739857e-08,4.48304469417967e-06,4.22643944232427e-06,UTS2/PTAFR/LPAR3/XCL2/XCL1/RGS18/RGS1/RGS13/RGS2/TACR1/XCR1/PROK2/UTS2B/GNRH1/NPFFR1/RASGRP2/GRK2/DGKA/PMCH/LPAR6/CYSLTR2/LTB4R/GNG2/GPR65/GPR68/GPR132/RASGRP1/PLCB2/GCGR/KISS1R/FFAR2/GNG8/PROKR2/RGS19/CYSLTR1/P2RY10/BTK/HCRTR1/AGT/GPR39/AGTR1/ADRA1B/TAC1/TRHR/QRFP/OPN4/MMP3/EDNRB/BDKRB2/BDKRB1/NMB/GRP/GPR4/GNRH2/EDN3,55
R-HSA-6798695,Neutrophil degranulation,97/1291,477/10616,1.3702185047576e-07,1.01738723978252e-05,9.59152953330321e-06,KCNAB2/SLC2A5/TNFRSF1B/PADI2/FGR/PTAFR/CD53/CTSS/MNDA/HSPA6/FCGR3B/SELL/PTPRC/CR1/TMEM63A/CXCR2/CXCR1/NBEAL2/PLAC8/HPSE/TLR2/DOCK2/STK10/DOK3/HLA-B/HSPA1A/HSPA1B/VNN1/CLEC5A/AOC1/FCN1/ALOX5/ADAM8/AMPD3/TBC1D10C/TCIRG1/CRACR2A/PTPN6/C3AR1/CLEC12A/OLR1/LRMP/BIN2/NCKAP1L/ARHGAP9/LYZ/GLIPR1/HVCN1/B2M/CTSH/MMP25/ITGAL/PYCARD/ITGAM/ITGAX/COTL1/P2RX1/CD300A/RAB37/UNC13D/TMC6/ARHGAP45/ADGRE3/TYROBP/CEACAM3/C5AR1/SIGLEC9/CD33/SIGLEC5/SIGLEC14/OSCAR/LAIR1/FCAR/SIRPB1/SNAP25/MMP9/TRPM2/ITGB2/ADA2/NFAM1/CYBB/CFP/PSMD14/PSMD1/PRSS3/TUBB4B/GSTP1/NDUFC2/MGST1/MLEC/DNAJC3/SERPINA3/HP/CRISPLD2/ELANE/FTL/SLPI,97
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,32/1291,101/10616,1.68332489756184e-07,1.17634704606086e-05,1.10901405015839e-05,TNFRSF18/TNFRSF4/TNFRSF25/TNFRSF9/TNFRSF8/TNFRSF1B/FASLG/TNFSF4/EDAR/LTA/TNF/LTB/PSMB9/TNFSF8/NFKB2/BIRC3/CD27/TNFSF11/TNFSF13B/TNFRSF17/TNFRSF13B/PSMA8/TNFSF9/CD70/TNFRSF13C/CD40LG/PSMD14/PSMD1/TNFRSF11B/PSMB5/TNFRSF12A/PSMC4,32
R-HSA-202403,TCR signaling,35/1291,118/10616,2.77098635567973e-07,1.82885099474862e-05,1.7241692879785e-05,LCK/PTPN22/CD101/CD247/PTPRC/ZAP70/INPP5D/TRAT1/FYB1/ITK/LCP2/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/PSMB9/HLA-DPA1/HLA-DPB1/CARD11/PAG1/CD3E/CD3D/CD3G/CD4/EVL/CSK/LAT/PSMA8/GRAP2/WAS/PSMD14/PSMD1/PSMB5/PSMC4,35
R-HSA-202733,Cell surface interactions at the vascular wall,38/1291,137/10616,5.78323215565491e-07,3.61604200048317e-05,3.40906316543868e-05,LCK/CD2/CD84/CD48/CD244/SELL/FCAMR/ITGA4/INPP5D/JCHAIN/CD74/TREM1/DOK2/JAML/PTPN6/OLR1/SELPLG/SLC7A7/SPN/ITGAL/ITGAM/ITGAX/SLC7A5/CEACAM3/SIRPG/ITGB2/VPREB1/IGLL1/VPREB3/GRB14/ATP1B3/SLC7A11/ITGB3/SLC7A10/MAG/ANGPT4/THBD/PROCR,38
R-HSA-2172127,DAP12 interactions,18/1291,43/10616,9.15216461581866e-07,5.43638578179629e-05,5.12521218485845e-05,LCK/LCP2/TREM2/TREM1/CLEC5A/KLRD1/KLRK1/KLRC2/B2M/LAT/PLCG2/CD300LB/CD300E/TYROBP/SIGLEC14/SIRPB1/GRAP2/BTK,18
R-HSA-451927,Interleukin-2 family signaling,18/1291,44/10616,1.37401382412375e-06,7.77299249075721e-05,7.32807372866e-05,PIK3CD/LCK/STAT4/INPP5D/IL5RA/IL2/CSF2/HAVCR2/PTK2B/PTPN6/IL21R/LGALS9/JAK3/CSF2RB/IL2RB/CSF2RA/IL2RG/IL9R,18
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,31/1291,108/10616,2.84624356126152e-06,0.000153697152308122,0.000144899672209678,TNFRSF1B/IL23R/VCAM1/IL6R/FASLG/IL1B/IL12A/IL4/IL12B/IRF4/TNF/GATA3/ALOX5/IL18/IL23A/BATF/IL4R/ITGAM/ITGAX/CCL22/BIRC5/FCER2/JAK3/MMP9/ITGB2/OSM/IL2RG/POMC/CEBPD/MMP3/HSP90B1,31
R-HSA-6783783,Interleukin-10 signaling,18/1291,47/10616,4.25831295758754e-06,0.000219951121461478,0.00020736132663035,TNFRSF1B/PTAFR/IL1B/CCL20/CCR2/CCR5/CD80/CD86/IL12A/CXCL10/CSF2/IL12B/TNF/CCL19/IL18/IL10RA/CCL22/FCER2,18
R-HSA-8851680,Butyrophilin (BTN) family interactions,8/1291,12/10616,1.47538671514831e-05,0.000730316423998416,0.000688513800402547,BTN3A2/BTN2A2/BTN3A1/BTN3A3/BTN1A1/BTNL2/XDH/BTNL8,8
R-HSA-2500257,Resolution of Sister Chromatid Cohesion,32/1291,124/10616,2.24993793044084e-05,0.00106917050454549,0.0010079721928375,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/CDK1/CDCA5/KNTC1/BUB1B/KNL1/CCNB2/PLK1/AURKB/BIRC5/NDC80/SKA1/SPC24/CENPM/ERCC6L/CENPI/TUBB2A/TUBB4B/TUBA1B/TUBA1C,32
R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),7/1291,10/10616,3.32780749955336e-05,0.00152055204210361,0.00143351707673068,TNFRSF18/CR1/CTLA4/IL2/IFNG/NFATC2/FOXP3,7
R-HSA-622312,Inflammasomes,10/1291,20/10616,3.98272578933045e-05,0.0017523993473054,0.0016520936607593,AIM2/NLRP3/NFKB2/CASP1/P2RX7/PSTPIP1/MEFV/PYCARD/NLRP1/TXN,10
R-HSA-5663220,RHO GTPases Activate Formins,33/1291,138/10616,8.75209000539392e-05,0.00371338675943142,0.00350083600215757,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/KNTC1/DIAPH3/EVL/BUB1B/KNL1/PLK1/AURKB/FMNL1/BIRC5/NDC80/SKA1/SPC24/CENPM/ERCC6L/CENPI/RHOB/TUBB2A/TUBB4B/TUBA1B/TUBA1C,33
R-HSA-141424,Amplification of signal from the kinetochores,25/1291,94/10616,0.000102003323684443,0.00401571331142828,0.00378585766733979,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/SKA1/SPC24/CENPM/ERCC6L/CENPI,25
R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,25/1291,94/10616,0.000102003323684443,0.00401571331142828,0.00378585766733979,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/SKA1/SPC24/CENPM/ERCC6L/CENPI,25
R-HSA-2424491,DAP12 signaling,12/1291,30/10616,0.000104787131863869,0.00401571331142828,0.00378585766733979,LCK/LCP2/TREM2/KLRD1/KLRK1/KLRC2/B2M/LAT/PLCG2/TYROBP/GRAP2/BTK,12
R-HSA-2132295,MHC class II antigen presentation,30/1291,123/10616,0.000123412414001609,0.00458168586980973,0.00431943449005631,KIF2C/CTSS/KIF15/CENPE/KIF20A/CD74/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DOB/HLA-DMB/HLA-DOA/HLA-DPA1/HLA-DPB1/KIF11/SPTBN2/LAG3/RACGAP1/KIF23/CTSH/IFI30/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C/LGMN/AP1M2,30
R-HSA-844456,The NLRP3 inflammasome,8/1291,15/10616,0.000136718063100955,0.00492185027163439,0.00464012820221424,NLRP3/NFKB2/CASP1/P2RX7/PSTPIP1/MEFV/PYCARD/TXN,8
R-HSA-912526,Interleukin receptor SHC signaling,11/1291,27/10616,0.000167613693468479,0.00585661964236921,0.00552139225543226,PIK3CD/INPP5D/IL5RA/IL2/CSF2/PTPN6/JAK3/CSF2RB/IL2RB/CSF2RA/IL2RG,11
R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,12/1291,32/10616,0.000216802652985615,0.00735890147848317,0.00693768489553969,PIK3CD/DAPP1/BLK/PIK3AP1/PTPN6/CD19/PLCG2/CD79B/VAV1/CD22/CD79A/BTK,12
R-HSA-1236975,Antigen processing-Cross presentation,25/1291,99/10616,0.00024811304508587,0.00818773048783372,0.00771907251378263,FCGR1A/CTSS/NCF2/CD207/TLR1/TLR6/TLR2/HLA-F/HLA-G/HLA-B/TAP2/TAP1/PSMB9/NCF1/B2M/PSMA8/NCF4/CYBB/BTK/PSMD14/PSMD1/PSMB5/PDIA3/CALR/PSMC4,25
R-HSA-69620,Cell Cycle Checkpoints,56/1291,290/10616,0.000262569884657855,0.00843062224252787,0.00794806137342696,CLSPN/CDCA8/KIF2C/ORC1/CDC7/H2BC21/NUF2/CENPF/H2BU1/EXO1/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CCNA2/CENPU/CENPK/CENPH/CDC25C/H2BC4/H2BC5/H2BC11/H2BC13/PSMB9/CDKN2A/CDK1/ATM/KNTC1/BUB1B/KNL1/CCNB2/BLM/PKMYT1/RMI2/PLK1/ORC6/AURKB/BRIP1/BIRC5/NDC80/PSMA8/SKA1/SPC24/MCM8/UBE2C/CDC45/CENPM/GTSE1/ERCC6L/CENPI/PSMD14/PSMD1/PSMB5/PSMC4,56
R-HSA-983170,Antigen Presentation: Folding, assembly and peptide loading of class I MHC,10/1291,25/10616,0.000396981740769426,0.0124109028430021,0.0117005144647831,ERAP2/HLA-F/HLA-G/HLA-B/TAP2/TAP1/B2M/HSPA5/PDIA3/CALR,10
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,8/1291,17/10616,0.000412537579512412,0.0125665293451473,0.0118472330526641,LTA/LTB/BIRC3/TNFSF11/TNFSF13B/TNFRSF13C/CD40LG/TNFRSF12A,8
R-HSA-983189,Kinesins,17/1291,59/10616,0.000465377310045282,0.0138217061083449,0.0130305646812679,KIF2C/KIF21B/KIF15/CENPE/KIF20A/KIFC1/KIF25/KIF11/RACGAP1/KIF23/KIF18B/KIF19/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C,17
R-HSA-69618,Mitotic Spindle Checkpoint,26/1291,110/10616,0.000572954742255183,0.0166017130194916,0.0156514466177026,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/SKA1/SPC24/UBE2C/CENPM/ERCC6L/CENPI,26
R-HSA-68882,Mitotic Anaphase,40/1291,199/10616,0.000851965767163142,0.0236886844809708,0.0223327665140466,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/LMNB1/PSMB9/CDCA5/ESPL1/TMPO/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/PSMA8/SKA1/SPC24/UBE2C/CENPM/ERCC6L/CENPI/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,40
R-HSA-5661231,Metallothioneins bind metals,6/1291,11/10616,0.000857418714378574,0.0236886844809708,0.0223327665140466,MT2A/MT1E/MT1M/MT1A/MT1F/MT1X,6
R-HSA-2555396,Mitotic Metaphase and Anaphase,40/1291,200/10616,0.00094312843996085,0.025464467878943,0.024006905744458,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/LMNB1/PSMB9/CDCA5/ESPL1/TMPO/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/PSMA8/SKA1/SPC24/UBE2C/CENPM/ERCC6L/CENPI/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,40
R-HSA-2467813,Separation of Sister Chromatids,38/1291,188/10616,0.00101749542921155,0.0268618793311848,0.0253243306825985,CDCA8/KIF2C/NUF2/CENPF/CENPA/BUB1/SPC25/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/PSMB9/CDCA5/ESPL1/KNTC1/BUB1B/KNL1/PLK1/AURKB/BIRC5/NDC80/PSMA8/SKA1/SPC24/UBE2C/CENPM/ERCC6L/CENPI/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,38
R-HSA-194315,Signaling by Rho GTPases,77/1291,451/10616,0.00112101846588064,0.0289515203797001,0.0272943626475287,CDCA8/KIF2C/H3C13/H2BC21/IQGAP3/ARHGAP30/NUF2/NCF2/KIF14/CENPF/H2BU1/CENPA/ARHGAP25/BUB1/ARHGAP15/SPC25/WIPF1/SRGAP3/SGO1/RHOH/CENPE/MAD2L1/CENPU/DEPDC1B/CENPK/CENPH/CDC25C/CYFIP2/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/FGD2/TAGAP/NCF1/FGD3/RACGAP1/NCKAP1L/ARHGAP9/KNTC1/DIAPH3/EVL/BUB1B/KNL1/RHOV/PLK1/PRKCB/AURKB/FMNL1/BIRC5/NDC80/SKA1/ARHGAP45/VAV1/SPC24/GMIP/ARHGEF1/TIAM1/NCF4/RAC2/CENPM/CYBB/WAS/ERCC6L/CENPI/BTK/ARHGEF6/ARHGAP4/RHOB/TUBB2A/ARHGEF5/TUBB4B/TUBA1B/TUBA1C/ARHGAP36,77
R-HSA-68877,Mitotic Prometaphase,39/1291,197/10616,0.00132528532409522,0.0334987013835131,0.0315812672975881,CDCA8/KIF2C/NUF2/NEK2/CENPF/CENPA/NCAPH/BUB1/SPC25/SGO1/NCAPG/CEP135/CENPE/MAD2L1/PLK4/CENPU/CENPK/CENPH/CNTRL/CDK1/CDCA5/KNTC1/BUB1B/KNL1/CCNB2/PLK1/AURKB/BIRC5/NDC80/SKA1/SPC24/SFI1/CENPM/ERCC6L/CENPI/TUBB2A/TUBB4B/TUBA1B/TUBA1C,39
R-HSA-168643,Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways,15/1291,54/10616,0.00149070552107436,0.0365663772834681,0.0344733523211147,AIM2/NLRP3/CASP8/TNFAIP3/CARD9/NFKB2/BIRC3/CASP1/P2RX7/PSTPIP1/MEFV/PYCARD/NOD2/NLRP1/TXN,15
R-HSA-2029481,FCGR activation,6/1291,12/10616,0.00153898894290691,0.0365663772834681,0.0344733523211147,FGR/FCGR1A/FCGR3A/CD247/CD3G/HCK,6
R-HSA-9020558,Interleukin-2 signaling,6/1291,12/10616,0.00153898894290691,0.0365663772834681,0.0344733523211147,LCK/IL2/PTK2B/JAK3/IL2RB/IL2RG,6
R-HSA-156711,Polo-like kinase mediated events,7/1291,16/10616,0.00163280889201673,0.0380348424258016,0.0358577639031126,CENPF/CDC25C/FOXM1/CCNB2/PKMYT1/PLK1/MYBL2,7
R-HSA-3238698,WNT ligand biogenesis and trafficking,9/1291,26/10616,0.00255694423728695,0.0557048856659358,0.0525163905268081,WNT6/WNT10A/WNT7A/WNT16/WNT8B/WNT10B/WNT1/WNT2/WNT9B,9
R-HSA-5693554,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),9/1291,26/10616,0.00255694423728695,0.0557048856659358,0.0525163905268081,EXO1/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/BRIP1,9
R-HSA-1679131,Trafficking and processing of endosomal TLR,6/1291,13/10616,0.00256580679487472,0.0557048856659358,0.0525163905268081,CTSS/TLR9/TLR7/TLR8/HSP90B1/LGMN,6
R-HSA-202424,Downstream TCR signaling,22/1291,97/10616,0.00257892989194147,0.0557048856659358,0.0525163905268081,LCK/CD247/INPP5D/TRAT1/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/PSMB9/HLA-DPA1/HLA-DPB1/CARD11/CD3E/CD3D/CD3G/CD4/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,22
R-HSA-913531,Interferon Signaling,38/1291,199/10616,0.00295439190774956,0.0626753140429727,0.0590878381549911,PTAFR/GBP1/GBP2/GBP4/GBP5/VCAM1/FCGR1A/TRIM46/TRIM17/NUP210/IRF1/IRF4/HLA-F/HLA-G/HLA-B/HLA-DRA/HLA-DRB1/HLA-DQA1/HLA-DQB1/HLA-DQB2/HLA-DPA1/HLA-DPB1/IRF5/TRIM14/TRIM22/PTPN6/IFNG/OAS1/OAS3/OAS2/OASL/B2M/CIITA/IRF8/XAF1/IFI30/MX2/MT2A,38
R-HSA-5365859,RA biosynthesis pathway,8/1291,22/10616,0.00310512299550098,0.064440686646441,0.0607521624949613,DHRS9/ALDH8A1/SDR16C5/RDH16/ALDH1A3/DHRS3/AKR1C3/CRABP1,8
R-HSA-6806667,Metabolism of fat-soluble vitamins,13/1291,47/10616,0.00314609412920335,0.064440686646441,0.0607521624949613,GPC2/TTPA/APOC2/LRP8/CLPS/AKR1B10/LPL/AKR1C1/AKR1C3/RBP4/PNLIP/APOA1/LDLR,13
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,18/1291,75/10616,0.00320961070116731,0.0646274154743519,0.0609282031408031,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/FGF20/PIK3AP1/ESR2/CD19/VAV1/RAC2/IRS1/KLB/EGF/FGF18,18
R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,9/1291,27/10616,0.0034277717116343,0.0678698798903592,0.063985071950507,LCK/CD247/CD8B/CD28/DOCK2/CD4/B2M/HCK/AP1M2,9
R-HSA-512988,Interleukin-3, Interleukin-5 and GM-CSF signaling,13/1291,48/10616,0.00384411750615278,0.0740905067253677,0.0698496359700437,PIK3CD/INPP5D/IL5RA/IL2/CSF2/PTPN6/VAV1/JAK3/HCK/CSF2RB/IL2RB/CSF2RA/IL2RG,13
R-HSA-195258,RHO GTPase Effectors,56/1291,324/10616,0.00386667627691313,0.0740905067253677,0.0698496359700437,CDCA8/KIF2C/H3C13/H2BC21/IQGAP3/NUF2/NCF2/KIF14/CENPF/H2BU1/CENPA/BUB1/SPC25/WIPF1/SGO1/CENPE/MAD2L1/CENPU/CENPK/CENPH/CDC25C/CYFIP2/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/NCF1/NCKAP1L/KNTC1/DIAPH3/EVL/BUB1B/KNL1/PLK1/PRKCB/AURKB/FMNL1/BIRC5/NDC80/SKA1/SPC24/NCF4/RAC2/CENPM/CYBB/WAS/ERCC6L/CENPI/BTK/RHOB/TUBB2A/TUBB4B/TUBA1B/TUBA1C,56
R-HSA-5660526,Response to metal ions,6/1291,14/10616,0.00403216718439029,0.0760351526199312,0.0716829721669385,MT2A/MT1E/MT1M/MT1A/MT1F/MT1X,6
R-HSA-975634,Retinoid metabolism and transport,12/1291,43/10616,0.00413602597139455,0.0767749820940112,0.0723804544994045,GPC2/APOC2/LRP8/CLPS/AKR1B10/LPL/AKR1C1/AKR1C3/RBP4/PNLIP/APOA1/LDLR,12
R-HSA-2871809,FCERI mediated Ca+2 mobilization,10/1291,33/10616,0.00452464014541355,0.0814435226174439,0.0767817721645936,TXK/ITK/LCP2/MS4A2/LAT/PLCG2/VAV1/NFATC2/GRAP2/BTK,10
R-HSA-5693568,Resolution of D-loop Structures through Holliday Junction Intermediates,10/1291,33/10616,0.00452464014541355,0.0814435226174439,0.0767817721645936,EXO1/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/EME1/BRIP1,10
R-HSA-416700,Other semaphorin interactions,7/1291,19/10616,0.00517662676545628,0.0917885462292845,0.0865346563777767,PTPRC/TREM2/CD72/SEMA4D/PLXNC1/SEMA7A/TYROBP,7
R-HSA-5693537,Resolution of D-Loop Structures,10/1291,34/10616,0.00572500887307223,0.10001927266485,0.094294263791778,EXO1/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/EME1/BRIP1,10
R-HSA-1236977,Endosomal/Vacuolar pathway,5/1291,11/10616,0.00647798813392988,0.109940712901553,0.103647810142878,CTSS/HLA-F/HLA-G/HLA-B/B2M,5
R-HSA-68689,CDC6 association with the ORC:origin complex,5/1291,11/10616,0.00647798813392988,0.109940712901553,0.103647810142878,E2F2/ORC1/ORC6/MCM8/E2F1,5
R-HSA-114604,GPVI-mediated activation cascade,10/1291,35/10616,0.00715988849591264,0.119802077931609,0.112944719935523,LCK/LCP2/PIK3CG/PTPN6/LAT/PLCG2/PIK3R5/VAV1/RAC2/RHOB,10
R-HSA-983705,Signaling by the B Cell Receptor (BCR),23/1291,112/10616,0.00766153858768553,0.126415386696811,0.119179489141775,PIK3CD/DAPP1/PSMB9/NFKBIE/CARD11/BLK/PIK3AP1/PTPN6/RASGRP1/PRKCB/CD19/PLCG2/CD79B/PSMA8/VAV1/CD22/CD79A/NFATC2/BTK/PSMD14/PSMD1/PSMB5/PSMC4,23
R-HSA-373080,Class B/2 (Secretin family receptors),20/1291,94/10616,0.00834585554102141,0.135820224421006,0.12804600282115,UCN/WNT6/WNT10A/WNT7A/WNT16/WNT8B/WNT10B/WNT1/GNG2/CRHR1/GCGR/ADGRE1/ADGRE3/ADGRE2/GNG8/VIPR1/WNT2/CALCA/DHH/WNT9B,20
R-HSA-391160,Signal regulatory protein family interactions,6/1291,16/10616,0.0086790447976837,0.13747606959531,0.129607068978743,FYB1/PTK2B/PTPN6/TYROBP/SIRPB1/SIRPG,6
R-HSA-418038,Nucleotide-like (purinergic) receptors,6/1291,16/10616,0.0086790447976837,0.13747606959531,0.129607068978743,P2RY13/P2RY12/LPAR6/ADORA2A/P2RY10/P2RY14,6
R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),7/1291,21/10616,0.00960744896705271,0.144962725638393,0.136665195888047,ALOX5/ALOX5AP/DPEP3/DPEP2/CYP4F8/CYP4F3/CYP4B1,7
R-HSA-9008059,Interleukin-37 signaling,7/1291,21/10616,0.00960744896705271,0.144962725638393,0.136665195888047,PTPN7/IL18R1/SIGIRR/CASP1/PTPN6/PTPN5/PTPN9,7
R-HSA-2142753,Arachidonic acid metabolism,14/1291,59/10616,0.00975662924658056,0.144962725638393,0.136665195888047,TBXAS1/PTGDS/ALOX5/ALOX5AP/DPEP3/DPEP2/ALOX12/ALOX15B/CYP4F8/CYP4F3/CYP4B1/PON3/AKR1C3/CBR1,14
R-HSA-1236974,ER-Phagosome pathway,18/1291,83/10616,0.00980935160668052,0.144962725638393,0.136665195888047,TLR1/TLR6/TLR2/HLA-F/HLA-G/HLA-B/TAP2/TAP1/PSMB9/B2M/PSMA8/BTK/PSMD14/PSMD1/PSMB5/PDIA3/CALR/PSMC4,18
R-HSA-211979,Eicosanoids,5/1291,12/10616,0.0100058446989463,0.144962725638393,0.136665195888047,TBXAS1/CYP4F8/CYP4F3/CYP4F12/CYP4B1,5
R-HSA-389359,CD28 dependent Vav1 pathway,5/1291,12/10616,0.0100058446989463,0.144962725638393,0.136665195888047,LCK/CD28/CD80/CD86/VAV1,5
R-HSA-417957,P2Y receptors,5/1291,12/10616,0.0100058446989463,0.144962725638393,0.136665195888047,P2RY13/P2RY12/LPAR6/P2RY10/P2RY14,5
R-HSA-2187338,Visual phototransduction,21/1291,102/10616,0.0102243615689584,0.146343874023164,0.137967288641367,DHRS9/GUCA1B/GPC2/RDH16/STRA6/RGS9/PDE6G/APOC2/DHRS3/LRP8/CLPS/OPN1SW/AKR1B10/LPL/AKR1C1/AKR1C3/RBP4/PNLIP/APOA1/RDH12/LDLR,21
R-HSA-3299685,Detoxification of Reactive Oxygen Species,10/1291,37/10616,0.0108471637276935,0.153409887005952,0.144628849702581,NCF2/NCF1/NCF4/CYBB/PRDX1/GSR/TXN/PRDX5/GSTP1/TXNRD1,10
R-HSA-1592389,Activation of Matrix Metalloproteinases,9/1291,33/10616,0.0144337682614916,0.201733137584141,0.190186122974948,SPOCK3/MMP25/MMP9/MMP11/PRSS1/MMP3/CTRB2/CTRB1/ELANE,9
R-HSA-2168880,Scavenging of heme from plasma,5/1291,13/10616,0.014655868388991,0.202455484257225,0.190867123205465,JCHAIN/AMBP/APOA1/HP/HPR,5
R-HSA-209776,Metabolism of amine-derived hormones,6/1291,18/10616,0.0162611928667965,0.219625418491764,0.207054266591562,DBH/AANAT/DIO1/TPO/DIO3/DUOX2,6
R-HSA-68886,M Phase,62/1291,391/10616,0.0162685495179084,0.219625418491764,0.207054266591562,CDCA8/KIF2C/H3C13/H2BC21/NUF2/NEK2/CENPF/H2BU1/CENPA/NCAPH/BUB1/SPC25/NUP210/SGO1/NCAPG/CEP135/CENPE/MAD2L1/PLK4/CENPU/CENPK/CENPH/LMNB1/KIF20A/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/CNTRL/CDK1/CDCA5/ESPL1/TMPO/KNTC1/BUB1B/KNL1/CCNB2/KIF23/PLK1/PRKCB/AURKB/BIRC5/NDC80/PSMA8/SKA1/SPC24/UBE2C/SFI1/CENPM/ERCC6L/CENPI/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,62
R-HSA-909733,Interferon alpha/beta signaling,15/1291,69/10616,0.0170997801550088,0.228253245215174,0.215188244647302,GBP2/IRF1/IRF4/HLA-F/HLA-G/HLA-B/IRF5/PTPN6/OAS1/OAS3/OAS2/OASL/IRF8/XAF1/MX2,15
R-HSA-166658,Complement cascade,13/1291,57/10616,0.0173589384147996,0.229137987075354,0.216022344717506,C4BPA/CR2/CR1/C2/CFB/FCN1/C3AR1/CD19/GZMM/C5AR1/CFP/FCN3/ELANE,13
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,30/1291,168/10616,0.019188362018657,0.250503011847961,0.23616445561424,KIF2C/H3C13/KIF21B/DOCK10/KIF15/CENPE/IRF1/KIF20A/DOCK2/H3C4/H3C12/KIFC1/MICAL1/MYB/KIF25/DOCK8/GATA3/KIF11/HBD/RACGAP1/KIF23/KIF18B/KIF19/GATA1/KIF4A/TUBB2A/DOCK5/TUBB4B/TUBA1B/TUBA1C,30
R-HSA-5423646,Aflatoxin activation and detoxification,6/1291,19/10616,0.0213771464520305,0.27604402157622,0.260243522024719,ACY3/DPEP3/DPEP2/MGST3/ACY1/MGST1,6
R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,15/1291,72/10616,0.0246775731037758,0.300213578929046,0.283029636700784,H2BC21/H2BU1/CENPA/HJURP/CENPU/CENPK/CENPH/H2BC4/H2BC5/H2BC11/H2BC13/KNL1/OIP5/CENPM/CENPI,15
R-HSA-774815,Nucleosome assembly,15/1291,72/10616,0.0246775731037758,0.300213578929046,0.283029636700784,H2BC21/H2BU1/CENPA/HJURP/CENPU/CENPK/CENPH/H2BC4/H2BC5/H2BC11/H2BC13/KNL1/OIP5/CENPM/CENPI,15
R-HSA-209968,Thyroxine biosynthesis,4/1291,10/10616,0.0249769944279182,0.300213578929046,0.283029636700784,DIO1/TPO/DIO3/DUOX2,4
R-HSA-5602498,MyD88 deficiency (TLR2/4),4/1291,10/10616,0.0249769944279182,0.300213578929046,0.283029636700784,TLR1/TLR6/TLR2/BTK,4
R-HSA-9020958,Interleukin-21 signaling,4/1291,10/10616,0.0249769944279182,0.300213578929046,0.283029636700784,STAT4/IL21R/JAK3/IL2RG,4
R-HSA-1266695,Interleukin-7 signaling,9/1291,36/10616,0.0252768613989476,0.300213578929046,0.283029636700784,H3C13/IL7R/H3C4/H3C12/IL7/JAK3/IL2RG/IRS1/CISH,9
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,9/1291,36/10616,0.0252768613989476,0.300213578929046,0.283029636700784,TBXAS1/GCLM/POMC/UGT1A1/ACY1/TPMT/GCLC/CYP27B1/CYP19A1,9
R-HSA-216083,Integrin cell surface interactions,17/1291,85/10616,0.0255267040441464,0.300213578929046,0.283029636700784,VCAM1/ITGA4/COL7A1/SPP1/COL9A1/ITGB7/ITGAL/ITGAM/ITGAX/ITGAD/MADCAM1/ICAM5/ICAM3/ITGB2/COL8A1/KDR/ITGB3,17
R-HSA-210991,Basigin interactions,7/1291,25/10616,0.0257759133423929,0.300213578929046,0.283029636700784,SLC7A7/SPN/SLC7A5/ATP1B3/SLC7A11/SLC7A10/MAG,7
R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,7/1291,25/10616,0.0257759133423929,0.300213578929046,0.283029636700784,CCNA2/CDC25C/CDK1/FOXM1/CCNB2/PKMYT1/PLK1,7
R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,6/1291,20/10616,0.0274783033557921,0.313886772948856,0.295920189985454,LCK/CD8B/CD28/CD4/B2M/AP1M2,6
R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,6/1291,20/10616,0.0274783033557921,0.313886772948856,0.295920189985454,TP73/TP63/TP53INP1/ATM/TP53AIP1/PMAIP1,6
R-HSA-391903,Eicosanoid ligand-binding receptors,5/1291,15/10616,0.0278185337541245,0.314746839046666,0.296731026710661,OXER1/CYSLTR2/LTB4R/PTGDR/CYSLTR1,5
R-HSA-1474244,Extracellular matrix organization,48/1291,301/10616,0.0288707684556946,0.323570499295898,0.30504962896583,MATN1/VCAM1/CTSS/TNR/LAMB3/CAPN14/ITGA4/COL7A1/SPP1/SPOCK3/ADAM19/COL19A1/COL9A1/COL26A1/COL22A1/MUSK/ADAMTS14/ADAM12/ADAM8/ITGB7/MMP25/ITGAL/ITGAM/ITGAX/ITGAD/LAMA3/MADCAM1/ICAM5/ICAM3/MMP9/ITGB2/MMP11/ADAMTS4/TNN/COL8A1/PCOLCE2/PLOD2/KDR/ADAMTS16/SCUBE3/PRSS1/MMP3/MFAP5/PPIB/CTRB2/CTRB1/ITGB3/ELANE,48
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,10/1291,44/10616,0.0353601681968917,0.387354840503375,0.365183014615976,TP73/TP63/TP53INP1/FAS/CASP1/ATM/TP53AIP1/BCL2L14/BIRC5/PMAIP1,10
R-HSA-2514853,Condensation of Prometaphase Chromosomes,4/1291,11/10616,0.0355478551673401,0.387354840503375,0.365183014615976,NCAPH/NCAPG/CDK1/CCNB2,4
R-HSA-5603041,IRAK4 deficiency (TLR2/4),4/1291,11/10616,0.0355478551673401,0.387354840503375,0.365183014615976,TLR1/TLR6/TLR2/BTK,4
R-HSA-139853,Elevation of cytosolic Ca2+ levels,5/1291,16/10616,0.0365183014615976,0.387354840503375,0.365183014615976,P2RX7/P2RX2/P2RX5/P2RX1/P2RX6,5
R-HSA-159418,Recycling of bile acids and salts,5/1291,16/10616,0.0365183014615976,0.387354840503375,0.365183014615976,ABCB11/SLCO1A2/NR1H4/STARD5/ABCC3,5
R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),5/1291,16/10616,0.0365183014615976,0.387354840503375,0.365183014615976,LMNB1/H1-4/H1-3/H1-5/HIRA,5
R-HSA-9616222,Transcriptional regulation of granulopoiesis,17/1291,89/10616,0.038165788109248,0.400472798498721,0.377550113062767,CSF3R/GFI1/H3C13/H2BC21/IL6R/H2BU1/LEF1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MYB/SPI1/CEBPE/E2F1,17
R-HSA-8963743,Digestion and absorption,7/1291,27/10616,0.038429207936746,0.400472798498721,0.377550113062767,SLC2A5/GUCA2A/AMY2A/CLPS/PNLIP/PNLIPRP1/PIR,7
R-HSA-447115,Interleukin-12 family signaling,12/1291,57/10616,0.0388418713554031,0.401253418871469,0.378286051461317,IL23R/STAT4/IL12A/LMNB1/IL12B/IL23A/IFNG/LCP1/EBI3/IL27RA/IL12RB1/TALDO1,12
R-HSA-6811558,PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,19/1291,103/10616,0.0407569558351621,0.417407444242867,0.393515435649841,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/FGF20/PIP4K2A/PIK3AP1/ESR2/CD19/VAV1/RAC2/IRS1/KLB/EGF/FGF18,19
R-HSA-199418,Negative regulation of the PI3K/AKT network,20/1291,110/10616,0.0417325605741186,0.423745999675666,0.399491178145409,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/FGF20/PIP4K2A/PIK3AP1/ESR2/CD19/VAV1/TRIB3/RAC2/IRS1/KLB/EGF/FGF18,20
R-HSA-166663,Initial triggering of complement,6/1291,22/10616,0.0428709366203546,0.427988846260347,0.403491168191573,C2/CFB/FCN1/GZMM/CFP/FCN3,6
R-HSA-8935690,Digestion,6/1291,22/10616,0.0428709366203546,0.427988846260347,0.403491168191573,GUCA2A/AMY2A/CLPS/PNLIP/PNLIPRP1/PIR,6
R-HSA-977606,Regulation of Complement cascade,10/1291,46/10616,0.0465515833021173,0.460860674690961,0.434481444153095,C4BPA/CR2/CR1/C2/CFB/C3AR1/CD19/C5AR1/CFP/ELANE,10
R-HSA-69481,G2/M Checkpoints,28/1291,167/10616,0.047580369980022,0.462925856105048,0.436428416530012,CLSPN/ORC1/CDC7/H2BC21/H2BU1/EXO1/CDC25C/H2BC4/H2BC5/H2BC11/H2BC13/PSMB9/CDK1/ATM/CCNB2/BLM/PKMYT1/RMI2/ORC6/BRIP1/PSMA8/MCM8/CDC45/GTSE1/PSMD14/PSMD1/PSMB5/PSMC4,28
R-HSA-210990,PECAM1 interactions,4/1291,12/10616,0.048318860401537,0.462925856105048,0.436428416530012,LCK/INPP5D/PTPN6/ITGB3,4
R-HSA-6803207,TP53 Regulates Transcription of Caspase Activators and Caspases,4/1291,12/10616,0.048318860401537,0.462925856105048,0.436428416530012,TP73/TP63/CASP1/ATM,4
R-HSA-8984722,Interleukin-35 Signalling,4/1291,12/10616,0.048318860401537,0.462925856105048,0.436428416530012,STAT4/IL12A/EBI3/IL27RA,4
R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,5/1291,18/10616,0.0584220607488413,0.550836572774789,0.519307206656367,GZMH/AGT/CPB1/ENPEP/ACE2,5
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,5/1291,18/10616,0.0584220607488413,0.550836572774789,0.519307206656367,LMF1/APOC2/CIDEC/LPL/ANGPTL4,5
R-HSA-2219528,PI3K/AKT Signaling in Cancer,18/1291,101/10616,0.0606561015227145,0.556515063507442,0.524660665932942,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/FGF20/PIK3AP1/ESR2/CD19/VAV1/RAC2/IRS1/KLB/EGF/FGF18,18
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,9/1291,42/10616,0.0620107355322773,0.556515063507442,0.524660665932942,JCHAIN/AMBP/APOA1/HYOU1/HSP90B1/HP/HPR/CALR/FTL,9
R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,9/1291,42/10616,0.0620107355322773,0.556515063507442,0.524660665932942,EXO1/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/BRIP1,9
R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,6/1291,24/10616,0.0627719011026913,0.556515063507442,0.524660665932942,ABCB11/NR1H4/HSD17B4/AKR1C1/AKR1C2/AKR1C3,6
R-HSA-449836,Other interleukin signaling,6/1291,24/10616,0.0627719011026913,0.556515063507442,0.524660665932942,CSF3R/CSF1R/CD4/IL16/IL34/SNAP25,6
R-HSA-5260271,Diseases of Immune System,6/1291,24/10616,0.0627719011026913,0.556515063507442,0.524660665932942,TLR10/TLR1/TLR6/TLR2/NFKB2/BTK,6
R-HSA-5602358,Diseases associated with the TLR signaling cascade,6/1291,24/10616,0.0627719011026913,0.556515063507442,0.524660665932942,TLR10/TLR1/TLR6/TLR2/NFKB2/BTK,6
R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,6/1291,24/10616,0.0627719011026913,0.556515063507442,0.524660665932942,NCF2/NCF1/PRKCB/NCF4/RAC2/CYBB,6
R-HSA-418360,Platelet calcium homeostasis,7/1291,30/10616,0.0640232807096621,0.559262187375578,0.527250547020747,P2RX7/P2RX2/P2RX5/P2RX1/ATP2A3/P2RX6/ATP2A2,7
R-HSA-8963899,Plasma lipoprotein remodeling,7/1291,30/10616,0.0640232807096621,0.559262187375578,0.527250547020747,LMF1/APOC2/CIDEC/LPL/APOA1/LIPG/ANGPTL4,7
R-HSA-194840,Rho GTPase cycle,23/1291,137/10616,0.0667742039589575,0.579034702943369,0.545891302438193,ARHGAP30/ARHGAP25/ARHGAP15/SRGAP3/RHOH/DEPDC1B/FGD2/TAGAP/FGD3/RACGAP1/ARHGAP9/RHOV/ARHGAP45/VAV1/GMIP/ARHGEF1/TIAM1/RAC2/ARHGEF6/ARHGAP4/RHOB/ARHGEF5/ARHGAP36,23
R-HSA-1296072,Voltage gated Potassium channels,9/1291,43/10616,0.0703430438683484,0.596910972254271,0.562744350946787,KCNAB2/KCNA2/KCNA3/KCNH8/KCNH3/KCNH4/KCNG1/KCNV1/KCNC3,9
R-HSA-194068,Bile acid and bile salt metabolism,9/1291,43/10616,0.0703430438683484,0.596910972254271,0.562744350946787,ABCB11/SLCO1A2/NR1H4/STARD5/HSD17B4/AKR1C1/AKR1C2/AKR1C3/ABCC3,9
R-HSA-5362517,Signaling by Retinoic Acid,9/1291,43/10616,0.0703430438683484,0.596910972254271,0.562744350946787,DHRS9/PDK1/ALDH8A1/SDR16C5/RDH16/ALDH1A3/DHRS3/AKR1C3/CRABP1,9
R-HSA-422085,Synthesis, secretion, and deacylation of Ghrelin,5/1291,19/10616,0.0716523872834166,0.603709475834744,0.569153714591678,UCN/ACHE/MBOAT4/BCHE/IGF1,5
R-HSA-2029485,Role of phospholipids in phagocytosis,6/1291,25/10616,0.0744548446059436,0.622903911210289,0.587249478582091,FCGR1A/FCGR3A/CD247/CD3G/PLD4/PLCG2,6
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,14/1291,77/10616,0.0791557014222363,0.640795211671459,0.604116697872082,PSMB9/CDK1/CCNB2/PLK1/PSMA8/GTSE1/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,14
R-HSA-109704,PI3K Cascade,9/1291,44/10616,0.0793386404695802,0.640795211671459,0.604116697872082,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18,9
R-HSA-2453864,Retinoid cycle disease events,4/1291,14/10616,0.0803690964133395,0.640795211671459,0.604116697872082,STRA6/OPN1SW/RBP4/RDH12,4
R-HSA-2474795,Diseases associated with visual transduction,4/1291,14/10616,0.0803690964133395,0.640795211671459,0.604116697872082,STRA6/OPN1SW/RBP4/RDH12,4
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,4/1291,14/10616,0.0803690964133395,0.640795211671459,0.604116697872082,TP73/TP63/BCL2L14/BIRC5,4
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,4/1291,14/10616,0.0803690964133395,0.640795211671459,0.604116697872082,CCNA2/E2F8/E2F7/E2F1,4
R-HSA-71240,Tryptophan catabolism,4/1291,14/10616,0.0803690964133395,0.640795211671459,0.604116697872082,KMO/TDO2/SLC7A5/ACMSD,4
R-HSA-1474228,Degradation of the extracellular matrix,23/1291,140/10616,0.0810416239517932,0.641849661698202,0.605110792173389,CTSS/LAMB3/CAPN14/COL7A1/SPP1/SPOCK3/COL19A1/COL9A1/COL26A1/ADAM8/MMP25/LAMA3/MMP9/MMP11/ADAMTS4/COL8A1/ADAMTS16/SCUBE3/PRSS1/MMP3/CTRB2/CTRB1/ELANE,23
R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,17/1291,98/10616,0.0820015927128388,0.64515160359505,0.608223734029003,KIF2C/KIF21B/KIF15/CENPE/KIF20A/KIFC1/KIF25/KIF11/RACGAP1/KIF23/KIF18B/KIF19/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C,17
R-HSA-397795,G-protein beta:gamma signalling,7/1291,32/10616,0.0857027718947531,0.664742073842102,0.626692864228244,PIK3CG/GNG2/PLCB2/PIK3R5/GNG8/BTK/ARHGEF6,7
R-HSA-5213460,RIPK1-mediated regulated necrosis,5/1291,20/10616,0.086377081925958,0.664742073842102,0.626692864228244,FASLG/CASP8/FAS/BIRC3/MLKL,5
R-HSA-5218859,Regulated Necrosis,5/1291,20/10616,0.086377081925958,0.664742073842102,0.626692864228244,FASLG/CASP8/FAS/BIRC3/MLKL,5
R-HSA-69002,DNA Replication Pre-Initiation,15/1291,85/10616,0.0872893632317912,0.664742073842102,0.626692864228244,E2F2/ORC1/CDC7/PSMB9/ORC6/CDT1/PSMA8/MCM8/E2F1/CDC45/RPA4/PSMD14/PSMD1/PSMB5/PSMC4,15
R-HSA-912446,Meiotic recombination,15/1291,85/10616,0.0872893632317912,0.664742073842102,0.626692864228244,H3C13/H2BC21/H2BU1/MND1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MSH5/ATM/BRCA2/RAD51/BLM,15
R-HSA-1296071,Potassium Channels,17/1291,99/10616,0.0883336197594762,0.668409810664062,0.630150663252314,KCNAB2/KCNA2/KCNA3/KCNH8/KCNJ5/KCNH3/GNG2/HCN4/KCNH4/KCNK6/KCNN4/GNG8/KCNG1/KCNV1/GABBR2/ABCC8/KCNC3,17
R-HSA-211897,Cytochrome P450 - arranged by substrate type,12/1291,65/10616,0.0904706775433634,0.680247879250099,0.641311131952956,TBXAS1/NR1H4/CYP4F8/CYP4F3/CYP4F12/CYP2S1/CYP4B1/POMC/POR/CYP51A1/CYP27B1/CYP19A1,12
R-HSA-2428928,IRS-related events triggered by IGF1R,10/1291,52/10616,0.093478479654563,0.695475635668301,0.655667265949914,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18/IGF1,10
R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,8/1291,39/10616,0.0936667522785591,0.695475635668301,0.655667265949914,EXO1/XRCC2/ATM/BRCA2/RAD51/BLM/RMI2/BRIP1,8
R-HSA-1474165,Reproduction,23/1291,143/10616,0.0972210104834796,0.699291891170582,0.659265082585061,OVGP1/H3C13/H2BC21/H2BU1/MND1/LMNB1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MSH5/STAG3/ATM/HVCN1/BRCA2/REC8/RAD51/BLM/SMC1B/ZP1/CATSPERB,23
R-HSA-389356,CD28 co-stimulation,7/1291,33/10616,0.0979280738942455,0.699291891170582,0.659265082585061,LCK/CD28/CD80/CD86/VAV1/TRIB3/GRAP2,7
R-HSA-4085001,Sialic acid metabolism,7/1291,33/10616,0.0979280738942455,0.699291891170582,0.659265082585061,ST6GAL1/ST8SIA4/ST8SIA1/ST8SIA2/SLC17A5/ST3GAL1/ST8SIA3,7
R-HSA-68962,Activation of the pre-replicative complex,7/1291,33/10616,0.0979280738942455,0.699291891170582,0.659265082585061,ORC1/CDC7/ORC6/CDT1/MCM8/CDC45/RPA4,7
R-HSA-193807,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,4/1291,15/10616,0.0994783919257815,0.699291891170582,0.659265082585061,NR1H4/AKR1C1/AKR1C2/AKR1C3,4
R-HSA-211935,Fatty acids,4/1291,15/10616,0.0994783919257815,0.699291891170582,0.659265082585061,CYP4F8/CYP4F3/CYP4F12/CYP4B1,4
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),4/1291,15/10616,0.0994783919257815,0.699291891170582,0.659265082585061,TBXAS1/PTGDS/AKR1C3/CBR1,4
R-HSA-4419969,Depolymerisation of the Nuclear Lamina,4/1291,15/10616,0.0994783919257815,0.699291891170582,0.659265082585061,LMNB1/CDK1/TMPO/PRKCB,4
R-HSA-71336,Pentose phosphate pathway,4/1291,15/10616,0.0994783919257815,0.699291891170582,0.659265082585061,PGD/TKT/TALDO1/G6PD,4
R-HSA-196741,Cobalamin (Cbl, vitamin B12) transport and metabolism,5/1291,21/10616,0.102549093430542,0.716637194091084,0.675617556718867,CTRC/PRSS1/PRSS3/CTRB2/CTRB1,5
R-HSA-2428924,IGF1R signaling cascade,10/1291,53/10616,0.103321864393173,0.717815057889412,0.676728000703823,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18/IGF1,10
R-HSA-1483166,Synthesis of PA,8/1291,40/10616,0.105257310895376,0.727009798509924,0.685396443039659,PLA2G2D/LIPH/LPCAT4/PLA2G4D/PLD6/GPAM/GPD1/PLA2G1B,8
R-HSA-2980736,Peptide hormone metabolism,15/1291,88/10616,0.109815527117465,0.747655464340914,0.704860370422411,UCN/DPP4/MYRIP/ACHE/MBOAT4/GZMH/AGT/POMC/CPB1/BCHE/ENPEP/IGF1/GRP/PCSK2/ACE2,15
R-HSA-196854,Metabolism of vitamins and cofactors,29/1291,189/10616,0.109957193791859,0.747655464340914,0.704860370422411,CD38/SLC23A1/VNN1/VNN2/GPC2/TTPA/ENPP2/SLC52A1/ACP5/APOC2/CTRC/LRP8/NMNAT2/AOX1/CLPS/AKR1B10/PRSS1/LPL/PRSS3/AKR1C1/AKR1C3/RBP4/PNLIP/NNMT/APOA1/CTRB2/CTRB1/FASN/LDLR,29
R-HSA-112311,Neurotransmitter clearance,3/1291,10/10616,0.112022451727847,0.747655464340914,0.704860370422411,ACHE/BCHE/SLC6A4,3
R-HSA-168799,Neurotoxicity of clostridium toxins,3/1291,10/10616,0.112022451727847,0.747655464340914,0.704860370422411,VAMP1/STX1B/SNAP25,3
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,3/1291,10/10616,0.112022451727847,0.747655464340914,0.704860370422411,HSPA5/HSP90B1/CALR,3
R-HSA-8964058,HDL remodeling,3/1291,10/10616,0.112022451727847,0.747655464340914,0.704860370422411,APOC2/APOA1/LIPG,3
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),10/1291,54/10616,0.113740766023693,0.754882849363951,0.711674066740425,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18/IGF1,10
R-HSA-1500620,Meiosis,19/1291,117/10616,0.114622058322241,0.756505584926793,0.713203918449502,H3C13/H2BC21/H2BU1/MND1/LMNB1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MSH5/STAG3/ATM/BRCA2/REC8/RAD51/BLM/SMC1B,19
R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,6/1291,28/10616,0.116298790177493,0.757209129267963,0.713867192575858,INPP5D/PLCZ1/PLD4/PLCB2/PLCG2/INPP5J,6
R-HSA-69205,G1/S-Specific Transcription,6/1291,28/10616,0.116298790177493,0.757209129267963,0.713867192575858,ORC1/RRM2/CDK1/CDT1/E2F1/CDC45,6
R-HSA-68867,Assembly of the pre-replicative complex,12/1291,68/10616,0.117361629165869,0.757209129267963,0.713867192575858,E2F2/ORC1/PSMB9/ORC6/CDT1/PSMA8/MCM8/E2F1/PSMD14/PSMD1/PSMB5/PSMC4,12
R-HSA-113510,E2F mediated regulation of DNA replication,5/1291,22/10616,0.120101492492362,0.757209129267963,0.713867192575858,ORC1/CDK1/ORC6/MCM8/E2F1,5
R-HSA-389357,CD28 dependent PI3K/Akt signaling,5/1291,22/10616,0.120101492492362,0.757209129267963,0.713867192575858,LCK/CD28/CD80/CD86/TRIB3,5
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,5/1291,22/10616,0.120101492492362,0.757209129267963,0.713867192575858,FASLG/LMNB1/CDC25C/CDK5R1/PRDX1,5
R-HSA-8863678,Neurodegenerative Diseases,5/1291,22/10616,0.120101492492362,0.757209129267963,0.713867192575858,FASLG/LMNB1/CDC25C/CDK5R1/PRDX1,5
R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,4/1291,16/10616,0.120465088747176,0.757209129267963,0.713867192575858,CCNA2/CDK1/E2F1/MYBL2,4
R-HSA-392517,Rap1 signalling,4/1291,16/10616,0.120465088747176,0.757209129267963,0.713867192575858,RASGRP2/SIPA1/RASGRP1/RAP1GAP,4
R-HSA-112399,IRS-mediated signalling,9/1291,48/10616,0.12193888242612,0.762438906959111,0.718797622722394,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18,9
R-HSA-1474290,Collagen formation,15/1291,90/10616,0.126604747189204,0.785137854884071,0.740197304267811,CTSS/LAMB3/COL7A1/COL19A1/COL9A1/COL26A1/COL22A1/ADAMTS14/LAMA3/MMP9/COL8A1/PCOLCE2/PLOD2/MMP3/PPIB,15
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,13/1291,76/10616,0.127466564227581,0.785137854884071,0.740197304267811,NEK2/MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PLK1/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,13
R-HSA-9607240,FLT3 Signaling,39/1291,267/10616,0.12755185689615,0.785137854884071,0.740197304267811,DUSP2/IL5RA/TLR9/RASA2/EREG/IL2/CSF2/PSMB9/FGF20/APBB1IP/RASGEF1A/PDE3B/SPTBN2/FLT3/RASGRP1/CSK/RASGRF1/LAT/ARRB2/PSMA8/RASAL3/JAK3/FLT3LG/TRIB3/HCK/CSF2RB/IL2RB/CSF2RA/IL2RG/PSMD14/IRS1/PSMD1/KLB/EGF/FGF18/GFRA2/PSMB5/ITGB3/PSMC4,39
R-HSA-1482801,Acyl chain remodelling of PS,5/1291,23/10616,0.138950264702435,0.835760527101944,0.787922382453012,PLA2G2D/OSBPL10/LPCAT4/PLA2G4D/PLA2G1B,5
R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),5/1291,23/10616,0.138950264702435,0.835760527101944,0.787922382453012,DHRS9/RDH16/STRA6/RBP4/RDH12,5
R-HSA-1222556,ROS and RNS production in phagocytes,7/1291,36/10616,0.139920138016906,0.835760527101944,0.787922382453012,NCF2/NCF1/TCIRG1/HVCN1/NCF4/RAC2/CYBB,7
R-HSA-3371378,Regulation by c-FLIP,3/1291,11/10616,0.140700425438038,0.835760527101944,0.787922382453012,FASLG/CASP8/FAS,3
R-HSA-5218900,CASP8 activity is inhibited,3/1291,11/10616,0.140700425438038,0.835760527101944,0.787922382453012,FASLG/CASP8/FAS,3
R-HSA-69416,Dimerization of procaspase-8,3/1291,11/10616,0.140700425438038,0.835760527101944,0.787922382453012,FASLG/CASP8/FAS,3
R-HSA-8963691,Phenylalanine and tyrosine metabolism,3/1291,11/10616,0.140700425438038,0.835760527101944,0.787922382453012,IL4I1/HGD/HPD,3
R-HSA-180292,GAB1 signalosome,4/1291,17/10616,0.143158744189573,0.841943505431749,0.793751452932289,EREG/PAG1/CSK/EGF,4
R-HSA-199220,Vitamin B5 (pantothenate) metabolism,4/1291,17/10616,0.143158744189573,0.841943505431749,0.793751452932289,VNN1/VNN2/ENPP2/FASN,4
R-HSA-5684996,MAPK1/MAPK3 signaling,37/1291,255/10616,0.143964605771609,0.842512077126463,0.794287480119224,IL6R/DUSP2/IL5RA/RASA2/EREG/IL2/CSF2/PSMB9/FGF20/APBB1IP/RASGEF1A/CDK1/SPTBN2/FLT3/RASGRP1/CSK/RASGRF1/LAT/ARRB2/PSMA8/RASAL3/JAK3/FLT3LG/CSF2RB/IL2RB/CSF2RA/IL2RG/PSMD14/IRS1/PSMD1/KLB/EGF/FGF18/GFRA2/PSMB5/ITGB3/PSMC4,37
R-HSA-936837,Ion transport by P-type ATPases,10/1291,57/10616,0.148354020040496,0.862131336951934,0.812783752008557,ATP1A4/FXYD2/ATP2A3/ATP8B3/FXYD7/ATP1A3/ATP1A1/ATP1B3/ATP2A2/ATP4A,10
R-HSA-1482839,Acyl chain remodelling of PE,6/1291,30/10616,0.149494154387288,0.862131336951934,0.812783752008557,PLA2G2D/LPCAT4/PLA2G4D/PLAAT1/PLA2G1B/ABHD4,6
R-HSA-5683826,Surfactant metabolism,6/1291,30/10616,0.149494154387288,0.862131336951934,0.812783752008557,ADRA2A/CTSH/ADA2/ADORA2A/CSF2RB/CSF2RA,6
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,20/1291,129/10616,0.150812037278887,0.865529953078829,0.815987834552432,TP73/H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/MYB/GATA3/SPI1/PSMA8/GATA1/PSMD14/PSMD1/PSMB5/PSMC4,20
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,15/1291,93/10616,0.154387282562239,0.876198434538045,0.82604566219075,CD52/FCGR3B/LYPD6B/MDGA1/VNN1/VNN3/VNN2/NTNG2/IZUMO1R/MSLN/PRSS21/LYPD3/PRND/LY6K/TECTB,15
R-HSA-176187,Activation of ATR in response to replication stress,7/1291,37/10616,0.15558251778999,0.876198434538045,0.82604566219075,CLSPN/ORC1/CDC7/CDC25C/ORC6/MCM8/CDC45,7
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,14/1291,86/10616,0.156358643200392,0.876198434538045,0.82604566219075,NEK2/MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PLK1/AURKB/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,14
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,14/1291,86/10616,0.156358643200392,0.876198434538045,0.82604566219075,FGR/FCGR1A/FCGR3A/CD247/WIPF1/CYFIP2/CD3G/NCKAP1L/PLD4/PLCG2/VAV1/HCK/WAS/BTK,14
R-HSA-453276,Regulation of mitotic cell cycle,14/1291,86/10616,0.156358643200392,0.876198434538045,0.82604566219075,NEK2/MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PLK1/AURKB/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,14
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,13/1291,79/10616,0.158103182321697,0.881814932385801,0.831340676996715,H2BC21/H2BU1/CCNA2/LMNB1/H2BC4/H1-4/H2BC5/H1-3/H2BC11/H2BC13/H1-5/ATM/HIRA,13
R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,4/1291,18/10616,0.16736922517264,0.907380097835246,0.855442516477673,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-5675482,Regulation of necroptotic cell death,4/1291,18/10616,0.16736922517264,0.907380097835246,0.855442516477673,FASLG/CASP8/FAS/BIRC3,4
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,12/1291,73/10616,0.171150657936437,0.907380097835246,0.855442516477673,NEK2/MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,12
R-HSA-176974,Unwinding of DNA,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,MCM8/GINS1/CDC45,3
R-HSA-211958,Miscellaneous substrates,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,CYP4F3/CYP2S1/CYP4B1,3
R-HSA-2160916,Hyaluronan uptake and degradation,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,HMMR/HYAL2/LYVE1,3
R-HSA-375281,Hormone ligand-binding receptors,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,GNRH1/TSHR/GNRH2,3
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,HSPA5/HSP90B1/CALR,3
R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,TP73/TP63/FAS,3
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),3/1291,12/10616,0.171494280450204,0.907380097835246,0.855442516477673,PIK3CD/PIK3CG/PIK3R5,3
R-HSA-420499,Class C/3 (Metabotropic glutamate/pheromone receptors),7/1291,38/10616,0.172007411110782,0.907380097835246,0.855442516477673,TAS1R3/GRM2/TAS2R5/TAS2R19/TAS2R43/GRM8/GABBR2,7
R-HSA-446652,Interleukin-1 family signaling,21/1291,139/10616,0.172485342903826,0.907380097835246,0.855442516477673,PTPN7/IL18R1/IL18RAP/IL1B/IL4/PSMB9/ALOX5/NFKB2/SIGIRR/CASP1/IL18/PTPN6/NOD2/PSMA8/IL36RN/PSMD14/PSMD1/PTPN5/PSMB5/PTPN9/PSMC4,21
R-HSA-8878171,Transcriptional regulation by RUNX1,34/1291,237/10616,0.172616079217816,0.907380097835246,0.855442516477673,TNFRSF18/TP73/H3C13/H2BC21/CR1/H2BU1/CTLA4/IL2/CSF2/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/RUNX2/MYB/BLK/PAX5/GATA3/SPI1/IFNG/PRKCB/GP1BA/PSMA8/NFATC2/GATA1/FOXP3/PSMD14/PSMD1/GPAM/PSMB5/PSMC4,34
R-HSA-68827,CDT1 association with the CDC6:ORC:origin complex,10/1291,59/10616,0.174077803849251,0.90961903392243,0.857553297974008,ORC1/PSMB9/ORC6/CDT1/PSMA8/MCM8/PSMD14/PSMD1/PSMB5/PSMC4,10
R-HSA-6803157,Antimicrobial peptides,15/1291,95/10616,0.174573349944709,0.90961903392243,0.857553297974008,GNLY/CCR2/TLR1/TLR2/CCR6/CD4/LYZ/RNASE6/PGLYRP2/DEFB124/ITLN1/DEFB131A/PRSS3/CHGA/ELANE,15
R-HSA-8854691,Interleukin-20 family signaling,5/1291,25/10616,0.180132791963316,0.930425029793128,0.877168378256147,IL24/STAT4/IL22RA2/IL26/JAK3,5
R-HSA-9006335,Signaling by Erythropoietin,5/1291,25/10616,0.180132791963316,0.930425029793128,0.877168378256147,PIK3CD/PIK3CG/PLCG2/PIK3R5/VAV1,5
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,20/1291,133/10616,0.185172018707832,0.950386740361358,0.895987499330574,TXK/ITK/LCP2/PSMB9/CARD11/LAT2/MS4A2/RASGRP2/RASGRP1/LAT/PLCG2/PSMA8/VAV1/NFATC2/GRAP2/BTK/PSMD14/PSMD1/PSMB5/PSMC4,20
R-HSA-76002,Platelet activation, signaling and aggregation,37/1291,262/10616,0.185900792948541,0.950386740361358,0.895987499330574,LCK/PLEK/P2RY12/PCYOX1L/LCP2/PIK3CG/APBB1IP/ADRA2A/FERMT3/RASGRP2/CTSW/PTPN6/DGKA/GNG2/RASGRP1/CSK/PRKCB/LAT/PLCG2/ARRB2/GP1BA/PIK3R5/RAB27B/VAV1/GNG8/PRKCG/RAC2/RHOB/MANF/MMRN1/EGF/HSPA5/APOA1/IGF1/SERPINA3/SCG3/ITGB3,37
R-HSA-2871796,FCERI mediated MAPK activation,6/1291,32/10616,0.186397399414307,0.950386740361358,0.895987499330574,LCP2/MS4A2/LAT/PLCG2/VAV1/GRAP2,6
R-HSA-76009,Platelet Aggregation (Plug Formation),7/1291,39/10616,0.189144430230331,0.960271722707835,0.905306674606713,APBB1IP/ADRA2A/RASGRP2/RASGRP1/CSK/GP1BA/ITGB3,7
R-HSA-1482925,Acyl chain remodelling of PG,4/1291,19/10616,0.192893715276433,0.966910268980599,0.911565236749386,PLA2G2D/LPCAT4/PLA2G4D/PLA2G1B,4
R-HSA-190872,Transport of connexons to the plasma membrane,4/1291,19/10616,0.192893715276433,0.966910268980599,0.911565236749386,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-3000480,Scavenging by Class A Receptors,4/1291,19/10616,0.192893715276433,0.966910268980599,0.911565236749386,APOA1/HSP90B1/CALR/FTL,4
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,12/1291,75/10616,0.195566173519259,0.976187454373445,0.920311404796514,NEK2/MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,12
R-HSA-5673001,RAF/MAP kinase cascade,35/1291,249/10616,0.201687359902494,0.98240169806408,0.926169951036843,DUSP2/IL5RA/RASA2/EREG/IL2/CSF2/PSMB9/FGF20/APBB1IP/RASGEF1A/SPTBN2/FLT3/RASGRP1/CSK/RASGRF1/LAT/ARRB2/PSMA8/RASAL3/JAK3/FLT3LG/CSF2RB/IL2RB/CSF2RA/IL2RG/PSMD14/IRS1/PSMD1/KLB/EGF/FGF18/GFRA2/PSMB5/ITGB3/PSMC4,35
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,10/1291,61/10616,0.201730640621211,0.98240169806408,0.926169951036843,FCGR1A/FCGR3A/CD247/WIPF1/CYFIP2/CD3G/NCKAP1L/VAV1/WAS/BTK,10
R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,5/1291,26/10616,0.202239011983017,0.98240169806408,0.926169951036843,FASLG/CASP8/FAS/DCC/MAGED1,5
R-HSA-140342,Apoptosis induced DNA fragmentation,3/1291,13/10616,0.203958507529799,0.98240169806408,0.926169951036843,H1-4/H1-3/H1-5,3
R-HSA-432047,Passive transport by Aquaporins,3/1291,13/10616,0.203958507529799,0.98240169806408,0.926169951036843,AQP3/AQP9/AQP2,3
R-HSA-5357786,TNFR1-induced proapoptotic signaling,3/1291,13/10616,0.203958507529799,0.98240169806408,0.926169951036843,CASP8/TNF/TNFAIP3,3
R-HSA-68884,Mitotic Telophase/Cytokinesis,3/1291,13/10616,0.203958507529799,0.98240169806408,0.926169951036843,KIF20A/KIF23/PLK1,3
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,3/1291,13/10616,0.203958507529799,0.98240169806408,0.926169951036843,EREG/PTK6/EGF,3
R-HSA-74751,Insulin receptor signalling cascade,9/1291,54/10616,0.204253551701875,0.98240169806408,0.926169951036843,TLR9/FGF20/PDE3B/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18,9
R-HSA-9020591,Interleukin-12 signaling,8/1291,47/10616,0.206117281641827,0.987368268510041,0.930852239672766,STAT4/IL12A/LMNB1/IL12B/IFNG/LCP1/IL12RB1/TALDO1,8
R-HSA-453274,Mitotic G2-G2/M phases,28/1291,197/10616,0.214661807789658,0.999999999999475,0.942760942760448,NEK2/CENPF/CEP135/CCNA2/PLK4/CDC25C/HMMR/PSMB9/CNTRL/CDK1/FOXM1/CCNB2/PKMYT1/PLK1/PSMA8/TPX2/E2F1/MYBL2/SFI1/GTSE1/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,28
R-HSA-1483206,Glycerophospholipid biosynthesis,19/1291,129/10616,0.218695469916585,0.999999999999475,0.942760942760448,PLA2G2D/OSBPL10/LIPH/ACHE/PLD4/LPCAT4/PLA2G4D/CPNE7/PLD6/MFSD2A/BCHE/PLAAT1/ETNPPL/GPAM/DGAT2/GPD1/PLA2G1B/ABHD4/LPCAT2,19
R-HSA-1500931,Cell-Cell communication,19/1291,129/10616,0.218695469916585,0.999999999999475,0.942760942760448,NECTIN4/LAMB3/FYB1/CLDN15/PTK2B/CDH17/PTPN6/CDH3/LAMA3/NPHS1/KIRREL2/TYROBP/SIRPB1/SIRPG/CDH4/ARHGEF6/FLNC/CLDN7/CLDN2,19
R-HSA-418597,G alpha (z) signalling events,8/1291,48/10616,0.222952961484968,0.999999999999475,0.942760942760448,ADCY8/ADRA2A/GNG2/PRKCB/ADCY7/GNG8/PRKCG/RGS19,8
R-HSA-1538133,G0 and Early G1,5/1291,27/10616,0.225191982399559,0.999999999999475,0.942760942760448,CCNA2/CDK1/TOP2A/E2F1/MYBL2,5
R-HSA-354192,Integrin alphaIIb beta3 signaling,5/1291,27/10616,0.225191982399559,0.999999999999475,0.942760942760448,APBB1IP/RASGRP2/RASGRP1/CSK/ITGB3,5
R-HSA-9006921,Integrin signaling,5/1291,27/10616,0.225191982399559,0.999999999999475,0.942760942760448,APBB1IP/RASGRP2/RASGRP1/CSK/ITGB3,5
R-HSA-192105,Synthesis of bile acids and bile salts,6/1291,34/10616,0.226414393906844,0.999999999999475,0.942760942760448,ABCB11/NR1H4/HSD17B4/AKR1C1/AKR1C2/AKR1C3,6
R-HSA-5607764,CLEC7A (Dectin-1) signaling,15/1291,100/10616,0.230335486968403,0.999999999999475,0.942760942760448,IL1B/CASP8/PSMB9/CARD11/CARD9/NFKB2/CLEC7A/PYCARD/PLCG2/PSMA8/NFATC2/PSMD14/PSMD1/PSMB5/PSMC4,15
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,10/1291,63/10616,0.231108055696717,0.999999999999475,0.942760942760448,ST6GAL1/ST8SIA4/ST8SIA1/ST8SIA2/RENBP/UAP1/GMPPB/SLC17A5/ST3GAL1/ST8SIA3,10
R-HSA-5578775,Ion homeostasis,9/1291,56/10616,0.235810773838669,0.999999999999475,0.942760942760448,ATP1A4/FXYD2/ATP2A3/FXYD7/ATP1A3/ATP1A1/ATP1B3/TRDN/ATP2A2,9
R-HSA-73886,Chromosome Maintenance,16/1291,108/10616,0.236053152735951,0.999999999999475,0.942760942760448,H2BC21/H2BU1/CENPA/HJURP/CENPU/TERT/CENPK/CENPH/H2BC4/H2BC5/H2BC11/H2BC13/KNL1/OIP5/CENPM/CENPI,16
R-HSA-162594,Early Phase of HIV Life Cycle,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,CXCR4/CCR5/CD4,3
R-HSA-162658,Golgi Cisternae Pericentriolar Stack Reorganization,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,CDK1/CCNB2/PLK1,3
R-HSA-190322,FGFR4 ligand binding and activation,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-193775,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,AKR1C1/AKR1C2/AKR1C3,3
R-HSA-3371568,Attenuation phase,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,HSPA1A/HSPA1B/DNAJB1,3
R-HSA-419408,Lysosphingolipid and LPA receptors,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,LPAR3/S1PR4/S1PR5,3
R-HSA-6804759,Regulation of TP53 Activity through Association with Co-factors,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,TP73/TP63/POU4F1,3
R-HSA-8983432,Interleukin-15 signaling,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,JAK3/IL2RB/IL2RG,3
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,3/1291,14/10616,0.23766471056156,0.999999999999475,0.942760942760448,TLR9/TLR7/TLR8,3
R-HSA-68949,Orc1 removal from chromatin,11/1291,71/10616,0.240586603759736,0.999999999999475,0.942760942760448,ORC1/CCNA2/PSMB9/ORC6/CDT1/PSMA8/MCM8/PSMD14/PSMD1/PSMB5/PSMC4,11
R-HSA-5683057,MAPK family signaling cascades,40/1291,294/10616,0.245183024760002,0.999999999999475,0.942760942760448,IL6R/DUSP2/IL5RA/RASA2/EREG/IL2/CSF2/PSMB9/FGF20/APBB1IP/RASGEF1A/CDK1/SPTBN2/FLT3/RASGRP1/CSK/RASGRF1/LAT/ARRB2/IGF2BP1/PSMA8/DNAJB1/RASAL3/JAK3/FLT3LG/CSF2RB/IL2RB/CSF2RA/IL2RG/PSMD14/IRS1/PSMD1/KLB/EGF/FGF18/GFRA2/PSMB5/ETV4/ITGB3/PSMC4,40
R-HSA-5334118,DNA methylation,10/1291,64/10616,0.246371286295373,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/DNMT3L,10
R-HSA-189200,Cellular hexose transport,4/1291,21/10616,0.247046116010171,0.999999999999475,0.942760942760448,SLC2A6/SLC5A2/SLC5A10/SLC2A7,4
R-HSA-389513,CTLA4 inhibitory signaling,4/1291,21/10616,0.247046116010171,0.999999999999475,0.942760942760448,LCK/CTLA4/CD80/CD86,4
R-HSA-168638,NOD1/2 Signaling Pathway,6/1291,35/10616,0.24738315876868,0.999999999999475,0.942760942760448,CASP8/TNFAIP3/CARD9/BIRC3/CASP1/NOD2,6
R-HSA-416482,G alpha (12/13) signalling events,12/1291,79/10616,0.24865419427975,0.999999999999475,0.942760942760448,FGD2/FGD3/GNG2/VAV1/ARHGEF1/GNG8/TIAM1/BTK/ARHGEF6/RHOB/ADRA1B/ARHGEF5,12
R-HSA-1482788,Acyl chain remodelling of PC,5/1291,28/10616,0.248864415491312,0.999999999999475,0.942760942760448,PLA2G2D/LPCAT4/PLA2G4D/PLA2G1B/LPCAT2,5
R-HSA-3295583,TRP channels,5/1291,28/10616,0.248864415491312,0.999999999999475,0.942760942760448,MCOLN2/TRPM8/MLKL/TRPV3/TRPM2,5
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,11/1291,72/10616,0.255202044721237,0.999999999999475,0.942760942760448,MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,11
R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),8/1291,50/10616,0.258020508146279,0.999999999999475,0.942760942760448,FCGR1A/CD207/PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,12/1291,80/10616,0.262694153226224,0.999999999999475,0.942760942760448,MAD2L1/CCNA2/PSMB9/CDK1/BUB1B/PLK1/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,12
R-HSA-69275,G2/M Transition,27/1291,195/10616,0.263439819098713,0.999999999999475,0.942760942760448,NEK2/CENPF/CEP135/CCNA2/PLK4/CDC25C/HMMR/PSMB9/CNTRL/CDK1/FOXM1/CCNB2/PKMYT1/PLK1/PSMA8/TPX2/MYBL2/SFI1/GTSE1/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,27
R-HSA-1660661,Sphingolipid de novo biosynthesis,7/1291,43/10616,0.263664305865862,0.999999999999475,0.942760942760448,SPTSSB/CERS3/ACER1/PLPP3/SGMS2/PLPP1/ORMDL2,7
R-HSA-1483257,Phospholipid metabolism,29/1291,211/10616,0.267421669806571,0.999999999999475,0.942760942760448,PIK3CD/PLA2G2D/TNFAIP8L2/INPP5D/OSBPL10/LIPH/TNFAIP8/ACHE/PIK3CG/PIP4K2A/GDPD5/PLD4/LPCAT4/PLA2G4D/GDPD3/CPNE7/PIK3R5/PLD6/MFSD2A/BCHE/PLAAT1/ETNPPL/GPAM/DGAT2/GPD1/PLA2G1B/ABHD4/LPCAT2/INPP5J,29
R-HSA-453279,Mitotic G1-G1/S phases,21/1291,149/10616,0.267447808789935,0.999999999999475,0.942760942760448,E2F2/ORC1/CDC7/RRM2/CCNA2/PSMB9/CDKN2A/CDK1/ORC6/CDT1/TOP2A/MCM8/E2F1/MYBL2/PTK6/CDC45/RPA4/PSMD14/PSMD1/PSMB5/PSMC4,21
R-HSA-5357801,Programmed Cell Death,25/1291,180/10616,0.268202029319892,0.999999999999475,0.942760942760448,TP73/CLSPN/FASLG/CASP8/TP63/LMNB1/H1-4/H1-3/H1-5/PSMB9/CDKN2A/FAS/BIRC3/MLKL/PSMA8/DCC/PMAIP1/CARD8/E2F1/STK26/PSMD14/PSMD1/PSMB5/PSMC4/MAGED1,25
R-HSA-2299718,Condensation of Prophase Chromosomes,11/1291,73/10616,0.270114387537895,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/CDK1/PLK1,11
R-HSA-2214320,Anchoring fibril formation,3/1291,15/10616,0.272211290220505,0.999999999999475,0.942760942760448,LAMB3/COL7A1/LAMA3,3
R-HSA-5099900,WNT5A-dependent internalization of FZD4,3/1291,15/10616,0.272211290220505,0.999999999999475,0.942760942760448,PRKCB/ARRB2/PRKCG,3
R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,3/1291,15/10616,0.272211290220505,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-975577,N-Glycan antennae elongation,3/1291,15/10616,0.272211290220505,0.999999999999475,0.942760942760448,ST6GAL1/ST8SIA2/ST8SIA3,3
R-HSA-389977,Post-chaperonin tubulin folding pathway,4/1291,22/10616,0.275256032347462,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-1461973,Defensins,8/1291,51/10616,0.276154217447457,0.999999999999475,0.942760942760448,CCR2/TLR1/TLR2/CCR6/CD4/DEFB124/DEFB131A/PRSS3,8
R-HSA-69306,DNA Replication,18/1291,127/10616,0.279487585390942,0.999999999999475,0.942760942760448,E2F2/ORC1/CDC7/CCNA2/PSMB9/ORC6/CDT1/PSMA8/MCM8/GINS1/E2F1/UBE2C/CDC45/RPA4/PSMD14/PSMD1/PSMB5/PSMC4,18
R-HSA-211859,Biological oxidations,30/1291,221/10616,0.286587325778589,0.999999999999475,0.942760942760448,UGT3A2/TBXAS1/AOC1/ACY3/NR1H4/DPEP3/DPEP2/CYP4F8/CYP4F3/CYP4F12/CYP2S1/CYP4B1/GCLM/MGST3/EPHX1/POMC/UGT1A1/ACY1/UGDH/TPMT/GCLC/POR/CYP51A1/GSTP1/NNMT/MGST1/CYP27B1/CYP19A1/ACSM2A/SULT1A2,30
R-HSA-5083635,Defective B3GALTL causes Peters-plus syndrome (PpS),6/1291,37/10616,0.290803487782722,0.999999999999475,0.942760942760448,ADAMTS14/ADAMTS10/CFP/ADAMTS4/ADAMTS16/ADAMTS15,6
R-HSA-5685938,HDR through Single Strand Annealing (SSA),6/1291,37/10616,0.290803487782722,0.999999999999475,0.942760942760448,EXO1/ATM/RAD51/BLM/RMI2/BRIP1,6
R-HSA-5689901,Metalloprotease DUBs,6/1291,37/10616,0.290803487782722,0.999999999999475,0.942760942760448,H2AW/NLRP3/H2AC11/H2AC13/STAMBPL1/PSMD14,6
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,10/1291,67/10616,0.294078406087127,0.999999999999475,0.942760942760448,COL7A1/COL19A1/COL9A1/COL26A1/COL22A1/ADAMTS14/COL8A1/PCOLCE2/PLOD2/PPIB,10
R-HSA-5685942,HDR through Homologous Recombination (HRR),10/1291,67/10616,0.294078406087127,0.999999999999475,0.942760942760448,EXO1/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/EME1/BRIP1,10
R-HSA-381070,IRE1alpha activates chaperones,8/1291,52/10616,0.294620361181937,0.999999999999475,0.942760942760448,ERN1/PDIA6/DNAJB11/WFS1/HSPA5/HYOU1/DNAJC3/MYDGF,8
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,13/1291,90/10616,0.296859292269498,0.999999999999475,0.942760942760448,RUNX3/H3C13/H2BC21/H2BU1/LEF1/TERT/TCF7/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12,13
R-HSA-5693538,Homology Directed Repair,19/1291,137/10616,0.305532443293208,0.999999999999475,0.942760942760448,CLSPN/H2BC21/H2BU1/EXO1/POLQ/CCNA2/H2BC4/H2BC5/H2BC11/H2BC13/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/EME1/BRIP1,19
R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,3/1291,16/10616,0.307229644406658,0.999999999999475,0.942760942760448,FASLG/CASP8/FAS,3
R-HSA-1834941,STING mediated induction of host immune responses,3/1291,16/10616,0.307229644406658,0.999999999999475,0.942760942760448,CGAS/NLRC3/NLRP4,3
R-HSA-168898,Toll-like Receptor Cascades,21/1291,153/10616,0.310161391307215,0.999999999999475,0.942760942760448,CTSS/CASP8/TLR9/TLR10/TLR1/TLR6/TLR2/CD180/LY86/NFKB2/SIGIRR/BIRC3/ITGAM/NOD2/PLCG2/ITGB2/TLR7/TLR8/BTK/HSP90B1/LGMN,21
R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,6/1291,38/10616,0.31307775215871,0.999999999999475,0.942760942760448,ADAMTS14/ADAMTS10/CFP/ADAMTS4/ADAMTS16/ADAMTS15,6
R-HSA-8978868,Fatty acid metabolism,24/1291,177/10616,0.315526044601579,0.999999999999475,0.942760942760448,THEM5/ACSL6/TBXAS1/PTGDS/ALOX5/ALOX5AP/DPEP3/DPEP2/ALOX12/ALOX15B/ACSBG2/CYP4F8/CYP4F3/ELOVL1/CYP4B1/HSD17B4/CROT/PON3/AKR1C3/THRSP/ACOT1/FASN/ACAA2/CBR1,24
R-HSA-1296065,Inwardly rectifying K+ channels,5/1291,31/10616,0.322919465117699,0.999999999999475,0.942760942760448,KCNJ5/GNG2/GNG8/GABBR2/ABCC8,5
R-HSA-2022928,HS-GAG biosynthesis,5/1291,31/10616,0.322919465117699,0.999999999999475,0.942760942760448,GPC2/HS3ST3A1/HS3ST3B1/HS6ST2/HS3ST5,5
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),18/1291,131/10616,0.326690477991584,0.999999999999475,0.942760942760448,CLSPN/H2BC21/H2BU1/EXO1/CCNA2/H2BC4/H2BC5/H2BC11/H2BC13/XRCC2/ATM/RAD51AP1/BRCA2/RAD51/BLM/RMI2/EME1/BRIP1,18
R-HSA-174824,Plasma lipoprotein assembly, remodeling, and clearance,10/1291,69/10616,0.327145000966539,0.999999999999475,0.942760942760448,SOAT2/LMF1/APOBR/APOC2/CIDEC/LPL/APOA1/LIPG/ANGPTL4/LDLR,10
R-HSA-977225,Amyloid fiber formation,15/1291,108/10616,0.33191105421982,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/NAT8/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/SORL1/LYZ/B2M/CALCA/APOA1,15
R-HSA-5619084,ABC transporter disorders,11/1291,77/10616,0.332168931918266,0.999999999999475,0.942760942760448,ABCB11/PSMB9/ABCB4/PSMA8/PSMD14/ABCB6/PSMD1/ABCC8/APOA1/PSMB5/PSMC4,11
R-HSA-3371571,HSF1-dependent transactivation,4/1291,24/10616,0.332942939618382,0.999999999999475,0.942760942760448,HSPA1A/HSPA1B/DNAJB1/CRYAB,4
R-HSA-977068,Termination of O-glycan biosynthesis,4/1291,24/10616,0.332942939618382,0.999999999999475,0.942760942760448,ST6GAL1/MUC19/MUC16/ST3GAL1,4
R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,6/1291,39/10616,0.335611083418416,0.999999999999475,0.942760942760448,TTLL2/AGBL2/TUBB2A/TUBB4B/TUBA1B/TUBA1C,6
R-HSA-977444,GABA B receptor activation,6/1291,39/10616,0.335611083418416,0.999999999999475,0.942760942760448,ADCY8/KCNJ5/GNG2/ADCY7/GNG8/GABBR2,6
R-HSA-991365,Activation of GABAB receptors,6/1291,39/10616,0.335611083418416,0.999999999999475,0.942760942760448,ADCY8/KCNJ5/GNG2/ADCY7/GNG8/GABBR2,6
R-HSA-73728,RNA Polymerase I Promoter Opening,9/1291,62/10616,0.338801083894365,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12,9
R-HSA-1482922,Acyl chain remodelling of PI,3/1291,17/10616,0.342387694453176,0.999999999999475,0.942760942760448,PLA2G2D/PLA2G4D/PLA2G1B,3
R-HSA-2142845,Hyaluronan metabolism,3/1291,17/10616,0.342387694453176,0.999999999999475,0.942760942760448,HMMR/HYAL2/LYVE1,3
R-HSA-432142,Platelet sensitization by LDL,3/1291,17/10616,0.342387694453176,0.999999999999475,0.942760942760448,FGR/PTPN6/LRP8,3
R-HSA-110056,MAPK3 (ERK1) activation,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,IL6R/CDK1,2
R-HSA-1462054,Alpha-defensins,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,CD4/PRSS3,2
R-HSA-170660,Adenylate cyclase activating pathway,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,ADCY8/ADCY7,2
R-HSA-193697,p75NTR regulates axonogenesis,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,OMG/MAG,2
R-HSA-194002,Glucocorticoid biosynthesis,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,HSD11B1/POMC,2
R-HSA-418889,Caspase activation via Dependence Receptors in the absence of ligand,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,DCC/MAGED1,2
R-HSA-419771,Opsins,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,OPN1SW/OPN4,2
R-HSA-428542,Regulation of commissural axon pathfinding by SLIT and ROBO,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,ROBO2/DCC,2
R-HSA-5687613,Diseases associated with surfactant metabolism,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,CSF2RB/CSF2RA,2
R-HSA-75072,mRNA Editing,2/1291,10/10616,0.347987222224572,0.999999999999475,0.942760942760448,APOBEC3A/APOBEC3H,2
R-HSA-5626467,RHO GTPases activate IQGAPs,5/1291,32/10616,0.348201329136846,0.999999999999475,0.942760942760448,IQGAP3/TUBB2A/TUBB4B/TUBA1B/TUBA1C,5
R-HSA-5621481,C-type lectin receptors (CLRs),19/1291,141/10616,0.352445961387211,0.999999999999475,0.942760942760448,IL1B/CASP8/PSMB9/CARD11/CARD9/NFKB2/CLEC7A/MUC19/PYCARD/PLCG2/CLEC10A/PSMA8/MUC16/ICAM3/NFATC2/PSMD14/PSMD1/PSMB5/PSMC4,19
R-HSA-3214815,HDACs deacetylate histones,13/1291,94/10616,0.3544544746746,0.999999999999475,0.942760942760448,H2BC18/H3C13/H2BC21/H2AW/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2AC11/H2BC13/H2AC13/H3C12,13
R-HSA-69473,G2/M DNA damage checkpoint,13/1291,94/10616,0.3544544746746,0.999999999999475,0.942760942760448,H2BC21/H2BU1/EXO1/CDC25C/H2BC4/H2BC5/H2BC11/H2BC13/CDK1/ATM/BLM/RMI2/BRIP1,13
R-HSA-913709,O-linked glycosylation of mucins,9/1291,63/10616,0.356749921927307,0.999999999999475,0.942760942760448,ST6GAL1/GCNT4/MUC19/CHST4/MUC16/B3GNT3/GALNT17/ST3GAL1/GALNT9,9
R-HSA-1296041,Activation of G protein gated Potassium channels,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,KCNJ5/GNG2/GNG8/GABBR2,4
R-HSA-1296059,G protein gated Potassium channels,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,KCNJ5/GNG2/GNG8/GABBR2,4
R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,NEK2/MAD2L1/BUB1B/UBE2C,4
R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-392451,G beta:gamma signalling through PI3Kgamma,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,PIK3CG/GNG2/PIK3R5/GNG8,4
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,IKZF1/DLGAP5/HEYL/HES1,4
R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,4/1291,25/10616,0.362049634409824,0.999999999999475,0.942760942760448,KCNJ5/GNG2/GNG8/GABBR2,4
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,8/1291,56/10616,0.370779107837408,0.999999999999475,0.942760942760448,HSPA1A/HSPA1B/PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-5173105,O-linked glycosylation,15/1291,111/10616,0.37253417469475,0.999999999999475,0.942760942760448,ST6GAL1/GCNT4/ADAMTS14/MUC19/CHST4/ADAMTS10/MUC16/B3GNT3/CFP/ADAMTS4/ADAMTS16/GALNT17/ST3GAL1/ADAMTS15/GALNT9,15
R-HSA-163359,Glucagon signaling in metabolic regulation,5/1291,33/10616,0.373584200495234,0.999999999999475,0.942760942760448,ADCY8/GNG2/ADCY7/GCGR/GNG8,5
R-HSA-352230,Amino acid transport across the plasma membrane,5/1291,33/10616,0.373584200495234,0.999999999999475,0.942760942760448,SLC6A20/SLC7A7/SLC7A5/SLC7A11/SLC7A10,5
R-HSA-5357905,Regulation of TNFR1 signaling,5/1291,33/10616,0.373584200495234,0.999999999999475,0.942760942760448,CASP8/TNF/TNFAIP3/TRAF1/BIRC3,5
R-HSA-1442490,Collagen degradation,9/1291,64/10616,0.37481188048526,0.999999999999475,0.942760942760448,COL7A1/COL19A1/COL9A1/COL26A1/MMP9/MMP11/COL8A1/MMP3/ELANE,9
R-HSA-8957322,Metabolism of steroids,20/1291,151/10616,0.377052411805887,0.999999999999475,0.942760942760448,ABCB11/SLCO1A2/NR1H4/STARD5/DHCR24/HSD11B1/POMC/HSD17B4/CYP51A1/AKR1B15/AKR1C1/AKR1C2/AKR1C3/GPAM/CYP27B1/LGMN/CYP19A1/ABCC3/FASN/NSDHL,20
R-HSA-1369062,ABC transporters in lipid homeostasis,3/1291,18/10616,0.377391388309284,0.999999999999475,0.942760942760448,ABCD2/ABCA7/APOA1,3
R-HSA-1912420,Pre-NOTCH Processing in Golgi,3/1291,18/10616,0.377391388309284,0.999999999999475,0.942760942760448,LFNG/ATP2A3/ATP2A2,3
R-HSA-210993,Tie2 Signaling,3/1291,18/10616,0.377391388309284,0.999999999999475,0.942760942760448,DOK2/GRB14/ANGPT4,3
R-HSA-5635838,Activation of SMO,3/1291,18/10616,0.377391388309284,0.999999999999475,0.942760942760448,GRK2/ARRB2/DHH,3
R-HSA-8964315,G beta:gamma signalling through BTK,3/1291,18/10616,0.377391388309284,0.999999999999475,0.942760942760448,GNG2/GNG8/BTK,3
R-HSA-212300,PRC2 methylates histones and DNA,10/1291,72/10616,0.37794657450956,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/EZH2,10
R-HSA-8854518,AURKA Activation by TPX2,10/1291,72/10616,0.37794657450956,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/HMMR/CNTRL/CDK1/PLK1/TPX2/SFI1/TUBB4B,10
R-HSA-1461957,Beta defensins,6/1291,41/10616,0.381115665541505,0.999999999999475,0.942760942760448,CCR2/TLR1/TLR2/CCR6/DEFB124/DEFB131A,6
R-HSA-418346,Platelet homeostasis,12/1291,88/10616,0.38238732295922,0.999999999999475,0.942760942760448,FGR/PTPN6/P2RX7/P2RX2/GNG2/P2RX5/P2RX1/ATP2A3/GNG8/P2RX6/LRP8/ATP2A2,12
R-HSA-8878159,Transcriptional regulation by RUNX3,13/1291,96/10616,0.383964045449597,0.999999999999475,0.942760942760448,RUNX3/ITGA4/SPP1/LEF1/TCF7/PSMB9/CDKN2A/ITGAL/PSMD14/PSMD1/HES1/PSMB5/PSMC4,13
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,7/1291,49/10616,0.386351243605446,0.999999999999475,0.942760942760448,CCNA2/CDC25C/CDK1/E2F8/E2F7/E2F1/RGCC,7
R-HSA-69541,Stabilization of p53,8/1291,57/10616,0.390137506639299,0.999999999999475,0.942760942760448,PSMB9/CDKN2A/ATM/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-1187000,Fertilization,4/1291,26/10616,0.391106111214698,0.999999999999475,0.942760942760448,OVGP1/HVCN1/ZP1/CATSPERB,4
R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,4/1291,26/10616,0.391106111214698,0.999999999999475,0.942760942760448,ST6GAL1/ST8SIA2/MGAT3/ST8SIA3,4
R-HSA-373755,Semaphorin interactions,9/1291,65/10616,0.392946219901725,0.999999999999475,0.942760942760448,PTPRC/TREM2/CD72/SEMA4D/PLXNC1/SEMA7A/CDK5R1/TYROBP/RHOB,9
R-HSA-196791,Vitamin D (calciferol) metabolism,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,CYP27B1/LGMN,2
R-HSA-2468052,Establishment of Sister Chromatid Cohesion,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,ESCO2/CDCA5,2
R-HSA-2534343,Interaction With Cumulus Cells And The Zona Pellucida,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,OVGP1/ZP1,2
R-HSA-446107,Type I hemidesmosome assembly,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,LAMB3/LAMA3,2
R-HSA-71288,Creatine metabolism,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,CKMT1B/CKMT1A,2
R-HSA-9020956,Interleukin-27 signaling,2/1291,11/10616,0.394050954843802,0.999999999999475,0.942760942760448,EBI3/IL27RA,2
R-HSA-5693607,Processing of DNA double-strand break ends,13/1291,97/10616,0.398819095900786,0.999999999999475,0.942760942760448,CLSPN/H2BC21/H2BU1/EXO1/CCNA2/H2BC4/H2BC5/H2BC11/H2BC13/ATM/BLM/RMI2/BRIP1,13
R-HSA-8953750,Transcriptional Regulation by E2F6,5/1291,34/10616,0.398958305079438,0.999999999999475,0.942760942760448,CDC7/RRM2/EZH2/RAD51/E2F1,5
R-HSA-211945,Phase I - Functionalization of compounds,14/1291,105/10616,0.399508710700855,0.999999999999475,0.942760942760448,TBXAS1/AOC1/NR1H4/CYP4F8/CYP4F3/CYP4F12/CYP2S1/CYP4B1/EPHX1/POMC/POR/CYP51A1/CYP27B1/CYP19A1,14
R-HSA-109581,Apoptosis,23/1291,177/10616,0.400169508463234,0.999999999999475,0.942760942760448,TP73/CLSPN/FASLG/CASP8/TP63/LMNB1/H1-4/H1-3/H1-5/PSMB9/CDKN2A/FAS/PSMA8/DCC/PMAIP1/CARD8/E2F1/STK26/PSMD14/PSMD1/PSMB5/PSMC4/MAGED1,23
R-HSA-162909,Host Interactions of HIV factors,17/1291,129/10616,0.400575650864705,0.999999999999475,0.942760942760448,LCK/CD247/CD8B/CD28/NUP210/DOCK2/PSMB9/CD4/B2M/PSMA8/HCK/APOBEC3G/PSMD14/PSMD1/PSMB5/AP1M2/PSMC4,17
R-HSA-193648,NRAGE signals death through JNK,8/1291,58/10616,0.409524579118363,0.999999999999475,0.942760942760448,FGD2/FGD3/VAV1/ARHGEF1/TIAM1/ARHGEF6/ARHGEF5/MAGED1,8
R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,9/1291,66/10616,0.411113064456792,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12,9
R-HSA-69563,p53-Dependent G1 DNA Damage Response,9/1291,66/10616,0.411113064456792,0.999999999999475,0.942760942760448,CCNA2/PSMB9/CDKN2A/ATM/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,9/1291,66/10616,0.411113064456792,0.999999999999475,0.942760942760448,CCNA2/PSMB9/CDKN2A/ATM/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-176412,Phosphorylation of the APC/C,3/1291,19/10616,0.411984702002943,0.999999999999475,0.942760942760448,CDK1/PLK1/UBE2C,3
R-HSA-5686938,Regulation of TLR by endogenous ligand,3/1291,19/10616,0.411984702002943,0.999999999999475,0.942760942760448,TLR1/TLR6/TLR2,3
R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),3/1291,19/10616,0.411984702002943,0.999999999999475,0.942760942760448,ALOX5/ALOX5AP/ALOX12,3
R-HSA-69052,Switching of origins to a post-replicative state,12/1291,90/10616,0.413437795780729,0.999999999999475,0.942760942760448,ORC1/CCNA2/PSMB9/ORC6/CDT1/PSMA8/MCM8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,12
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,14/1291,106/10616,0.413825549574658,0.999999999999475,0.942760942760448,TACR1/EREG/IL7R/KIAA0319/SYT8/GRK2/CD3D/CD3G/CD4/ARRB2/FCHO1/AGTR1/EGF/LDLR,14
R-HSA-211976,Endogenous sterols,4/1291,27/10616,0.419960742312983,0.999999999999475,0.942760942760448,NR1H4/POMC/CYP51A1/CYP19A1,4
R-HSA-5621480,Dectin-2 family,4/1291,27/10616,0.419960742312983,0.999999999999475,0.942760942760448,MUC19/PLCG2/CLEC10A/MUC16,4
R-HSA-69206,G1/S Transition,17/1291,131/10616,0.426442072759589,0.999999999999475,0.942760942760448,ORC1/CDC7/RRM2/CCNA2/PSMB9/CDK1/ORC6/CDT1/MCM8/E2F1/PTK6/CDC45/RPA4/PSMD14/PSMD1/PSMB5/PSMC4,17
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,6/1291,43/10616,0.426669662074793,0.999999999999475,0.942760942760448,ADCY8/AQP3/GNG2/ADCY7/GNG8/AQP2,6
R-HSA-75893,TNF signaling,6/1291,43/10616,0.426669662074793,0.999999999999475,0.942760942760448,CASP8/TNF/TNFAIP3/TRAF1/BIRC3/SMPD3,6
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,16/1291,123/10616,0.427058975114008,0.999999999999475,0.942760942760448,CD38/SLC23A1/VNN1/VNN2/ENPP2/SLC52A1/ACP5/CTRC/NMNAT2/AOX1/PRSS1/PRSS3/NNMT/CTRB2/CTRB1/FASN,16
R-HSA-350562,Regulation of ornithine decarboxylase (ODC),7/1291,51/10616,0.428097214764262,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/NQO1/PSMC4,7
R-HSA-194138,Signaling by VEGF,14/1291,107/10616,0.428160961391477,0.999999999999475,0.942760942760448,SH2D2A/NCF2/CYFIP2/NCF1/PTK2B/NCKAP1L/PRKCB/VAV1/TRIB3/NCF4/CYBB/KDR/PGF/ITGB3,14
R-HSA-4420097,VEGFA-VEGFR2 Pathway,13/1291,99/10616,0.428620362844815,0.999999999999475,0.942760942760448,SH2D2A/NCF2/CYFIP2/NCF1/PTK2B/NCKAP1L/PRKCB/VAV1/TRIB3/NCF4/CYBB/KDR/ITGB3,13
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),11/1291,83/10616,0.429255706450398,0.999999999999475,0.942760942760448,PSMB9/NFKBIE/CARD11/RASGRP1/PRKCB/PSMA8/NFATC2/PSMD14/PSMD1/PSMB5/PSMC4,11
R-HSA-1169091,Activation of NF-kappaB in B cells,9/1291,67/10616,0.429273614893464,0.999999999999475,0.942760942760448,PSMB9/NFKBIE/CARD11/PRKCB/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-427359,SIRT1 negatively regulates rRNA expression,9/1291,67/10616,0.429273614893464,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12,9
R-HSA-73887,Death Receptor Signalling,18/1291,140/10616,0.43836877205622,0.999999999999475,0.942760942760448,FASLG/CASP8/TNF/FGD2/TNFAIP3/FGD3/TRAF1/FAS/BIRC3/SMPD3/OMG/VAV1/ARHGEF1/TIAM1/ARHGEF6/ARHGEF5/MAG/MAGED1,18
R-HSA-174403,Glutathione synthesis and recycling,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,GCLM/GCLC,2
R-HSA-1839130,Signaling by activated point mutants of FGFR3,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-2033514,FGFR3 mutant receptor activation,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,FCER2/HES1,2
R-HSA-4641265,Repression of WNT target genes,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,LEF1/TCF7,2
R-HSA-5578768,Physiological factors,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,NPPC/TBX5,2
R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,SLC28A3/SLC29A4,2
R-HSA-879518,Transport of organic anions,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,SLCO1A2/SLCO2A1,2
R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,2/1291,12/10616,0.438562289722522,0.999999999999475,0.942760942760448,TFAP2E/CITED1,2
R-HSA-8856688,Golgi-to-ER retrograde transport,17/1291,132/10616,0.439396233336759,0.999999999999475,0.942760942760448,KIF2C/KIF21B/KIF15/CENPE/KIF20A/KIFC1/KIF25/KIF11/RACGAP1/KIF23/KIF18B/KIF19/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C,17
R-HSA-163685,Integration of energy metabolism,14/1291,108/10616,0.442496053948957,0.999999999999475,0.942760942760448,ADCY8/ADRA2A/GNG2/AKAP5/PLCB2/ADCY7/GCGR/GNG8/SNAP25/TKT/ADIPOQ/TALDO1/ABCC8/FASN,14
R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,MAD2L1/BUB1B/UBE2C,3
R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,MAD2L1/BUB1B/UBE2C,3
R-HSA-190241,FGFR2 ligand binding and activation,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,FGF20/FGFBP1/FGF18,3
R-HSA-418217,G beta:gamma signalling through PLC beta,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,GNG2/PLCB2/GNG8,3
R-HSA-5654719,SHC-mediated cascade:FGFR4,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-5654720,PI-3K cascade:FGFR4,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-8964616,G beta:gamma signalling through CDC42,3/1291,20/10616,0.445948554071571,0.999999999999475,0.942760942760448,GNG2/GNG8/ARHGEF6,3
R-HSA-5693532,DNA Double-Strand Break Repair,21/1291,165/10616,0.446945126661586,0.999999999999475,0.942760942760448,CLSPN/H2BC21/H2BU1/EXO1/POLQ/CCNA2/H2BC4/H2BC5/H2BC11/H2BC13/XRCC2/ATM/RAD51AP1/BRCA2/TDP1/RAD51/BLM/RMI2/EME1/BRIP1/EYA1,21
R-HSA-3906995,Diseases associated with O-glycosylation of proteins,9/1291,68/10616,0.447390338946471,0.999999999999475,0.942760942760448,LFNG/ADAMTS14/MUC19/ADAMTS10/MUC16/CFP/ADAMTS4/ADAMTS16/ADAMTS15,9
R-HSA-69615,G1/S DNA Damage Checkpoints,9/1291,68/10616,0.447390338946471,0.999999999999475,0.942760942760448,CCNA2/PSMB9/CDKN2A/ATM/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-180534,Vpu mediated degradation of CD4,7/1291,52/10616,0.448860280877068,0.999999999999475,0.942760942760448,PSMB9/CD4/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-2980766,Nuclear Envelope Breakdown,7/1291,52/10616,0.448860280877068,0.999999999999475,0.942760942760448,NUP210/LMNB1/CDK1/TMPO/CCNB2/PLK1/PRKCB,7
R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,7/1291,52/10616,0.448860280877068,0.999999999999475,0.942760942760448,PSMB9/ATM/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-445717,Aquaporin-mediated transport,7/1291,52/10616,0.448860280877068,0.999999999999475,0.942760942760448,ADCY8/AQP3/GNG2/AQP9/ADCY7/GNG8/AQP2,7
R-HSA-75153,Apoptotic execution phase,7/1291,52/10616,0.448860280877068,0.999999999999475,0.942760942760448,CLSPN/CASP8/LMNB1/H1-4/H1-3/H1-5/STK26,7
R-HSA-111933,Calmodulin induced events,5/1291,36/10616,0.449276485359004,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/ADCY7/PRKCG,5
R-HSA-111997,CaM pathway,5/1291,36/10616,0.449276485359004,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/ADCY7/PRKCG,5
R-HSA-156590,Glutathione conjugation,5/1291,36/10616,0.449276485359004,0.999999999999475,0.942760942760448,GCLM/MGST3/GCLC/GSTP1/MGST1,5
R-HSA-190861,Gap junction assembly,5/1291,36/10616,0.449276485359004,0.999999999999475,0.942760942760448,GJA4/TUBB2A/TUBB4B/TUBA1B/TUBA1C,5
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,5/1291,36/10616,0.449276485359004,0.999999999999475,0.942760942760448,WIPF1/CYFIP2/NCKAP1L/WAS/BTK,5
R-HSA-8948216,Collagen chain trimerization,6/1291,44/10616,0.449279294581654,0.999999999999475,0.942760942760448,COL7A1/COL19A1/COL9A1/COL26A1/COL22A1/COL8A1,6
R-HSA-195721,Signaling by WNT,41/1291,329/10616,0.458496119343248,0.999999999999475,0.942760942760448,RUNX3/RSPO1/H3C13/H2BC21/H2BU1/WNT6/WNT10A/WNT7A/LEF1/TERT/TCF7/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/WNT16/WNT8B/WNT10B/WNT1/GNG2/CCDC88C/PLCB2/KREMEN2/PRKCB/ARRB2/PDE6G/PSMA8/GNG8/PRKCG/RAC2/PSMD14/PSMD1/DKK2/WNT2/PSMB5/WNT9B/PSMC4/SOX3,41
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,8/1291,61/10616,0.467397493222074,0.999999999999475,0.942760942760448,CTSS/LAMB3/COL7A1/COL9A1/LAMA3/MMP9/COL8A1/MMP3,8
R-HSA-109606,Intrinsic Pathway for Apoptosis,7/1291,53/10616,0.469478757869058,0.999999999999475,0.942760942760448,TP73/CASP8/TP63/CDKN2A/PMAIP1/CARD8/E2F1,7
R-HSA-5689603,UCH proteinases,13/1291,102/10616,0.473232859413174,0.999999999999475,0.942760942760448,H2AW/H2AC11/H2AC13/PSMB9/PSMA8/OGT/PSMD14/PSMD1/UCHL1/MBD6/UCHL3/PSMB5/PSMC4,13
R-HSA-9619483,Activation of AMPK downstream of NMDARs,4/1291,29/10616,0.476532629928655,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,3/1291,21/10616,0.479098960415137,0.999999999999475,0.942760942760448,NFKB2/NLRP4/ZBP1,3
R-HSA-500657,Presynaptic function of Kainate receptors,3/1291,21/10616,0.479098960415137,0.999999999999475,0.942760942760448,GNG2/PLCB2/GNG8,3
R-HSA-5619115,Disorders of transmembrane transporters,22/1291,176/10616,0.479657782796112,0.999999999999475,0.942760942760448,ABCB11/NUP210/SLC6A20/PSMB9/ABCB4/SLC7A7/SLC24A5/SLC12A1/SLC5A2/SLC12A3/PSMA8/PSMD14/ABCB6/PSMD1/SLCO2A1/SLC17A5/SLC27A4/HK1/ABCC8/APOA1/PSMB5/PSMC4,22
R-HSA-1221632,Meiotic synapsis,10/1291,78/10616,0.480526182278718,0.999999999999475,0.942760942760448,H2BC21/H2BU1/LMNB1/H2BC4/H2BC5/H2BC11/H2BC13/STAG3/REC8/SMC1B,10
R-HSA-446193,Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein,10/1291,78/10616,0.480526182278718,0.999999999999475,0.942760942760448,ST6GAL1/ST8SIA4/ST8SIA1/ST8SIA2/RENBP/UAP1/GMPPB/SLC17A5/ST3GAL1/ST8SIA3,10
R-HSA-74752,Signaling by Insulin receptor,10/1291,78/10616,0.480526182278718,0.999999999999475,0.942760942760448,TLR9/FGF20/PDE3B/TCIRG1/FLT3/FLT3LG/TRIB3/IRS1/KLB/FGF18,10
R-HSA-179812,GRB2 events in EGFR signaling,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-190239,FGFR3 ligand binding and activation,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-190372,FGFR3c ligand binding and activation,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-190375,FGFR2c ligand binding and activation,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,ELOVL1/HSD17B4,2
R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,ELOVL1/HSD17B4,2
R-HSA-2995383,Initiation of Nuclear Envelope Reformation,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,LMNB1/TMPO,2
R-HSA-2995410,Nuclear Envelope Reassembly,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,LMNB1/TMPO,2
R-HSA-3270619,IRF3-mediated induction of type I IFN,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,NLRC3/NLRP4,2
R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-74217,Purine salvage,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,AMPD1/AMPD3,2
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,CDC25C/CDK1,2
R-HSA-75109,Triglyceride biosynthesis,2/1291,13/10616,0.481217522848471,0.999999999999475,0.942760942760448,GPAM/DGAT2,2
R-HSA-180585,Vif-mediated degradation of APOBEC3G,7/1291,54/10616,0.489903119388815,0.999999999999475,0.942760942760448,PSMB9/PSMA8/APOBEC3G/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-6809371,Formation of the cornified envelope,16/1291,128/10616,0.493674585861423,0.999999999999475,0.942760942760448,TCHH/CSTA/PKP2/KRT72/KRT73/KRT23/KRT17/DSC3/CELA2A/LCE1F/SPRR2F/KRT78/KRT8/KRT18/PRSS8/KLK12,16
R-HSA-111996,Ca-dependent events,5/1291,38/10616,0.49842579108963,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/ADCY7/PRKCG,5
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,5/1291,38/10616,0.49842579108963,0.999999999999475,0.942760942760448,STAT4/LMNB1/IFNG/LCP1/TALDO1,5
R-HSA-114452,Activation of BH3-only proteins,4/1291,30/10616,0.504021561198909,0.999999999999475,0.942760942760448,TP73/TP63/PMAIP1/E2F1,4
R-HSA-499943,Interconversion of nucleotide di- and triphosphates,4/1291,30/10616,0.504021561198909,0.999999999999475,0.942760942760448,RRM2/GSR/TXN/TXNRD1,4
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,4/1291,30/10616,0.504021561198909,0.999999999999475,0.942760942760448,TNF/TNFAIP3/TRAF1/BIRC3,4
R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-110331,Cleavage of the damaged purine,7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,HPSE/GPC2/HS3ST3A1/HS3ST3B1/HS6ST2/HS3ST5/CSPG4,7
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,HSPA1A/HSPA1B/DNAJB1/TUBB2A/TUBB4B/TUBA1B/TUBA1C,7
R-HSA-73927,Depurination,7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-8941858,Regulation of RUNX3 expression and activity,7/1291,55/10616,0.510087211365035,0.999999999999475,0.942760942760448,RUNX3/PSMB9/CDKN2A/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-140875,Common Pathway of Fibrin Clot Formation,3/1291,22/10616,0.511284685899507,0.999999999999475,0.942760942760448,SERPINA5/THBD/PROCR,3
R-HSA-392170,ADP signalling through P2Y purinoceptor 12,3/1291,22/10616,0.511284685899507,0.999999999999475,0.942760942760448,P2RY12/GNG2/GNG8,3
R-HSA-5654712,FRS-mediated FGFR4 signaling,3/1291,22/10616,0.511284685899507,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-9033658,Blood group systems biosynthesis,3/1291,22/10616,0.511284685899507,0.999999999999475,0.942760942760448,RHD/FUT7/FUT2,3
R-HSA-912631,Regulation of signaling by CBL,3/1291,22/10616,0.511284685899507,0.999999999999475,0.942760942760448,PIK3CD/VAV1/HCK,3
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,9/1291,72/10616,0.518721477244527,0.999999999999475,0.942760942760448,PSMB9/PLK1/AURKB/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-156581,Methylation,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,TPMT/NNMT,2
R-HSA-166786,Creation of C4 and C2 activators,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,FCN1/FCN3,2
R-HSA-170670,Adenylate cyclase inhibitory pathway,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,ADCY8/ADCY7,2
R-HSA-180336,SHC1 events in EGFR signaling,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-418359,Reduction of cytosolic Ca++ levels,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,ATP2A3/ATP2A2,2
R-HSA-5682910,LGI-ADAM interactions,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,ADAM23/STX1B,2
R-HSA-877312,Regulation of IFNG signaling,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,PTPN6/IFNG,2
R-HSA-8941856,RUNX3 regulates NOTCH signaling,2/1291,14/10616,0.521809658229623,0.999999999999475,0.942760942760448,RUNX3/HES1,2
R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),5/1291,39/10616,0.522369130453044,0.999999999999475,0.942760942760448,GP1BA/F3/SERPINA5/THBD/PROCR,5
R-HSA-6783310,Fanconi Anemia Pathway,5/1291,39/10616,0.522369130453044,0.999999999999475,0.942760942760448,FANCD2/FANCI/FANCA/EME1/FANCB,5
R-HSA-428157,Sphingolipid metabolism,11/1291,89/10616,0.5257296105691,0.999999999999475,0.942760942760448,SPTSSB/GBA3/UGCG/CERS3/SMPD3/ENPP7/ACER1/PLPP3/SGMS2/PLPP1/ORMDL2,11
R-HSA-977443,GABA receptor activation,7/1291,56/10616,0.529988369011839,0.999999999999475,0.942760942760448,ADCY8/KCNJ5/GNG2/GABRG3/ADCY7/GNG8/GABBR2,7
R-HSA-2871837,FCERI mediated NF-kB activation,10/1291,81/10616,0.530627115639335,0.999999999999475,0.942760942760448,PSMB9/CARD11/MS4A2/RASGRP2/RASGRP1/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,10
R-HSA-5339562,Uptake and actions of bacterial toxins,4/1291,31/10616,0.530851501359088,0.999999999999475,0.942760942760448,VAMP1/STX1B/SNAP25/TXNRD1,4
R-HSA-5358346,Hedgehog ligand biogenesis,8/1291,65/10616,0.542344798935638,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/DHH/PSMB5/DISP2/PSMC4,8
R-HSA-8873719,RAB geranylgeranylation,8/1291,65/10616,0.542344798935638,0.999999999999475,0.942760942760448,RAB42/RAB3B/RAB39A/RAB37/RAB27B/RAB33A/RAB39B/RAB20,8
R-HSA-112409,RAF-independent MAPK1/3 activation,3/1291,23/10616,0.542384591269839,0.999999999999475,0.942760942760448,IL6R/DUSP2/CDK1,3
R-HSA-8956321,Nucleotide salvage,3/1291,23/10616,0.542384591269839,0.999999999999475,0.942760942760448,AMPD1/AMPD3/TYMP,3
R-HSA-446728,Cell junction organization,11/1291,91/10616,0.556816184978351,0.999999999999475,0.942760942760448,NECTIN4/LAMB3/CLDN15/CDH17/CDH3/LAMA3/CDH4/ARHGEF6/FLNC/CLDN7/CLDN2,11
R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,4/1291,32/10616,0.556944383105123,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-9012852,Signaling by NOTCH3,6/1291,49/10616,0.558145582057698,0.999999999999475,0.942760942760448,TACC3/IKZF1/DLGAP5/HEYL/HES1/EGF,6
R-HSA-1912422,Pre-NOTCH Expression and Processing,13/1291,108/10616,0.560207460381667,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/LFNG/ATP2A3/E2F1/ATP2A2,13
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,13/1291,108/10616,0.560207460381667,0.999999999999475,0.942760942760448,SLC6A20/SLC15A2/SLC1A2/SLC4A8/SLC7A7/SLC24A5/SLC12A1/SLC12A3/SLC7A5/SLC12A5/SLC7A11/SLC17A5/SLC7A10,13
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,RUNX2/TBX5,2
R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,NLRP4/ZBP1,2
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins ,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,APBB1IP/ITGB3,2
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,APBB1IP/ITGB3,2
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,KREMEN2/DKK2,2
R-HSA-6785631,ERBB2 Regulates Cell Motility,2/1291,15/10616,0.560209407154103,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-8953897,Cellular responses to external stimuli,59/1291,491/10616,0.561689026081885,0.999999999999475,0.942760942760448,E2F2/H3C13/H2BC21/HSPA6/NCF2/H2BU1/NUP210/CCNA2/LMNB1/H2BC4/H1-4/H2BC5/H3C4/H1-3/H2BC11/H2BC13/H1-5/H3C12/HSPA1A/HSPA1B/PSMB9/NCF1/EZH2/CDKN2A/TCIRG1/ATM/PSMA8/DNAJB1/E2F1/UBE2C/NCF4/CYBB/PRDX1/PSMD14/PSMD1/SH3BP4/HIGD1A/TUBB2A/GSR/TXN/HSPA5/TUBB4B/BAG3/PRDX5/GSTP1/CRYAB/TUBA1B/TUBA1C/TXNRD1/PSMB5/MT2A/MT1E/MT1M/MT1A/MT1F/MT1X/PSMC4/ID1/HIRA,59
R-HSA-1483255,PI Metabolism,10/1291,83/10616,0.563095116133897,0.999999999999475,0.942760942760448,PIK3CD/TNFAIP8L2/INPP5D/TNFAIP8/PIK3CG/PIP4K2A/GDPD5/GDPD3/PIK3R5/INPP5J,10
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),15/1291,125/10616,0.563448480488437,0.999999999999475,0.942760942760448,ENAM/SPP1/GZMH/MSLN/PDIA6/SCG2/WFS1/VGF/APOA1/IGFBP6/IGF1/HSP90B1/DNAJC3/SCG3/CHGB,15
R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,9/1291,75/10616,0.57016127119032,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12,9
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,16/1291,134/10616,0.571331758728124,0.999999999999475,0.942760942760448,PLEK/PCYOX1L/FERMT3/CTSW/PRKCB/RAB27B/PRKCG/MANF/MMRN1/EGF/HSPA5/APOA1/IGF1/SERPINA3/SCG3/ITGB3,16
R-HSA-4086400,PCP/CE pathway,11/1291,92/10616,0.572063659799004,0.999999999999475,0.942760942760448,PSMB9/WNT1/PRKCB/ARRB2/PSMA8/PRKCG/RAC2/PSMD14/PSMD1/PSMB5/PSMC4,11
R-HSA-210500,Glutamate Neurotransmitter Release Cycle,3/1291,24/10616,0.572304827220048,0.999999999999475,0.942760942760448,PPFIA4/SLC1A2/SNAP25,3
R-HSA-6783589,Interleukin-6 family signaling,3/1291,24/10616,0.572304827220048,0.999999999999475,0.942760942760448,IL6R/OSM/CNTFR,3
R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,3/1291,24/10616,0.572304827220048,0.999999999999475,0.942760942760448,ACSL6/ACSBG2/ELOVL1,3
R-HSA-982772,Growth hormone receptor signaling,3/1291,24/10616,0.572304827220048,0.999999999999475,0.942760942760448,PTPN6/IRS1/CISH,3
R-HSA-2559583,Cellular Senescence,23/1291,193/10616,0.575172270910782,0.999999999999475,0.942760942760448,E2F2/H3C13/H2BC21/H2BU1/CCNA2/LMNB1/H2BC4/H1-4/H2BC5/H3C4/H1-3/H2BC11/H2BC13/H1-5/H3C12/EZH2/CDKN2A/ATM/E2F1/UBE2C/TXN/ID1/HIRA,23
R-HSA-1483249,Inositol phosphate metabolism,6/1291,50/10616,0.578723303215942,0.999999999999475,0.942760942760448,INPP5D/PLCZ1/PLD4/PLCB2/PLCG2/INPP5J,6
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,6/1291,50/10616,0.578723303215942,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-381038,XBP1(S) activates chaperone genes,6/1291,50/10616,0.578723303215942,0.999999999999475,0.942760942760448,PDIA6/DNAJB11/WFS1/HYOU1/DNAJC3/MYDGF,6
R-HSA-2559585,Oncogene Induced Senescence,4/1291,33/10616,0.582235442775452,0.999999999999475,0.942760942760448,E2F2/CDKN2A/E2F1/ID1,4
R-HSA-418990,Adherens junctions interactions,4/1291,33/10616,0.582235442775452,0.999999999999475,0.942760942760448,NECTIN4/CDH17/CDH3/CDH4,4
R-HSA-420092,Glucagon-type ligand receptors,4/1291,33/10616,0.582235442775452,0.999999999999475,0.942760942760448,GNG2/GCGR/GNG8/VIPR1,4
R-HSA-8964043,Plasma lipoprotein clearance,4/1291,33/10616,0.582235442775452,0.999999999999475,0.942760942760448,SOAT2/APOBR/APOA1/LDLR,4
R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,11/1291,93/10616,0.587089923190316,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB2A/TUBB4B/TUBA1B/TUBA1C,11
R-HSA-351202,Metabolism of polyamines,7/1291,59/10616,0.587621179786671,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/NQO1/PSMC4,7
R-HSA-5387390,Hh mutants abrogate ligand secretion,7/1291,59/10616,0.587621179786671,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/DHH/PSMB5/PSMC4,7
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,7/1291,59/10616,0.587621179786671,0.999999999999475,0.942760942760448,PSMB9/NFKB2/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-983712,Ion channel transport,22/1291,186/10616,0.589825536886372,0.999999999999475,0.942760942760448,MCOLN2/CLCA2/ATP1A4/TRPM8/ANO9/TCIRG1/FXYD2/MLKL/TRPV3/ATP2A3/ATP8B3/FXYD7/ATP1A3/TRPM2/ATP1A1/ATP1B3/TRDN/SCNN1A/ANO4/ATP2A2/ASIC2/ATP4A,22
R-HSA-1489509,DAG and IP3 signaling,5/1291,42/10616,0.590942556045847,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/ADCY7/PRKCG,5
R-HSA-375280,Amine ligand-binding receptors,5/1291,42/10616,0.590942556045847,0.999999999999475,0.942760942760448,ADRA2A/HRH4/ADRA1B/ADRB1/CHRM4,5
R-HSA-5632684,Hedgehog 'on' state,10/1291,85/10616,0.594610912147772,0.999999999999475,0.942760942760448,PSMB9/GRK2/ARRB2/PSMA8/PSMD14/PSMD1/HHIP/DHH/PSMB5/PSMC4,10
R-HSA-69239,Synthesis of DNA,14/1291,119/10616,0.595235244988401,0.999999999999475,0.942760942760448,ORC1/CCNA2/PSMB9/ORC6/CDT1/PSMA8/MCM8/GINS1/UBE2C/CDC45/PSMD14/PSMD1/PSMB5/PSMC4,14
R-HSA-5658442,Regulation of RAS by GAPs,8/1291,68/10616,0.595677302120165,0.999999999999475,0.942760942760448,RASA2/PSMB9/PSMA8/RASAL3/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),8/1291,68/10616,0.595677302120165,0.999999999999475,0.942760942760448,H2BC21/H2BU1/H2BC4/H2BC5/H2BC11/H2BC13/ATM/TDP1,8
R-HSA-1433559,Regulation of KIT signaling,2/1291,16/10616,0.59634937326088,0.999999999999475,0.942760942760448,LCK/PTPN6,2
R-HSA-1963640,GRB2 events in ERBB2 signaling,2/1291,16/10616,0.59634937326088,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-1963642,PI3K events in ERBB2 signaling,2/1291,16/10616,0.59634937326088,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,2/1291,16/10616,0.59634937326088,0.999999999999475,0.942760942760448,LAT2/MS4A2,2
R-HSA-171306,Packaging Of Telomere Ends,6/1291,51/10616,0.598806781676166,0.999999999999475,0.942760942760448,H2BC21/H2BU1/H2BC4/H2BC5/H2BC11/H2BC13,6
R-HSA-156588,Glucuronidation,3/1291,25/10616,0.600975989875987,0.999999999999475,0.942760942760448,UGT3A2/UGT1A1/UGDH,3
R-HSA-191273,Cholesterol biosynthesis,3/1291,25/10616,0.600975989875987,0.999999999999475,0.942760942760448,DHCR24/CYP51A1/NSDHL,3
R-HSA-9006115,Signaling by NTRK2 (TRKB),3/1291,25/10616,0.600975989875987,0.999999999999475,0.942760942760448,CDK5R1/NTF4/TIAM1,3
R-HSA-5625740,RHO GTPases activate PKNs,11/1291,94/10616,0.601878597207769,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/CDC25C/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/RHOB,11
R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,7/1291,60/10616,0.606035468857022,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-110329,Cleavage of the damaged pyrimidine ,7/1291,60/10616,0.606035468857022,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,7/1291,60/10616,0.606035468857022,0.999999999999475,0.942760942760448,CCNA2/PSMB9/PTK6/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,7/1291,60/10616,0.606035468857022,0.999999999999475,0.942760942760448,PSMB9/NFKB2/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-73928,Depyrimidination,7/1291,60/10616,0.606035468857022,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-382556,ABC-family proteins mediated transport,12/1291,103/10616,0.608674580135962,0.999999999999475,0.942760942760448,PSMB9/ABCB4/ABCD2/PSMA8/ABCA7/PSMD14/ABCB6/PSMD1/APOA1/PSMB5/ABCC3/PSMC4,12
R-HSA-1433557,Signaling by SCF-KIT,5/1291,43/10616,0.612557410515722,0.999999999999475,0.942760942760448,LCK/PTPN6/VAV1/MMP9/GRAP2,5
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,8/1291,69/10616,0.612759290641699,0.999999999999475,0.942760942760448,HSPA6/NUP210/HSPA1A/HSPA1B/ATM/DNAJB1/HSPA5/BAG3,8
R-HSA-380259,Loss of Nlp from mitotic centrosomes,8/1291,69/10616,0.612759290641699,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB4B,8
R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,8/1291,69/10616,0.612759290641699,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB4B,8
R-HSA-3858494,Beta-catenin independent WNT signaling,17/1291,146/10616,0.61456087516417,0.999999999999475,0.942760942760448,LEF1/TCF7/PSMB9/WNT1/GNG2/PLCB2/PRKCB/ARRB2/PDE6G/PSMA8/GNG8/PRKCG/RAC2/PSMD14/PSMD1/PSMB5/PSMC4,17
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,6/1291,52/10616,0.618365020910831,0.999999999999475,0.942760942760448,PIK3CD/INPP5D/PIK3CG/PIP4K2A/PIK3R5/INPP5J,6
R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,6/1291,52/10616,0.618365020910831,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-69610,p53-Independent DNA Damage Response,6/1291,52/10616,0.618365020910831,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,6/1291,52/10616,0.618365020910831,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,6/1291,52/10616,0.618365020910831,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,14/1291,121/10616,0.621126965976246,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/HOXD1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/HOXA1/EZH2/HOXB3/POLR2L,14
R-HSA-5619507,Activation of HOX genes during differentiation,14/1291,121/10616,0.621126965976246,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/HOXD1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/HOXA1/EZH2/HOXB3/POLR2L,14
R-HSA-5668914,Diseases of metabolism,12/1291,104/10616,0.622499960462816,0.999999999999475,0.942760942760448,TBXAS1/CSF2RB/CSF2RA/GCLM/POMC/UGT1A1/ACY1/TPMT/GCLC/TALDO1/CYP27B1/CYP19A1,12
R-HSA-164378,PKA activation in glucagon signalling,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,ADCY8/ADCY7,2
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,NFKB2/ZBP1,2
R-HSA-2033519,Activated point mutants of FGFR2,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,PPFIA4/SNAP25,2
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,PRKCB/PRKCG,2
R-HSA-5083625,Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,MUC19/MUC16,2
R-HSA-5083636,Defective GALNT12 causes colorectal cancer 1 (CRCS1),2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,MUC19/MUC16,2
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,OSM/CNTFR,2
R-HSA-9018677,Biosynthesis of DHA-derived SPMs,2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,ALOX5/ALOX12,2
R-HSA-9034015,Signaling by NTRK3 (TRKC),2/1291,17/10616,0.630210930435241,0.999999999999475,0.942760942760448,PTPRO/IRS1,2
R-HSA-196071,Metabolism of steroid hormones,4/1291,35/10616,0.630214531888085,0.999999999999475,0.942760942760448,HSD11B1/POMC/AKR1B15/CYP19A1,4
R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,11/1291,96/10616,0.630684225679752,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/GP1BA/GATA1,11
R-HSA-425397,Transport of vitamins, nucleosides, and related molecules,5/1291,44/10616,0.633490502302141,0.999999999999475,0.942760942760448,SLC28A3/SLCO1A2/SLCO2A1/SLC29A4/SLC27A4,5
R-HSA-169911,Regulation of Apoptosis,6/1291,53/10616,0.637371777894887,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-73929,Base-Excision Repair, AP Site Formation,7/1291,62/10616,0.641514471312654,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-157118,Signaling by NOTCH,27/1291,234/10616,0.646073982471394,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/TACC3/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/LFNG/HDAC9/IKZF1/DLGAP5/ATP2A3/ARRB2/FCER2/E2F1/HEYL/PSMD14/PSMD1/HES1/EGF/ATP2A2/PSMB5/PSMC4,27
R-HSA-2559580,Oxidative Stress Induced Senescence,14/1291,123/10616,0.646199600674896,0.999999999999475,0.942760942760448,E2F2/H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/EZH2/CDKN2A/E2F1/TXN,14
R-HSA-5358351,Signaling by Hedgehog,17/1291,149/10616,0.648919843089381,0.999999999999475,0.942760942760448,PSMB9/ADCY8/GRK2/ADCY7/ARRB2/PSMA8/PSMD14/PSMD1/HHIP/TUBB2A/TUBB4B/DHH/TUBA1B/TUBA1C/PSMB5/DISP2/PSMC4,17
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,4/1291,36/10616,0.65283178770422,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-6804757,Regulation of TP53 Degradation,4/1291,36/10616,0.65283178770422,0.999999999999475,0.942760942760448,CCNA2/CDKN2A/CDK1/ATM,4
R-HSA-4615885,SUMOylation of DNA replication proteins,5/1291,45/10616,0.653715924110839,0.999999999999475,0.942760942760448,CDCA8/NUP210/AURKB/TOP2A/BIRC5,5
R-HSA-5687128,MAPK6/MAPK4 signaling,10/1291,89/10616,0.654219568741107,0.999999999999475,0.942760942760448,PSMB9/CDK1/IGF2BP1/PSMA8/DNAJB1/PSMD14/PSMD1/PSMB5/ETV4/PSMC4,10
R-HSA-114508,Effects of PIP2 hydrolysis,3/1291,27/10616,0.654399019320574,0.999999999999475,0.942760942760448,RASGRP2/DGKA/RASGRP1,3
R-HSA-5654716,Downstream signaling of activated FGFR4,3/1291,27/10616,0.654399019320574,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-68875,Mitotic Prophase,16/1291,141/10616,0.655571767093587,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/NUP210/LMNB1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/CDK1/TMPO/CCNB2/PLK1/PRKCB,16
R-HSA-112043,PLC beta mediated events,6/1291,54/10616,0.655805360208146,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/PLCB2/ADCY7/PRKCG,6
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,6/1291,54/10616,0.655805360208146,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-9604323,Negative regulation of NOTCH4 signaling,6/1291,54/10616,0.655805360208146,0.999999999999475,0.942760942760448,TACC3/PSMB9/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-1630316,Glycosaminoglycan metabolism,14/1291,124/10616,0.658406357384212,0.999999999999475,0.942760942760448,HPSE/HMMR/GPC2/KERA/CHST11/HS3ST3A1/HS3ST3B1/B3GNT3/HS6ST2/HYAL2/HS3ST5/ST3GAL1/LYVE1/CSPG4,14
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,8/1291,72/10616,0.661632554092995,0.999999999999475,0.942760942760448,CCNA2/PSMB9/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-111471,Apoptotic factor-mediated response,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,CDKN2A/CARD8,2
R-HSA-181429,Serotonin Neurotransmitter Release Cycle,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,PPFIA4/SNAP25,2
R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,PPFIA4/SNAP25,2
R-HSA-446353,Cell-extracellular matrix interactions,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,ARHGEF6/FLNC,2
R-HSA-5083632,Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,MUC19/MUC16,2
R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-5654704,SHC-mediated cascade:FGFR3,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-5654710,PI-3K cascade:FGFR3,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,CDC25C/CDK1,2
R-HSA-8963898,Plasma lipoprotein assembly,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,APOC2/APOA1,2
R-HSA-9037629,Lewis blood group biosynthesis,2/1291,18/10616,0.661813373200985,0.999999999999475,0.942760942760448,FUT7/FUT2,2
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,10/1291,90/10616,0.66832636736914,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-73772,RNA Polymerase I Promoter Escape,10/1291,90/10616,0.66832636736914,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-5619102,SLC transporter disorders,11/1291,99/10616,0.671776570624104,0.999999999999475,0.942760942760448,NUP210/SLC6A20/SLC7A7/SLC24A5/SLC12A1/SLC5A2/SLC12A3/SLCO2A1/SLC17A5/SLC27A4/HK1,11
R-HSA-112040,G-protein mediated events,6/1291,55/10616,0.673648398841996,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/PLCB2/ADCY7/PRKCG,6
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,6/1291,55/10616,0.673648398841996,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-4641257,Degradation of AXIN,6/1291,55/10616,0.673648398841996,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-6806003,Regulation of TP53 Expression and Degradation,4/1291,37/10616,0.674503775155604,0.999999999999475,0.942760942760448,CCNA2/CDKN2A/CDK1/ATM,4
R-HSA-75105,Fatty acyl-CoA biosynthesis,4/1291,37/10616,0.674503775155604,0.999999999999475,0.942760942760448,ACSL6/ACSBG2/ELOVL1/FASN,4
R-HSA-421270,Cell-cell junction organization,7/1291,64/10616,0.675067159873697,0.999999999999475,0.942760942760448,NECTIN4/CLDN15/CDH17/CDH3/CDH4/CLDN7/CLDN2,7
R-HSA-8957275,Post-translational protein phosphorylation,12/1291,108/10616,0.675240295749963,0.999999999999475,0.942760942760448,ENAM/SPP1/MSLN/PDIA6/SCG2/WFS1/VGF/APOA1/HSP90B1/DNAJC3/SCG3/CHGB,12
R-HSA-1483191,Synthesis of PC,3/1291,28/10616,0.679109686025052,0.999999999999475,0.942760942760448,ACHE/MFSD2A/BCHE,3
R-HSA-202040,G-protein activation,3/1291,28/10616,0.679109686025052,0.999999999999475,0.942760942760448,GNG2/GNG8/POMC,3
R-HSA-2022854,Keratan sulfate biosynthesis,3/1291,28/10616,0.679109686025052,0.999999999999475,0.942760942760448,KERA/B3GNT3/ST3GAL1,3
R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,3/1291,28/10616,0.679109686025052,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1C,3
R-HSA-400042,Adrenaline,noradrenaline inhibits insulin secretion,3/1291,28/10616,0.679109686025052,0.999999999999475,0.942760942760448,ADRA2A/GNG2/GNG8,3
R-HSA-9006931,Signaling by Nuclear Receptors,34/1291,298/10616,0.682962267428266,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/DHRS9/PDK1/ARL4C/EREG/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/ALDH8A1/MYB/SDR16C5/GATA3/RDH16/GNG2/ESR2/ALDH1A3/APOC2/GNG8/MMP9/DHRS3/EGF/AKR1C3/GPAM/POLR2L/MMP3/CRABP1/FASN/TFF3/CITED1,34
R-HSA-69242,S Phase,18/1291,161/10616,0.685249002987473,0.999999999999475,0.942760942760448,ORC1/CCNA2/PSMB9/ESCO2/CDCA5/ORC6/CDT1/PSMA8/MCM8/GINS1/E2F1/UBE2C/PTK6/CDC45/PSMD14/PSMD1/PSMB5/PSMC4,18
R-HSA-156580,Phase II - Conjugation of compounds,12/1291,109/10616,0.687739026664227,0.999999999999475,0.942760942760448,UGT3A2/GCLM/MGST3/UGT1A1/UGDH/TPMT/GCLC/GSTP1/NNMT/MGST1/ACSM2A/SULT1A2,12
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),12/1291,109/10616,0.687739026664227,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/CCNA2/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/CDKN2A/UBE2C,12
R-HSA-5362768,Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,6/1291,56/10616,0.690887602421615,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,TOP2A/E2F1,2
R-HSA-163615,PKA activation,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,ADCY8/ADCY7,2
R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,GNG2/GNG8,2
R-HSA-5576886,Phase 4 - resting membrane potential,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,KCNK12/KCNK6,2
R-HSA-70895,Branched-chain amino acid catabolism,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,IVD/HSD17B10,2
R-HSA-8964038,LDL clearance,2/1291,19/10616,0.691204981577226,0.999999999999475,0.942760942760448,SOAT2/LDLR,2
R-HSA-190828,Gap junction trafficking,5/1291,47/10616,0.691970901694695,0.999999999999475,0.942760942760448,GJA4/TUBB2A/TUBB4B/TUBA1B/TUBA1C,5
R-HSA-437239,Recycling pathway of L1,5/1291,47/10616,0.691970901694695,0.999999999999475,0.942760942760448,KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C,5
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,14/1291,127/10616,0.693619592388262,0.999999999999475,0.942760942760448,CASP8/TLR1/TLR6/TLR2/CD180/LY86/NFKB2/SIGIRR/BIRC3/ITGAM/NOD2/PLCG2/ITGB2/BTK,14
R-HSA-201681,TCF dependent signaling in response to WNT,26/1291,231/10616,0.69476182500169,0.999999999999475,0.942760942760448,RUNX3/RSPO1/H3C13/H2BC21/H2BU1/LEF1/TERT/TCF7/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/PSMB9/WNT8B/WNT1/CCDC88C/KREMEN2/PSMA8/PSMD14/PSMD1/DKK2/PSMB5/PSMC4/SOX3,26
R-HSA-111465,Apoptotic cleavage of cellular proteins,4/1291,38/10616,0.695218832104542,0.999999999999475,0.942760942760448,CLSPN/CASP8/LMNB1/STK26,4
R-HSA-5689896,Ovarian tumor domain proteases,4/1291,38/10616,0.695218832104542,0.999999999999475,0.942760942760448,TNIP3/TNFAIP3/CDK1/NOD2,4
R-HSA-1912408,Pre-NOTCH Transcription and Translation,10/1291,92/10616,0.695511275669551,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/E2F1,10
R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,10/1291,92/10616,0.695511275669551,0.999999999999475,0.942760942760448,EXO1/CCNA2/TP53INP1/ATM/BLM/RMI2/AURKB/CDK5R1/BRIP1/TPX2,10
R-HSA-420029,Tight junction interactions,3/1291,29/10616,0.702483961728482,0.999999999999475,0.942760942760448,CLDN15/CLDN7/CLDN2,3
R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,3/1291,29/10616,0.702483961728482,0.999999999999475,0.942760942760448,MYBL1/PLD6/POLR2L,3
R-HSA-8863795,Downregulation of ERBB2 signaling,3/1291,29/10616,0.702483961728482,0.999999999999475,0.942760942760448,EREG/MATK/EGF,3
R-HSA-204998,Cell death signalling via NRAGE, NRIF and NADE,8/1291,75/10616,0.706647859917697,0.999999999999475,0.942760942760448,FGD2/FGD3/VAV1/ARHGEF1/TIAM1/ARHGEF6/ARHGEF5/MAGED1,8
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,8/1291,75/10616,0.706647859917697,0.999999999999475,0.942760942760448,H2BC21/H2BU1/H2BC4/H2BC5/H2BC11/H2BC13/ATM/EYA1,8
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,9/1291,84/10616,0.707378786295866,0.999999999999475,0.942760942760448,TNF/WNT10B/WNT1/PPARG/ADIPOQ/LPL/CEBPD/FABP4/ANGPTL4,9
R-HSA-4641258,Degradation of DVL,6/1291,57/10616,0.707513498030746,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-114608,Platelet degranulation ,14/1291,129/10616,0.715863799697588,0.999999999999475,0.942760942760448,PLEK/PCYOX1L/FERMT3/CTSW/RAB27B/MANF/MMRN1/EGF/HSPA5/APOA1/IGF1/SERPINA3/SCG3/ITGB3,14
R-HSA-2022870,Chondroitin sulfate biosynthesis,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,CHST11/CSPG4,2
R-HSA-3560783,Defective B4GALT7 causes EDS, progeroid type,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,GPC2/CSPG4,2
R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,GPC2/CSPG4,2
R-HSA-381771,Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,DPP4/GRP,2
R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,GPC2/CSPG4,2
R-HSA-5625900,RHO GTPases activate CIT,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,KIF14/RHOB,2
R-HSA-5654706,FRS-mediated FGFR3 signaling,2/1291,20/10616,0.718455695744521,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-3000178,ECM proteoglycans,8/1291,76/10616,0.720750694657543,0.999999999999475,0.942760942760448,MATN1/TNR/COL9A1/MUSK/ITGAX/LAMA3/TNN/ITGB3,8
R-HSA-5693606,DNA Double Strand Break Response,8/1291,76/10616,0.720750694657543,0.999999999999475,0.942760942760448,H2BC21/H2BU1/H2BC4/H2BC5/H2BC11/H2BC13/ATM/EYA1,8
R-HSA-381119,Unfolded Protein Response (UPR),10/1291,94/10616,0.721275933508588,0.999999999999475,0.942760942760448,ERN1/PDIA6/DNAJB11/WFS1/HSPA5/HYOU1/HSP90B1/DNAJC3/MYDGF/CALR,10
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,7/1291,67/10616,0.721559537213098,0.999999999999475,0.942760942760448,PSMB9/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-3000157,Laminin interactions,3/1291,30/10616,0.724535339565102,0.999999999999475,0.942760942760448,LAMB3/COL7A1/LAMA3,3
R-HSA-1250342,PI3K events in ERBB4 signaling,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,EREG,1
R-HSA-1483115,Hydrolysis of LPC,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,PLA2G4D,1
R-HSA-190377,FGFR2b ligand binding and activation,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,FGFBP1,1
R-HSA-2161522,Abacavir transport and metabolism,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,SLC22A3,1
R-HSA-2465910,MASTL Facilitates Mitotic Progression,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,CDK1,1
R-HSA-399997,Acetylcholine regulates insulin secretion,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,PLCB2,1
R-HSA-418890,Role of second messengers in netrin-1 signaling,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,DCC,1
R-HSA-419812,Calcitonin-like ligand receptors,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,CALCA,1
R-HSA-425381,Bicarbonate transporters,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,SLC4A8,1
R-HSA-428643,Organic anion transporters,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,SLC17A5,1
R-HSA-442380,Zinc influx into cells by the SLC39 gene family,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,SLC39A14,1
R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,CAMK4,1
R-HSA-549127,Organic cation transport,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,SLC22A3,1
R-HSA-5685939,HDR through MMEJ (alt-NHEJ),1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,POLQ,1
R-HSA-70635,Urea cycle,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,NAGS,1
R-HSA-74182,Ketone body metabolism,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,HMGCS2,1
R-HSA-74749,Signal attenuation,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,IRS1,1
R-HSA-8866904,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,TFAP2E,1
R-HSA-8868766,rRNA processing in the mitochondrion,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,HSD17B10,1
R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/1291,10/10616,0.726709662658333,0.999999999999475,0.942760942760448,TXN,1
R-HSA-9006925,Intracellular signaling by second messengers,34/1291,304/10616,0.727200853409877,0.999999999999475,0.942760942760448,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/CAMK4/PSMB9/EZH2/FGF20/ADCY8/PIP4K2A/PIK3AP1/GRK2/ESR2/CD19/ADCY7/PSMA8/VAV1/PRKCG/TRIB3/RAC2/PSMD14/IRS1/PSMD1/PPARG/KLB/EGF/FGF18/PSMB5/PSMC4/SNAI1,34
R-HSA-157858,Gap junction trafficking and regulation,5/1291,49/10616,0.727231724732002,0.999999999999475,0.942760942760448,GJA4/TUBB2A/TUBB4B/TUBA1B/TUBA1C,5
R-HSA-177929,Signaling by EGFR,5/1291,49/10616,0.727231724732002,0.999999999999475,0.942760942760448,EREG/PAG1/ADAM12/CSK/EGF,5
R-HSA-5674135,MAP2K and MAPK activation,4/1291,40/10616,0.733769536463836,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-5610787,Hedgehog 'off' state,12/1291,113/10616,0.734789481491149,0.999999999999475,0.942760942760448,PSMB9/ADCY8/ADCY7/PSMA8/PSMD14/PSMD1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/PSMB5/PSMC4,12
R-HSA-1257604,PIP3 activates AKT signaling,29/1291,263/10616,0.742956875344143,0.999999999999475,0.942760942760448,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/PSMB9/EZH2/FGF20/PIP4K2A/PIK3AP1/ESR2/CD19/PSMA8/VAV1/TRIB3/RAC2/PSMD14/IRS1/PSMD1/PPARG/KLB/EGF/FGF18/PSMB5/PSMC4/SNAI1,29
R-HSA-111931,PKA-mediated phosphorylation of CREB,2/1291,21/10616,0.743651141568666,0.999999999999475,0.942760942760448,ADCY8/ADCY7,2
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,2/1291,21/10616,0.743651141568666,0.999999999999475,0.942760942760448,SEMA4D/RHOB,2
R-HSA-5218921,VEGFR2 mediated cell proliferation,2/1291,21/10616,0.743651141568666,0.999999999999475,0.942760942760448,PRKCB/KDR,2
R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,2/1291,21/10616,0.743651141568666,0.999999999999475,0.942760942760448,CDC25C/RGCC,2
R-HSA-196807,Nicotinate metabolism,3/1291,31/10616,0.745287179372889,0.999999999999475,0.942760942760448,CD38/NMNAT2/NNMT,3
R-HSA-399719,Trafficking of AMPA receptors,3/1291,31/10616,0.745287179372889,0.999999999999475,0.942760942760448,AKAP5/PRKCB/PRKCG,3
R-HSA-399721,Glutamate binding, activation of AMPA receptors and synaptic plasticity,3/1291,31/10616,0.745287179372889,0.999999999999475,0.942760942760448,AKAP5/PRKCB/PRKCG,3
R-HSA-5654733,Negative regulation of FGFR4 signaling,3/1291,31/10616,0.745287179372889,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-8941326,RUNX2 regulates bone development,3/1291,31/10616,0.745287179372889,0.999999999999475,0.942760942760448,RUNX2/HES1/SMAD6,3
R-HSA-5578749,Transcriptional regulation by small RNAs,11/1291,105/10616,0.745483253611035,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/NUP210/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,11
R-HSA-193704,p75 NTR receptor-mediated signalling,10/1291,96/10616,0.745580969984496,0.999999999999475,0.942760942760448,FGD2/FGD3/OMG/VAV1/ARHGEF1/TIAM1/ARHGEF6/ARHGEF5/MAG/MAGED1,10
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,9/1291,87/10616,0.746216756336244,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/CCNB2/PLK1/SFI1/TUBB4B,9
R-HSA-422356,Regulation of insulin secretion,8/1291,78/10616,0.747573456506441,0.999999999999475,0.942760942760448,ADCY8/ADRA2A/GNG2/AKAP5/PLCB2/GNG8/SNAP25/ABCC8,8
R-HSA-5576891,Cardiac conduction,15/1291,141/10616,0.748369302479522,0.999999999999475,0.942760942760448,ATP1A4/KCNK12/NPPC/FXYD2/ATP2A3/FXYD7/KCNK6/ATP1A3/KCNE1/CACNA1F/ATP1A1/ATP1B3/TRDN/ATP2A2/TBX5,15
R-HSA-8853659,RET signaling,4/1291,41/10616,0.751617212949121,0.999999999999475,0.942760942760448,PIK3CD/DOK2/RAP1GAP/GFRA2,4
R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,4/1291,41/10616,0.751617212949121,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-5610780,Degradation of GLI1 by the proteasome,6/1291,60/10616,0.75366822999865,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-5610783,Degradation of GLI2 by the proteasome,6/1291,60/10616,0.75366822999865,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,6/1291,60/10616,0.75366822999865,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-3214847,HATs acetylate histones,15/1291,142/10616,0.757994520317441,0.999999999999475,0.942760942760448,H2BC18/H3C13/H2BC21/H2AW/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2AC11/H2BC13/H2AC13/H3C12/MSL3/OGT,15
R-HSA-1059683,Interleukin-6 signaling,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,IL6R,1
R-HSA-111458,Formation of apoptosome,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,CARD8,1
R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,HIGD1A,1
R-HSA-1839122,Signaling by activated point mutants of FGFR1,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-189085,Digestion of dietary carbohydrate,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,AMY2A,1
R-HSA-193048,Androgen biosynthesis,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,POMC,1
R-HSA-2022923,Dermatan sulfate biosynthesis,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,CSPG4,1
R-HSA-2025928,Calcineurin activates NFAT,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,NFATC2,1
R-HSA-211999,CYP2E1 reactions,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,CYP2S1,1
R-HSA-2485179,Activation of the phototransduction cascade,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,PDE6G,1
R-HSA-2586552,Signaling by Leptin,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,IRS1,1
R-HSA-376172,DSCAM interactions,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,DCC,1
R-HSA-390247,Beta-oxidation of very long chain fatty acids,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,HSD17B4,1
R-HSA-400451,Free fatty acids regulate insulin secretion,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,PLCB2,1
R-HSA-4755510,SUMOylation of immune response proteins,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,NFKB2,1
R-HSA-73614,Pyrimidine salvage,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,TYMP,1
R-HSA-9028731,Activated NTRK2 signals through FRS2 and FRS3,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,NTF4,1
R-HSA-9627069,Regulation of the apoptosome activity,1/1291,11/10616,0.759975533439786,0.999999999999475,0.942760942760448,CARD8,1
R-HSA-392518,Signal amplification,3/1291,32/10616,0.76477091691783,0.999999999999475,0.942760942760448,P2RY12/GNG2/GNG8,3
R-HSA-451326,Activation of kainate receptors upon glutamate binding,3/1291,32/10616,0.76477091691783,0.999999999999475,0.942760942760448,GNG2/PLCB2/GNG8,3
R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),3/1291,32/10616,0.76477091691783,0.999999999999475,0.942760942760448,GNG2/ARRB2/GNG8,3
R-HSA-69190,DNA strand elongation,3/1291,32/10616,0.76477091691783,0.999999999999475,0.942760942760448,MCM8/GINS1/CDC45,3
R-HSA-1250196,SHC1 events in ERBB2 signaling,2/1291,22/10616,0.766887787135582,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,2/1291,22/10616,0.766887787135582,0.999999999999475,0.942760942760448,GP1BA/SERPINA5,2
R-HSA-2024096,HS-GAG degradation,2/1291,22/10616,0.766887787135582,0.999999999999475,0.942760942760448,HPSE/GPC2,2
R-HSA-5655332,Signaling by FGFR3 in disease,2/1291,22/10616,0.766887787135582,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-8853338,Signaling by FGFR3 point mutants in cancer,2/1291,22/10616,0.766887787135582,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-5678895,Defective CFTR causes cystic fibrosis,6/1291,61/10616,0.76781308509401,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,4/1291,42/10616,0.768530334728413,0.999999999999475,0.942760942760448,ADCY8/GNG2/AKAP5/GNG8,4
R-HSA-419037,NCAM1 interactions,4/1291,42/10616,0.768530334728413,0.999999999999475,0.942760942760448,ST8SIA4/COL9A1/ST8SIA2/GFRA2,4
R-HSA-3371556,Cellular response to heat stress,9/1291,89/10616,0.770055972139935,0.999999999999475,0.942760942760448,HSPA6/NUP210/HSPA1A/HSPA1B/ATM/DNAJB1/HSPA5/BAG3/CRYAB,9
R-HSA-4086398,Ca2+ pathway,6/1291,62/10616,0.781345079427727,0.999999999999475,0.942760942760448,LEF1/TCF7/GNG2/PLCB2/PDE6G/GNG8,6
R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,3/1291,33/10616,0.783024464332068,0.999999999999475,0.942760942760448,NUP210/HSPA1A/HSPA1B,3
R-HSA-1839126,FGFR2 mutant receptor activation,3/1291,33/10616,0.783024464332068,0.999999999999475,0.942760942760448,FGF20/FGF18/POLR2L,3
R-HSA-2262752,Cellular responses to stress,53/1291,477/10616,0.783279075940308,0.999999999999475,0.942760942760448,E2F2/H3C13/H2BC21/HSPA6/NCF2/H2BU1/NUP210/CCNA2/LMNB1/H2BC4/H1-4/H2BC5/H3C4/H1-3/H2BC11/H2BC13/H1-5/H3C12/HSPA1A/HSPA1B/PSMB9/NCF1/EZH2/CDKN2A/TCIRG1/ATM/PSMA8/DNAJB1/E2F1/UBE2C/NCF4/CYBB/PRDX1/PSMD14/PSMD1/SH3BP4/HIGD1A/TUBB2A/GSR/TXN/HSPA5/TUBB4B/BAG3/PRDX5/GSTP1/CRYAB/TUBA1B/TUBA1C/TXNRD1/PSMB5/PSMC4/ID1/HIRA,53
R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,8/1291,81/10616,0.784337873652692,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB4B,8
R-HSA-380287,Centrosome maturation,8/1291,81/10616,0.784337873652692,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB4B,8
R-HSA-2672351,Stimuli-sensing channels,11/1291,109/10616,0.787961232400634,0.999999999999475,0.942760942760448,MCOLN2/CLCA2/TRPM8/ANO9/MLKL/TRPV3/TRPM2/TRDN/SCNN1A/ANO4/ASIC2,11
R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,CDK1/UBE2C,2
R-HSA-212676,Dopamine Neurotransmitter Release Cycle,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,PPFIA4/SNAP25,2
R-HSA-373753,Nephrin family interactions,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,NPHS1/KIRREL2,2
R-HSA-400508,Incretin synthesis, secretion, and inactivation,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,DPP4/GRP,2
R-HSA-428930,Thromboxane signalling through TP receptor,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,GNG2/GNG8,2
R-HSA-5654695,PI-3K cascade:FGFR2,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-5654699,SHC-mediated cascade:FGFR2,2/1291,23/10616,0.7882690438847,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CAMK4,1
R-HSA-1296346,Tandem pore domain potassium channels,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,KCNK6,1
R-HSA-1475029,Reversible hydration of carbon dioxide,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CA4,1
R-HSA-190373,FGFR1c ligand binding and activation,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-209952,Peptide hormone biosynthesis,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,POMC,1
R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CASP8,1
R-HSA-430116,GP1b-IX-V activation signalling,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,GP1BA,1
R-HSA-622323,Presynaptic nicotinic acetylcholine receptors,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CHRNA6,1
R-HSA-629594,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CHRNA6,1
R-HSA-73621,Pyrimidine catabolism,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,TYMP,1
R-HSA-8963693,Aspartate and asparagine metabolism,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,ASPG,1
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/1291,12/10616,0.789194919232265,0.999999999999475,0.942760942760448,CASP8,1
R-HSA-111885,Opioid Signalling,9/1291,91/10616,0.792254332840029,0.999999999999475,0.942760942760448,CAMK4/ADCY8/GRK2/GNG2/PLCB2/ADCY7/GNG8/PRKCG/POMC,9
R-HSA-8856828,Clathrin-mediated endocytosis,15/1291,146/10616,0.794009871901798,0.999999999999475,0.942760942760448,TACR1/EREG/IL7R/KIAA0319/PACSIN1/SYT8/GRK2/CD3D/CD3G/CD4/ARRB2/FCHO1/AGTR1/EGF/LDLR,15
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,6/1291,63/10616,0.794271980743453,0.999999999999475,0.942760942760448,PSMB9/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,6/1291,63/10616,0.794271980743453,0.999999999999475,0.942760942760448,CGAS/NFKB2/NLRC3/NLRP4/ZBP1/POLR2L,6
R-HSA-195253,Degradation of beta-catenin by the destruction complex,8/1291,82/10616,0.795675107402087,0.999999999999475,0.942760942760448,LEF1/TCF7/PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-69231,Cyclin D associated events in G1,4/1291,44/10616,0.799631263266831,0.999999999999475,0.942760942760448,E2F2/CDKN2A/E2F1/PTK6,4
R-HSA-69236,G1 Phase,4/1291,44/10616,0.799631263266831,0.999999999999475,0.942760942760448,E2F2/CDKN2A/E2F1/PTK6,4
R-HSA-1638074,Keratan sulfate/keratin metabolism,3/1291,34/10616,0.800090793673727,0.999999999999475,0.942760942760448,KERA/B3GNT3/ST3GAL1,3
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,3/1291,34/10616,0.800090793673727,0.999999999999475,0.942760942760448,TNFAIP3/NLRC5/RNF125,3
R-HSA-8939902,Regulation of RUNX2 expression and activity,7/1291,73/10616,0.800312341650872,0.999999999999475,0.942760942760448,PSMB9/RUNX2/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-5663202,Diseases of signal transduction,41/1291,377/10616,0.80319129323895,0.999999999999475,0.942760942760448,PIK3CD/LCK/CD28/ICOS/TRAT1/CD80/CD86/EREG/PSMB9/HDAC9/FGF20/CNTRL/APBB1IP/PIK3AP1/ESR2/STRA6/CSK/KREMEN2/CD19/ARRB2/PSMA8/VAV1/RAC2/HEYL/PSMD14/IRS1/PSMD1/HES1/KLB/DKK2/EGF/FGF18/OPN1SW/ESRP1/RBP4/POLR2L/DHH/PSMB5/RDH12/ITGB3/PSMC4,41
R-HSA-69202,Cyclin E associated events during G1/S transition ,8/1291,83/10616,0.806560774704262,0.999999999999475,0.942760942760448,CCNA2/PSMB9/E2F1/PTK6/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-4608870,Asymmetric localization of PCP proteins,6/1291,64/10616,0.806603513936876,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-379716,Cytosolic tRNA aminoacylation,2/1291,24/10616,0.807902154490578,0.999999999999475,0.942760942760448,AIMP2/AARS1,2
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,2/1291,24/10616,0.807902154490578,0.999999999999475,0.942760942760448,LIN28A/DPPA4,2
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,2/1291,24/10616,0.807902154490578,0.999999999999475,0.942760942760448,RUNX2/HES1,2
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,2/1291,24/10616,0.807902154490578,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-5688426,Deubiquitination,31/1291,291/10616,0.811858468291088,0.999999999999475,0.942760942760448,CLSPN/H2BC18/H2BC21/H2AW/H2BU1/NLRP3/TNIP3/CCNA2/H2BC4/H2BC5/H2BC11/H2AC11/H2BC13/H2AC13/PSMB9/TNFAIP3/GATA3/CDK1/STAMBPL1/BIRC3/NOD2/ARRB2/PSMA8/OGT/PSMD14/PSMD1/UCHL1/MBD6/UCHL3/PSMB5/PSMC4,31
R-HSA-111461,Cytochrome c-mediated apoptotic response,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,CARD8,1
R-HSA-113501,Inhibition of replication initiation of damaged DNA by RB1/E2F1,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,E2F1,1
R-HSA-1237044,Erythrocytes take up carbon dioxide and release oxygen,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,CA4,1
R-HSA-1480926,O2/CO2 exchange in erythrocytes,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,CA4,1
R-HSA-1483213,Synthesis of PE,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,ETNPPL,1
R-HSA-2022857,Keratan sulfate degradation,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,KERA,1
R-HSA-2564830,Cytosolic iron-sulfur cluster assembly,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,BRIP1,1
R-HSA-2892247,POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,DPPA4,1
R-HSA-400511,Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP),1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,DPP4,1
R-HSA-425561,Sodium/Calcium exchangers,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,SLC24A5,1
R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,NFATC2,1
R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,1/1291,13/10616,0.814859702264248,0.999999999999475,0.942760942760448,FGF18,1
R-HSA-2514859,Inactivation, recovery and regulation of the phototransduction cascade,3/1291,35/10616,0.816016693216132,0.999999999999475,0.942760942760448,GUCA1B/RGS9/PDE6G,3
R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,3/1291,35/10616,0.816016693216132,0.999999999999475,0.942760942760448,NUP210/CDK1/CCNB2,3
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,3/1291,35/10616,0.816016693216132,0.999999999999475,0.942760942760448,MLEC/PDIA3/CALR,3
R-HSA-9018519,Estrogen-dependent gene expression,15/1291,149/10616,0.818418498000539,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MYB/GATA3/GPAM/POLR2L/TFF3/CITED1,15
R-HSA-1234174,Cellular response to hypoxia,7/1291,75/10616,0.822425103681493,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/HIGD1A/PSMB5/PSMC4,7
R-HSA-1643713,Signaling by EGFR in Cancer,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-400685,Sema4D in semaphorin signaling,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,SEMA4D/RHOB,2
R-HSA-418592,ADP signalling through P2Y purinoceptor 1,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,GNG2/GNG8,2
R-HSA-5654700,FRS-mediated FGFR2 signaling,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-5654708,Downstream signaling of activated FGFR3,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,2/1291,25/10616,0.825895734022281,0.999999999999475,0.942760942760448,TACC3/EGF,2
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,8/1291,85/10616,0.827002865294035,0.999999999999475,0.942760942760448,CCNA2/PSMB9/E2F1/PTK6/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-1660662,Glycosphingolipid metabolism,4/1291,46/10616,0.82726241959513,0.999999999999475,0.942760942760448,GBA3/UGCG/SMPD3/ENPP7,4
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,6/1291,66/10616,0.829527733809502,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-2514856,The phototransduction cascade,3/1291,36/10616,0.830851684626305,0.999999999999475,0.942760942760448,GUCA1B/RGS9/PDE6G,3
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,3/1291,36/10616,0.830851684626305,0.999999999999475,0.942760942760448,TFAP2E/MYBL2/CITED1,3
R-HSA-5633007,Regulation of TP53 Activity,16/1291,160/10616,0.832348498457279,0.999999999999475,0.942760942760448,TP73/EXO1/TP63/CCNA2/TP53INP1/CDKN2A/PIP4K2A/CDK1/ATM/POU4F1/BLM/RMI2/AURKB/CDK5R1/BRIP1/TPX2,16
R-HSA-5628897,TP53 Regulates Metabolic Genes,8/1291,86/10616,0.836574458367759,0.999999999999475,0.942760942760448,TP63/PRDX1/GSR/TXN/PRDX5/TXNRD1/COX7B/G6PD,8
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,10/1291,105/10616,0.836768571885293,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-1250347,SHC1 events in ERBB4 signaling,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,EREG,1
R-HSA-1855183,Synthesis of IP2, IP, and Ins in the cytosol,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,INPP5J,1
R-HSA-200425,Import of palmitoyl-CoA into the mitochondrial matrix,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,THRSP,1
R-HSA-2024101,CS/DS degradation,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,CSPG4,1
R-HSA-3656237,Defective EXT2 causes exostoses 2,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,GPC2,1
R-HSA-3656253,Defective EXT1 causes exostoses 1, TRPS2 and CHDS,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,GPC2,1
R-HSA-418885,DCC mediated attractive signaling,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,DCC,1
R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,ADCY8,1
R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,EXO1,1
R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,EXO1,1
R-HSA-8849471,PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,PTK6,1
R-HSA-8964539,Glutamate and glutamine metabolism,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,ALDH18A1,1
R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,CAMK4,1
R-HSA-9005895,Pervasive developmental disorders,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,CAMK4,1
R-HSA-9027284,Erythropoietin activates RAS,1/1291,14/10616,0.837402013343834,0.999999999999475,0.942760942760448,VAV1,1
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,4/1291,47/10616,0.83984767707424,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-6802949,Signaling by RAS mutants,4/1291,47/10616,0.83984767707424,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,4/1291,47/10616,0.83984767707424,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-9649948,Signaling downstream of RAS mutants,4/1291,47/10616,0.83984767707424,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ITGB3,4
R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,2/1291,26/10616,0.842357851701198,0.999999999999475,0.942760942760448,GPC2/CSPG4,2
R-HSA-5223345,Miscellaneous transport and binding events,2/1291,26/10616,0.842357851701198,0.999999999999475,0.942760942760448,ADD2/NIPAL1,2
R-HSA-6803529,FGFR2 alternative splicing,2/1291,26/10616,0.842357851701198,0.999999999999475,0.942760942760448,ESRP1/POLR2L,2
R-HSA-901042,Calnexin/calreticulin cycle,2/1291,26/10616,0.842357851701198,0.999999999999475,0.942760942760448,PDIA3/CALR,2
R-HSA-9009391,Extra-nuclear estrogen signaling,7/1291,77/10616,0.842574548453957,0.999999999999475,0.942760942760448,EREG/GNG2/ESR2/GNG8/MMP9/EGF/MMP3,7
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,51/1291,473/10616,0.844059785267624,0.999999999999475,0.942760942760448,LCK/SH2D2A/NCF2/LAMB3/TLR9/EREG/SPP1/CYFIP2/COL9A1/NCF1/FGF20/PTK2B/PAG1/ADAM12/PDE3B/TCIRG1/PTPN6/PTPRO/NCKAP1L/FLT3/GABRG3/CSK/PRKCB/CDK5R1/LAMA3/MATK/VAV1/NTF4/FLT3LG/TRIB3/MMP9/PTK6/TIAM1/ADORA2A/NCF4/GRAP2/CYBB/IRS1/FGFBP1/KLB/KDR/EGF/THBS4/FGF18/ESRP1/POLR2L/IGF1/PGF/ITGB3/SPINT2/FLRT3,51
R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,3/1291,37/10616,0.844647088403132,0.999999999999475,0.942760942760448,THEM5/ACOT1/ACAA2,3
R-HSA-8979227,Triglyceride metabolism,3/1291,37/10616,0.844647088403132,0.999999999999475,0.942760942760448,FABP4/GPAM/DGAT2,3
R-HSA-427413,NoRC negatively regulates rRNA expression,10/1291,106/10616,0.845118589006953,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-5620912,Anchoring of the basal body to the plasma membrane,9/1291,97/10616,0.849304188181966,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/PLK1/SFI1/TUBB4B/B9D1,9
R-HSA-211000,Gene Silencing by RNA,13/1291,135/10616,0.851434306210634,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/NUP210/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MYBL1/PLD6/POLR2L,13
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,8/1291,88/10616,0.854462848096038,0.999999999999475,0.942760942760448,HSPA1A/HSPA1B/PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,8
R-HSA-1989781,PPARA activates gene expression,11/1291,117/10616,0.857088584865201,0.999999999999475,0.942760942760448,HMGCS2/ABCB4/GLIPR1/NR1H4/TRIB3/AGT/PPARG/ME1/APOA1/TXNRD1/ANGPTL4,11
R-HSA-181431,Acetylcholine binding and downstream events,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,CHRNA6,1
R-HSA-5358508,Mismatch Repair,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,EXO1,1
R-HSA-549132,Organic cation/anion/zwitterion transport,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,SLC22A3,1
R-HSA-5637810,Constitutive Signaling by EGFRvIII,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,EGF,1
R-HSA-5637812,Signaling by EGFRvIII in Cancer,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,EGF,1
R-HSA-622327,Postsynaptic nicotinic acetylcholine receptors,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,CHRNA6,1
R-HSA-75892,Platelet Adhesion to exposed collagen,1/1291,15/10616,0.85720148521453,0.999999999999475,0.942760942760448,GP1BA,1
R-HSA-264876,Insulin processing,2/1291,27/10616,0.857394558291648,0.999999999999475,0.942760942760448,MYRIP/PCSK2,2
R-HSA-5576893,Phase 2 - plateau phase,2/1291,27/10616,0.857394558291648,0.999999999999475,0.942760942760448,KCNE1/CACNA1F,2
R-HSA-8948751,Regulation of PTEN stability and activity,6/1291,69/10616,0.8597788151987,0.999999999999475,0.942760942760448,PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,6
R-HSA-5250941,Negative epigenetic regulation of rRNA expression,10/1291,109/10616,0.868172030590402,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-73854,RNA Polymerase I Promoter Clearance,10/1291,109/10616,0.868172030590402,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-1614635,Sulfur amino acid metabolism,2/1291,28/10616,0.871108779235232,0.999999999999475,0.942760942760448,BHMT2/BHMT,2
R-HSA-201451,Signaling by BMP,2/1291,28/10616,0.871108779235232,0.999999999999475,0.942760942760448,GREM2/SMAD6,2
R-HSA-400206,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),11/1291,119/10616,0.871261401859637,0.999999999999475,0.942760942760448,HMGCS2/ABCB4/GLIPR1/NR1H4/TRIB3/AGT/PPARG/ME1/APOA1/TXNRD1/ANGPTL4,11
R-HSA-1227986,Signaling by ERBB2,4/1291,50/10616,0.873059949668183,0.999999999999475,0.942760942760448,EREG/MATK/PTK6/EGF,4
R-HSA-190242,FGFR1 ligand binding and activation,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,PDK1,1
R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,HES1,1
R-HSA-399956,CRMPs in Sema3A signaling,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,CDK5R1,1
R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-8949664,Processing of SMDT1,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,MCUB,1
R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/1291,16/10616,0.874591626011439,0.999999999999475,0.942760942760448,FASLG,1
R-HSA-8939211,ESR-mediated signaling,22/1291,222/10616,0.874981895337007,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/EREG/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/MYB/GATA3/GNG2/ESR2/GNG8/MMP9/EGF/GPAM/POLR2L/MMP3/TFF3/CITED1,22
R-HSA-157579,Telomere Maintenance,7/1291,81/10616,0.877357934049792,0.999999999999475,0.942760942760448,H2BC21/H2BU1/TERT/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-438064,Post NMDA receptor activation events,7/1291,81/10616,0.877357934049792,0.999999999999475,0.942760942760448,CAMK4/ADCY8/RASGRF1/TUBB2A/TUBB4B/TUBA1B/TUBA1C,7
R-HSA-3214841,PKMTs methylate histone lysines,6/1291,71/10616,0.877376642385687,0.999999999999475,0.942760942760448,H3C13/H3C4/H3C12/EZH2/NFKB2/SMYD3,6
R-HSA-5689880,Ub-specific processing proteases,21/1291,214/10616,0.880737229317705,0.999999999999475,0.942760942760448,CLSPN/H2BC18/H2BC21/H2AW/H2BU1/CCNA2/H2BC4/H2BC5/H2BC11/H2AC11/H2BC13/H2AC13/PSMB9/GATA3/BIRC3/ARRB2/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,21
R-HSA-73864,RNA Polymerase I Transcription,10/1291,111/10616,0.881950659683284,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/POLR2L,10
R-HSA-425407,SLC-mediated transmembrane transport,25/1291,251/10616,0.882642606156078,0.999999999999475,0.942760942760448,SLC6A20/SLC15A2/SLC22A3/SLC28A3/SLC2A6/SLC1A2/SLCO1A2/SLC4A8/SLC7A7/SLC24A5/SLC12A1/SLC5A2/SLC12A3/SLC7A5/SLC5A10/SLC12A5/SLC2A7/SLCO2A1/SLC7A11/SLC17A5/SLC29A4/SLC39A14/SLC27A4/SLC14A2/SLC7A10,25
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,4/1291,51/10616,0.882725862544891,0.999999999999475,0.942760942760448,EPHA10/MMP9/TIAM1/EPHA5,4
R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,4/1291,51/10616,0.882725862544891,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-390918,Peroxisomal lipid metabolism,2/1291,29/10616,0.883599506457954,0.999999999999475,0.942760942760448,HSD17B4/CROT,2
R-HSA-5218920,VEGFR2 mediated vascular permeability,2/1291,29/10616,0.883599506457954,0.999999999999475,0.942760942760448,VAV1/TRIB3,2
R-HSA-5654732,Negative regulation of FGFR3 signaling,2/1291,29/10616,0.883599506457954,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-9013694,Signaling by NOTCH4,7/1291,82/10616,0.884981664536911,0.999999999999475,0.942760942760448,TACC3/PSMB9/PSMD14/PSMD1/HES1/PSMB5/PSMC4,7
R-HSA-9020702,Interleukin-1 signaling,9/1291,102/10616,0.886712347641306,0.999999999999475,0.942760942760448,IL1B/PSMB9/NFKB2/NOD2/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,9
R-HSA-435354,Zinc transporters,1/1291,17/10616,0.889865419484952,0.999999999999475,0.942760942760448,SLC39A14,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/1291,17/10616,0.889865419484952,0.999999999999475,0.942760942760448,BTG1,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,3/1291,41/10616,0.890480771036088,0.999999999999475,0.942760942760448,GPC2/KERA/CSPG4,3
R-HSA-5654743,Signaling by FGFR4,3/1291,41/10616,0.890480771036088,0.999999999999475,0.942760942760448,FGF20/KLB/FGF18,3
R-HSA-3928663,EPHA-mediated growth cone collapse,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,EPHA10/EPHA5,2
R-HSA-4090294,SUMOylation of intracellular receptors,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,NR1H4/PPARG,2
R-HSA-525793,Myogenesis,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,BORCS8-MEF2B/CDH4,2
R-HSA-5654696,Downstream signaling of activated FGFR2,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,UBE2C/UCHL3,2
R-HSA-8874081,MET activates PTK2 signaling,2/1291,30/10616,0.894961232664586,0.999999999999475,0.942760942760448,LAMB3/LAMA3,2
R-HSA-375165,NCAM signaling for neurite out-growth,5/1291,63/10616,0.895465347609856,0.999999999999475,0.942760942760448,ST8SIA4/COL9A1/SPTBN2/ST8SIA2/GFRA2,5
R-HSA-71291,Metabolism of amino acids and derivatives,38/1291,372/10616,0.89651152660158,0.999999999999475,0.942760942760448,KMO/TDO2/PSMB9/DBH/SDS/HDC/SLC7A5/AANAT/PSMA8/IL4I1/DIO1/TPO/ACMSD/PSMD14/PSMD1/HGD/BHMT2/BHMT/AIMP2/GSR/ALDH18A1/NNMT/TXNRD1/SDSL/HPD/PSMB5/DIO3/ASPG/OCA2/IVD/CKMT1B/CKMT1A/DUOX2/NQO1/GCSH/NAGS/PSMC4/HSD17B10,38
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),3/1291,42/10616,0.899861573828986,0.999999999999475,0.942760942760448,CYP51A1/GPAM/FASN,3
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,3/1291,42/10616,0.899861573828986,0.999999999999475,0.942760942760448,LEF1/TCF7/SOX3,3
R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,3/1291,42/10616,0.899861573828986,0.999999999999475,0.942760942760448,GNG2/RGS9/GNG8,3
R-HSA-3700989,Transcriptional Regulation by TP53,37/1291,365/10616,0.903155857778658,0.999999999999475,0.942760942760448,TP73/EXO1/FANCD2/TP63/CCNA2/CDC25C/TP53INP1/CDKN2A/PIP4K2A/CDK1/FAS/E2F8/CASP1/ATM/TP53AIP1/BCL2L14/E2F7/POU4F1/FANCI/BLM/RMI2/AURKB/CDK5R1/BRIP1/BIRC5/PMAIP1/TPX2/E2F1/PRDX1/GSR/TXN/POLR2L/PRDX5/TXNRD1/RGCC/COX7B/G6PD,37
R-HSA-163210,Formation of ATP by chemiosmotic coupling,1/1291,18/10616,0.90328024573695,0.999999999999475,0.942760942760448,ATP5MC1,1
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/1291,18/10616,0.90328024573695,0.999999999999475,0.942760942760448,CNTRL,1
R-HSA-73780,RNA Polymerase III Chain Elongation,1/1291,18/10616,0.90328024573695,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-74259,Purine catabolism,1/1291,18/10616,0.90328024573695,0.999999999999475,0.942760942760448,XDH,1
R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,1/1291,18/10616,0.90328024573695,0.999999999999475,0.942760942760448,MMP3,1
R-HSA-182971,EGFR downregulation,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,EREG/EGF,2
R-HSA-1839124,FGFR1 mutant receptor activation,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,FGF20/CNTRL,2
R-HSA-445095,Interaction between L1 and Ankyrins,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,ANK1/SPTBN2,2
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,WNT8B/WNT1,2
R-HSA-5654687,Downstream signaling of activated FGFR1,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,FGF20/FLRT3,2
R-HSA-70268,Pyruvate metabolism,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,PDK1/ME1,2
R-HSA-8949613,Cristae formation,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,ATP5MC1/APOO,2
R-HSA-917977,Transferrin endocytosis and recycling,2/1291,31/10616,0.905283581167462,0.999999999999475,0.942760942760448,TFR2/TCIRG1,2
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,19/1291,201/10616,0.906001416141599,0.999999999999475,0.942760942760448,KIF2C/KIF21B/KIF15/CENPE/KIF20A/KIFC1/KIF25/KIF11/RAB39A/RACGAP1/KIF23/KIF18B/KIF19/CYTH4/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C,19
R-HSA-5620924,Intraflagellar transport,4/1291,54/10616,0.907973816062743,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-5655253,Signaling by FGFR2 in disease,3/1291,43/10616,0.908511625036816,0.999999999999475,0.942760942760448,FGF20/FGF18/POLR2L,3
R-HSA-445989,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,2/1291,32/10616,0.914651092117437,0.999999999999475,0.942760942760448,NFKB2/NOD2,2
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,EGF,1
R-HSA-168927,TICAM1, RIP1-mediated IKK complex recruitment,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,BIRC3,1
R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,UBE2C,1
R-HSA-197264,Nicotinamide salvaging,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,NNMT,1
R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,SLC6A20,1
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,EGF,1
R-HSA-6804760,Regulation of TP53 Activity through Methylation,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,ATM,1
R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-888590,GABA synthesis, release, reuptake and degradation,1/1291,19/10616,0.915062204856935,0.999999999999475,0.942760942760448,SNAP25,1
R-HSA-190236,Signaling by FGFR,7/1291,87/10616,0.917379556540235,0.999999999999475,0.942760942760448,FGF20/FGFBP1/KLB/FGF18/ESRP1/POLR2L/FLRT3,7
R-HSA-6802952,Signaling by BRAF and RAF fusions,5/1291,67/10616,0.922819463061579,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ESRP1/ITGB3,5
R-HSA-1980145,Signaling by NOTCH2,2/1291,33/10616,0.923143132619719,0.999999999999475,0.942760942760448,FCER2/HES1,2
R-HSA-5694530,Cargo concentration in the ER,2/1291,33/10616,0.923143132619719,0.999999999999475,0.942760942760448,COL7A1/LMAN1L,2
R-HSA-9022692,Regulation of MECP2 expression and activity,2/1291,33/10616,0.923143132619719,0.999999999999475,0.942760942760448,CAMK4/AURKB,2
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,19/1291,206/10616,0.925240753188591,0.999999999999475,0.942760942760448,CAMK4/CHRNA6/ADCY8/HTR3A/KCNJ5/GNG2/AKAP5/GABRG3/PLCB2/RASGRF1/PRKCB/ADCY7/GNG8/PRKCG/TUBB2A/GABBR2/TUBB4B/TUBA1B/TUBA1C,19
R-HSA-2028269,Signaling by Hippo,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,STK4,1
R-HSA-3232118,SUMOylation of transcription factors,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,CDKN2A,1
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,PPFIA4,1
R-HSA-5627117,RHO GTPases Activate ROCKs,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,RHOB,1
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,HES1,1
R-HSA-9603798,Class I peroxisomal membrane protein import,1/1291,20/10616,0.925409915862851,0.999999999999475,0.942760942760448,ABCD2,1
R-HSA-8878166,Transcriptional regulation by RUNX2,10/1291,120/10616,0.930123710428695,0.999999999999475,0.942760942760448,PSMB9/RUNX2/CDK1/PSMA8/PSMD14/PSMD1/HES1/PSMB5/SMAD6/PSMC4,10
R-HSA-3214858,RMTs methylate histone arginines,6/1291,79/10616,0.930287452126887,0.999999999999475,0.942760942760448,H3C13/H2AW/H3C4/H2AC11/H2AC13/H3C12,6
R-HSA-8852135,Protein ubiquitination,6/1291,79/10616,0.930287452126887,0.999999999999475,0.942760942760448,H2BC4/H2BC5/H2BC11/H2BC13/UBE2C/UCHL3,6
R-HSA-8854214,TBC/RABGAPs,3/1291,46/10616,0.930543608690002,0.999999999999475,0.942760942760448,SYTL1/TBC1D10C/RAB33A,3
R-HSA-4791275,Signaling by WNT in cancer,2/1291,34/10616,0.930833903803844,0.999999999999475,0.942760942760448,KREMEN2/DKK2,2
R-HSA-5654727,Negative regulation of FGFR2 signaling,2/1291,34/10616,0.930833903803844,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-15869,Metabolism of nucleotides,8/1291,100/10616,0.931235905901077,0.999999999999475,0.942760942760448,AMPD1/RRM2/AMPD3/TYMP/XDH/GSR/TXN/TXNRD1,8
R-HSA-210745,Regulation of gene expression in beta cells,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,FOXA2,1
R-HSA-445144,Signal transduction by L1,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,ITGB3,1
R-HSA-4641263,Regulation of FZD by ubiquitination,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,RSPO1,1
R-HSA-5620916,VxPx cargo-targeting to cilium,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,CNGA4,1
R-HSA-5621575,CD209 (DC-SIGN) signaling,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,ICAM3,1
R-HSA-5654688,SHC-mediated cascade:FGFR1,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-5654689,PI-3K cascade:FGFR1,1/1291,21/10616,0.93449785457756,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,6/1291,80/10616,0.935230826888673,0.999999999999475,0.942760942760448,NUP210/OAS1/OAS3/OAS2/OASL/MX2,6
R-HSA-112316,Neuronal System,41/1291,413/10616,0.935527398388224,0.999999999999475,0.942760942760448,KCNAB2/KCNA2/KCNA3/PPFIA4/KCNH8/CAMK4/ACHE/CHRNA6/ADCY8/SLC1A2/SYT12/HTR3A/KCNJ5/KCNH3/GNG2/AKAP5/GABRG3/APBA2/PLCB2/HCN4/RASGRF1/PRKCB/ADCY7/KCNH4/DLGAP1/KCNK6/KCNN4/GNG8/PRKCG/SNAP25/KCNG1/BCHE/TUBB2A/KCNV1/GABBR2/TUBB4B/ABCC8/TUBA1B/TUBA1C/SLC6A4/KCNC3,41
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,3/1291,47/10616,0.936727422209259,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,3/1291,47/10616,0.936727422209259,0.999999999999475,0.942760942760448,ARL4C/APOC2/FASN,3
R-HSA-73884,Base Excision Repair,7/1291,91/10616,0.93730179361607,0.999999999999475,0.942760942760448,H2BC21/H2BU1/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13,7
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,4/1291,59/10616,0.939465857941706,0.999999999999475,0.942760942760448,H2BC4/H2BC5/H2BC11/H2BC13,4
R-HSA-3781865,Diseases of glycosylation,12/1291,143/10616,0.941636498274337,0.999999999999475,0.942760942760448,LFNG/GPC2/ADAMTS14/MUC19/KERA/ADAMTS10/MUC16/CFP/ADAMTS4/ADAMTS16/ADAMTS15/CSPG4,12
R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,1/1291,22/10616,0.942479286360512,0.999999999999475,0.942760942760448,RASGRF1,1
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/1291,22/10616,0.942479286360512,0.999999999999475,0.942760942760448,NOD2,1
R-HSA-6802957,Oncogenic MAPK signaling,5/1291,71/10616,0.943632108774272,0.999999999999475,0.942760942760448,APBB1IP/CSK/ARRB2/ESRP1/ITGB3,5
R-HSA-6805567,Keratinization,19/1291,212/10616,0.943884539045825,0.999999999999475,0.942760942760448,TCHH/CSTA/KRTAP5-1/PKP2/KRT72/KRT73/KRT23/KRTAP29-1/KRTAP16-1/KRT17/DSC3/CELA2A/LCE1F/SPRR2F/KRT78/KRT8/KRT18/PRSS8/KLK12,19
R-HSA-8956319,Nucleobase catabolism,2/1291,36/10616,0.944083160156814,0.999999999999475,0.942760942760448,TYMP/XDH,2
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,7/1291,93/10616,0.945573607554705,0.999999999999475,0.942760942760448,CAMK4/ADCY8/RASGRF1/TUBB2A/TUBB4B/TUBA1B/TUBA1C,7
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,7/1291,94/10616,0.949333685904577,0.999999999999475,0.942760942760448,TLR1/TLR6/TLR2/NFKB2/SIGIRR/NOD2/BTK,7
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,7/1291,94/10616,0.949333685904577,0.999999999999475,0.942760942760448,TLR1/TLR6/TLR2/NFKB2/SIGIRR/NOD2/BTK,7
R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,NOD2,1
R-HSA-5654693,FRS-mediated FGFR1 signaling,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-73980,RNA Polymerase III Transcription Termination,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-8949215,Mitochondrial calcium ion transport,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,MCUB,1
R-HSA-937041,IKK complex recruitment mediated by RIP1,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,BIRC3,1
R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,1/1291,23/10616,0.949488842836685,0.999999999999475,0.942760942760448,CAMK4,1
R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,2/1291,37/10616,0.949765221399882,0.999999999999475,0.942760942760448,ARL4C/APOC2,2
R-HSA-112315,Transmission across Chemical Synapses,25/1291,272/10616,0.950961563598532,0.999999999999475,0.942760942760448,PPFIA4/CAMK4/ACHE/CHRNA6/ADCY8/SLC1A2/HTR3A/KCNJ5/GNG2/AKAP5/GABRG3/PLCB2/RASGRF1/PRKCB/ADCY7/GNG8/PRKCG/SNAP25/BCHE/TUBB2A/GABBR2/TUBB4B/TUBA1B/TUBA1C/SLC6A4,25
R-HSA-5654738,Signaling by FGFR2,5/1291,73/10616,0.952009727976262,0.999999999999475,0.942760942760448,FGF20/FGFBP1/FGF18/ESRP1/POLR2L,5
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,3/1291,50/10616,0.952353455456459,0.999999999999475,0.942760942760448,GPC2/CHST11/CSPG4,3
R-HSA-3214842,HDMs demethylate histones,3/1291,50/10616,0.952353455456459,0.999999999999475,0.942760942760448,H3C13/H3C4/H3C12,3
R-HSA-5654736,Signaling by FGFR1,3/1291,50/10616,0.952353455456459,0.999999999999475,0.942760942760448,FGF20/FGF18/FLRT3,3
R-HSA-390466,Chaperonin-mediated protein folding,7/1291,95/10616,0.952860006035596,0.999999999999475,0.942760942760448,GNG2/RGS9/GNG8/TUBB2A/TUBB4B/TUBA1B/TUBA1C,7
R-HSA-8986944,Transcriptional Regulation by MECP2,4/1291,62/10616,0.95329387283469,0.999999999999475,0.942760942760448,CAMK4/AURKB/PPARG/SST,4
R-HSA-2129379,Molecules associated with elastic fibres,2/1291,38/10616,0.954893554552247,0.999999999999475,0.942760942760448,MFAP5/ITGB3,2
R-HSA-5655302,Signaling by FGFR1 in disease,2/1291,38/10616,0.954893554552247,0.999999999999475,0.942760942760448,FGF20/CNTRL,2
R-HSA-156584,Cytosolic sulfonation of small molecules,1/1291,24/10616,0.955644785808255,0.999999999999475,0.942760942760448,SULT1A2,1
R-HSA-163560,Triglyceride catabolism,1/1291,24/10616,0.955644785808255,0.999999999999475,0.942760942760448,FABP4,1
R-HSA-203927,MicroRNA (miRNA) biogenesis,1/1291,24/10616,0.955644785808255,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-211981,Xenobiotics,1/1291,24/10616,0.955644785808255,0.999999999999475,0.942760942760448,CYP2S1,1
R-HSA-933542,TRAF6 mediated NF-kB activation,1/1291,24/10616,0.955644785808255,0.999999999999475,0.942760942760448,NFKB2,1
R-HSA-212165,Epigenetic regulation of gene expression,12/1291,148/10616,0.956578886451955,0.999999999999475,0.942760942760448,H3C13/H2BC21/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2BC13/H3C12/EZH2/DNMT3L/POLR2L,12
R-HSA-112310,Neurotransmitter release cycle,3/1291,51/10616,0.956705180013432,0.999999999999475,0.942760942760448,PPFIA4/SLC1A2/SNAP25,3
R-HSA-1226099,Signaling by FGFR in disease,4/1291,63/10616,0.957214450816035,0.999999999999475,0.942760942760448,FGF20/CNTRL/FGF18/POLR2L,4
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,7/1291,97/10616,0.959259439100455,0.999999999999475,0.942760942760448,TLR1/TLR6/TLR2/NFKB2/SIGIRR/NOD2/BTK,7
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,7/1291,97/10616,0.959259439100455,0.999999999999475,0.942760942760448,TLR1/TLR6/TLR2/NFKB2/SIGIRR/NOD2/BTK,7
R-HSA-383280,Nuclear Receptor transcription pathway,3/1291,52/10616,0.960682344475348,0.999999999999475,0.942760942760448,NR1H4/ESR2/PPARG,3
R-HSA-5654741,Signaling by FGFR3,2/1291,40/10616,0.963687030224738,0.999999999999475,0.942760942760448,FGF20/FGF18,2
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,4/1291,65/10616,0.964158801051604,0.999999999999475,0.942760942760448,FANCD2/ATM/FANCI/POLR2L,4
R-HSA-9614085,FOXO-mediated transcription,4/1291,65/10616,0.964158801051604,0.999999999999475,0.942760942760448,FASLG/BTG1/POMC/TXN,4
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,1/1291,26/10616,0.965798722083263,0.999999999999475,0.942760942760448,PPP1R15A,1
R-HSA-425410,Metal ion SLC transporters,1/1291,26/10616,0.965798722083263,0.999999999999475,0.942760942760448,SLC39A14,1
R-HSA-77387,Insulin receptor recycling,1/1291,26/10616,0.965798722083263,0.999999999999475,0.942760942760448,TCIRG1,1
R-HSA-912694,Regulation of IFNA signaling,1/1291,26/10616,0.965798722083263,0.999999999999475,0.942760942760448,PTPN6,1
R-HSA-162906,HIV Infection,20/1291,232/10616,0.966558024639486,0.999999999999475,0.942760942760448,LCK/CD247/CD8B/CXCR4/CD28/NUP210/CCR5/DOCK2/PSMB9/CD4/B2M/PSMA8/HCK/APOBEC3G/PSMD14/PSMD1/POLR2L/PSMB5/AP1M2/PSMC4,20
R-HSA-8875878,MET promotes cell motility,2/1291,41/10616,0.967441197362618,0.999999999999475,0.942760942760448,LAMB3/LAMA3,2
R-HSA-8848021,Signaling by PTK6,3/1291,54/10616,0.967628434736741,0.999999999999475,0.942760942760448,EREG/PTK6/EGF,3
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,3/1291,54/10616,0.967628434736741,0.999999999999475,0.942760942760448,EREG/PTK6/EGF,3
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,5/1291,78/10616,0.968228050489051,0.999999999999475,0.942760942760448,CASP8/TNFAIP3/NFKB2/NLRC5/RNF125,5
R-HSA-391251,Protein folding,7/1291,101/10616,0.969759056738725,0.999999999999475,0.942760942760448,GNG2/RGS9/GNG8/TUBB2A/TUBB4B/TUBA1B/TUBA1C,7
R-HSA-1368108,BMAL1:CLOCK,NPAS2 activates circadian gene expression,1/1291,27/10616,0.969968112998325,0.999999999999475,0.942760942760448,ARNTL2,1
R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,1/1291,27/10616,0.969968112998325,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-3000170,Syndecan interactions,1/1291,27/10616,0.969968112998325,0.999999999999475,0.942760942760448,ITGB3,1
R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,1/1291,27/10616,0.969968112998325,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,1/1291,27/10616,0.969968112998325,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),3/1291,55/10616,0.970650354392014,0.999999999999475,0.942760942760448,CYP51A1/GPAM/FASN,3
R-HSA-6799198,Complex I biogenesis,3/1291,55/10616,0.970650354392014,0.999999999999475,0.942760942760448,NDUFS5/NDUFB2/NDUFC2,3
R-HSA-186712,Regulation of beta-cell development,2/1291,42/10616,0.970820178539299,0.999999999999475,0.942760942760448,HES1/FOXA2,2
R-HSA-379724,tRNA Aminoacylation,2/1291,42/10616,0.970820178539299,0.999999999999475,0.942760942760448,AIMP2/AARS1,2
R-HSA-6794361,Neurexins and neuroligins,3/1291,56/10616,0.973403853565699,0.999999999999475,0.942760942760448,SYT12/APBA2/DLGAP1,3
R-HSA-350054,Notch-HLH transcription pathway,1/1291,28/10616,0.973629569804365,0.999999999999475,0.942760942760448,HDAC9,1
R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,1/1291,28/10616,0.973629569804365,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,1/1291,28/10616,0.973629569804365,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-168325,Viral Messenger RNA Synthesis,2/1291,43/10616,0.973859620173567,0.999999999999475,0.942760942760448,NUP210/POLR2L,2
R-HSA-6811438,Intra-Golgi traffic,2/1291,44/10616,0.976592055382971,0.999999999999475,0.942760942760448,RAB39A/CYTH4,2
R-HSA-72086,mRNA Capping,1/1291,29/10616,0.976844929209594,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-9615017,FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes,1/1291,29/10616,0.976844929209594,0.999999999999475,0.942760942760448,POMC,1
R-HSA-1236394,Signaling by ERBB4,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,EREG/GABRG3/EGF,3
R-HSA-186797,Signaling by PDGF,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,SPP1/COL9A1/THBS4,3
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-2644603,Signaling by NOTCH1 in Cancer,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,HDAC9/HEYL/HES1,3
R-HSA-917937,Iron uptake and transport,3/1291,58/10616,0.978192469117565,0.999999999999475,0.942760942760448,TFR2/TCIRG1/FTL,3
R-HSA-1566948,Elastic fibre formation,2/1291,45/10616,0.979047133355834,0.999999999999475,0.942760942760448,MFAP5/ITGB3,2
R-HSA-180786,Extension of Telomeres,1/1291,30/10616,0.979668504952526,0.999999999999475,0.942760942760448,TERT,1
R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,1/1291,30/10616,0.979668504952526,0.999999999999475,0.942760942760448,RASGRF1,1
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,1/1291,30/10616,0.979668504952526,0.999999999999475,0.942760942760448,PIP4K2A,1
R-HSA-3000171,Non-integrin membrane-ECM interactions,3/1291,59/10616,0.980267109001986,0.999999999999475,0.942760942760448,LAMB3/LAMA3/ITGB3,3
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,4/1291,72/10616,0.981040694624295,0.999999999999475,0.942760942760448,TUBB2A/TUBB4B/TUBA1B/TUBA1C,4
R-HSA-373760,L1CAM interactions,8/1291,119/10616,0.982143619370328,0.999999999999475,0.942760942760448,ANK1/SPTBN2/KIF4A/TUBB2A/TUBB4B/TUBA1B/TUBA1C/ITGB3,8
R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,ARRB2,1
R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,GCSH,1
R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),1/1291,31/10616,0.982148002412028,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-8943724,Regulation of PTEN gene transcription,3/1291,60/10616,0.982152546930812,0.999999999999475,0.942760942760448,EZH2/PPARG/SNAI1,3
R-HSA-1980143,Signaling by NOTCH1,4/1291,73/10616,0.982723649212587,0.999999999999475,0.942760942760448,HDAC9/ARRB2/HEYL/HES1,4
R-HSA-6807505,RNA polymerase II transcribes snRNA genes,4/1291,74/10616,0.984264485000522,0.999999999999475,0.942760942760448,NABP1/ELL3/POU2F2/POLR2L,4
R-HSA-1251985,Nuclear signaling by ERBB4,1/1291,32/10616,0.98432532209895,0.999999999999475,0.942760942760448,EREG,1
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/1291,32/10616,0.98432532209895,0.999999999999475,0.942760942760448,PPP1R15A,1
R-HSA-381042,PERK regulates gene expression,1/1291,32/10616,0.98432532209895,0.999999999999475,0.942760942760448,HSPA5,1
R-HSA-5656169,Termination of translesion DNA synthesis,1/1291,32/10616,0.98432532209895,0.999999999999475,0.942760942760448,PCLAF,1
R-HSA-73863,RNA Polymerase I Transcription Termination,1/1291,32/10616,0.98432532209895,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-113418,Formation of the Early Elongation Complex,1/1291,33/10616,0.986237265520176,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,1/1291,33/10616,0.986237265520176,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-180746,Nuclear import of Rev protein,1/1291,33/10616,0.986237265520176,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-180910,Vpr-mediated nuclear import of PICs,1/1291,33/10616,0.986237265520176,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-5654726,Negative regulation of FGFR1 signaling,1/1291,33/10616,0.986237265520176,0.999999999999475,0.942760942760448,FGF20,1
R-HSA-6807878,COPI-mediated anterograde transport,6/1291,100/10616,0.986740715144727,0.999999999999475,0.942760942760448,ANK1/SPTBN2/TUBB2A/TUBB4B/TUBA1B/TUBA1C,6
R-HSA-166520,Signaling by NTRKs,6/1291,101/10616,0.987813240938791,0.999999999999475,0.942760942760448,PTPRO/CDK5R1/NTF4/TIAM1/ADORA2A/IRS1,6
R-HSA-9007101,Rab regulation of trafficking,8/1291,124/10616,0.987817237915088,0.999999999999475,0.942760942760448,SYTL1/DENND2D/TBC1D10C/RAB39A/RAB27B/DENND1C/RAB33A/RAB39B,8
R-HSA-159227,Transport of the SLBP independent Mature mRNA,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-165054,Rev-mediated nuclear export of HIV RNA,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-4085377,SUMOylation of SUMOylation proteins,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-5663084,Diseases of carbohydrate metabolism,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,TALDO1,1
R-HSA-70263,Gluconeogenesis,1/1291,34/10616,0.987916155269156,0.999999999999475,0.942760942760448,SLC37A2,1
R-HSA-373752,Netrin-1 signaling,2/1291,50/10616,0.988024767845114,0.999999999999475,0.942760942760448,AGAP2/DCC,2
R-HSA-73894,DNA Repair,28/1291,331/10616,0.988371119541599,0.999999999999475,0.942760942760448,CLSPN/H2BC21/H2BU1/EXO1/FANCD2/POLQ/CCNA2/NEIL3/H2BC4/H2BC5/H2BC11/H2BC13/XRCC2/ATM/RAD51AP1/BRCA2/TDP1/RAD51/PCLAF/FANCI/BLM/RMI2/FANCA/EME1/BRIP1/FANCB/EYA1/POLR2L,28
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,5/1291,90/10616,0.988789957033633,0.999999999999475,0.942760942760448,DENND2D/RAB39A/RAB27B/DENND1C/RAB39B,5
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,5/1291,90/10616,0.988789957033633,0.999999999999475,0.942760942760448,TLR9/NFKB2/NOD2/TLR7/TLR8,5
R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,1/1291,35/10616,0.989390379758621,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-432720,Lysosome Vesicle Biogenesis,1/1291,35/10616,0.989390379758621,0.999999999999475,0.942760942760448,AP1M2,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,5/1291,91/10616,0.989752230885206,0.999999999999475,0.942760942760448,TLR9/NFKB2/NOD2/TLR7/TLR8,5
R-HSA-975155,MyD88 dependent cascade initiated on endosome,5/1291,91/10616,0.989752230885206,0.999999999999475,0.942760942760448,TLR9/NFKB2/NOD2/TLR7/TLR8,5
R-HSA-71387,Metabolism of carbohydrates,24/1291,295/10616,0.990358469903397,0.999999999999475,0.942760942760448,RHD/NUP210/HPSE/HMMR/GPC2/FUT7/SLC37A2/KERA/CHST11/HS3ST3A1/HS3ST3B1/B3GNT3/FUT2/HS6ST2/PGD/HYAL2/TKT/HS3ST5/ST3GAL1/HK1/TALDO1/LYVE1/CSPG4/G6PD,24
R-HSA-167287,HIV elongation arrest and recovery,1/1291,36/10616,0.990684871747244,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167290,Pausing and recovery of HIV elongation,1/1291,36/10616,0.990684871747244,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-176033,Interactions of Vpr with host cellular proteins,1/1291,36/10616,0.990684871747244,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-177243,Interactions of Rev with host cellular proteins,1/1291,36/10616,0.990684871747244,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-76046,RNA Polymerase III Transcription Initiation,1/1291,36/10616,0.990684871747244,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-6807070,PTEN Regulation,9/1291,139/10616,0.990870281109426,0.999999999999475,0.942760942760448,PSMB9/EZH2/PSMA8/PSMD14/PSMD1/PPARG/PSMB5/PSMC4/SNAI1,9
R-HSA-983169,Class I MHC mediated antigen processing & presentation,31/1291,369/10616,0.992466375482025,0.999999999999475,0.942760942760448,FCGR1A/CTSS/NCF2/CD207/FBXO41/KBTBD8/TLR1/TLR6/TLR2/ERAP2/HLA-F/HLA-G/HLA-B/TAP2/TAP1/PSMB9/NCF1/ASB2/B2M/PSMA8/UBE2C/NCF4/CYBB/BTK/PSMD14/PSMD1/HSPA5/PSMB5/PDIA3/CALR/PSMC4,31
R-HSA-3232142,SUMOylation of ubiquitinylation proteins,1/1291,38/10616,0.992819582056718,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,5/1291,95/10616,0.992872148022454,0.999999999999475,0.942760942760448,TLR9/NFKB2/NOD2/TLR7/TLR8,5
R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,2/1291,55/10616,0.993210249483782,0.999999999999475,0.942760942760448,PDK1/ME1,2
R-HSA-9639288,Amino acids regulate mTORC1,2/1291,55/10616,0.993210249483782,0.999999999999475,0.942760942760448,TCIRG1/SH3BP4,2
R-HSA-397014,Muscle contraction,15/1291,209/10616,0.993442873631173,0.999999999999475,0.942760942760448,ATP1A4/KCNK12/NPPC/FXYD2/ATP2A3/FXYD7/KCNK6/ATP1A3/KCNE1/CACNA1F/ATP1A1/ATP1B3/TRDN/ATP2A2/TBX5,15
R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1/1291,39/10616,0.993695921588272,0.999999999999475,0.942760942760448,PCLAF,1
R-HSA-446203,Asparagine N-linked glycosylation,24/1291,303/10616,0.993813696743713,0.999999999999475,0.942760942760448,COL7A1/ST6GAL1/ST8SIA4/ANK1/SPTBN2/ST8SIA1/LMAN1L/ST8SIA2/ASGR2/MGAT3/RENBP/UAP1/GMPPB/RPN1/TUBB2A/SLC17A5/ST3GAL1/TUBB4B/TUBA1B/TUBA1C/MLEC/PDIA3/ST8SIA3/CALR,24
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,2/1291,56/10616,0.993943819702971,0.999999999999475,0.942760942760448,PERM1/CAMK4,2
R-HSA-432722,Golgi Associated Vesicle Biogenesis,2/1291,56/10616,0.993943819702971,0.999999999999475,0.942760942760448,AP1M2/FTL,2
R-HSA-168276,NS1 Mediated Effects on Host Pathways,1/1291,40/10616,0.994465380341183,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/1291,40/10616,0.994465380341183,0.999999999999475,0.942760942760448,DUSP2,1
R-HSA-425366,Transport of bile salts and organic acids, metal ions and amine compounds,4/1291,85/10616,0.99452292010479,0.999999999999475,0.942760942760448,SLC6A20/SLC22A3/SLC39A14/SLC14A2,4
R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,1/1291,41/10616,0.995140984915647,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-74158,RNA Polymerase III Transcription,1/1291,41/10616,0.995140984915647,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,1/1291,41/10616,0.995140984915647,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-6794362,Protein-protein interactions at synapses,4/1291,87/10616,0.995501513372697,0.999999999999475,0.942760942760448,PPFIA4/SYT12/APBA2/DLGAP1,4
R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,1/1291,42/10616,0.99573417531507,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-168253,Host Interactions with Influenza Factors,1/1291,42/10616,0.99573417531507,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-3928662,EPHB-mediated forward signaling,1/1291,42/10616,0.99573417531507,0.999999999999475,0.942760942760448,TIAM1,1
R-HSA-948021,Transport to the Golgi and subsequent modification,12/1291,184/10616,0.996129462259417,0.999999999999475,0.942760942760448,COL7A1/ST6GAL1/ANK1/SPTBN2/LMAN1L/ST8SIA2/MGAT3/TUBB2A/TUBB4B/TUBA1B/TUBA1C/ST8SIA3,12
R-HSA-6782315,tRNA modification in the nucleus and cytosol,1/1291,43/10616,0.996254998056535,0.999999999999475,0.942760942760448,METTL1,1
R-HSA-112382,Formation of RNA Pol II elongation complex ,2/1291,61/10616,0.996593776898892,0.999999999999475,0.942760942760448,EAF2/POLR2L,2
R-HSA-75955,RNA Polymerase II Transcription Elongation,2/1291,61/10616,0.996593776898892,0.999999999999475,0.942760942760448,EAF2/POLR2L,2
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,3/1291,76/10616,0.996606792597954,0.999999999999475,0.942760942760448,NUP210/CDKN2A/BLM,3
R-HSA-3247509,Chromatin modifying enzymes,20/1291,274/10616,0.997013797102479,0.999999999999475,0.942760942760448,PADI2/PADI4/H2BC18/H3C13/H2BC21/H2AW/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2AC11/H2BC13/H2AC13/H3C12/EZH2/NFKB2/MSL3/OGT/SMYD3,20
R-HSA-4839726,Chromatin organization,20/1291,274/10616,0.997013797102479,0.999999999999475,0.942760942760448,PADI2/PADI4/H2BC18/H3C13/H2BC21/H2AW/H2BU1/H2BC4/H2BC5/H3C4/H2BC11/H2AC11/H2BC13/H2AC13/H3C12/EZH2/NFKB2/MSL3/OGT/SMYD3,20
R-HSA-2682334,EPH-Ephrin signaling,4/1291,92/10616,0.997265990533716,0.999999999999475,0.942760942760448,EPHA10/MMP9/TIAM1/EPHA5,4
R-HSA-5617833,Cilium Assembly,13/1291,200/10616,0.997291343337229,0.999999999999475,0.942760942760448,NEK2/CEP135/PLK4/CNTRL/CDK1/CNGA4/PLK1/SFI1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/B9D1,13
R-HSA-9033241,Peroxisomal protein import,2/1291,63/10616,0.997298598553545,0.999999999999475,0.942760942760448,HSD17B4/CROT,2
R-HSA-167169,HIV Transcription Elongation,1/1291,46/10616,0.997466243353748,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,1/1291,46/10616,0.997466243353748,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,1/1291,46/10616,0.997466243353748,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-4570464,SUMOylation of RNA binding proteins,1/1291,46/10616,0.997466243353748,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-5576892,Phase 0 - rapid depolarisation,1/1291,46/10616,0.997466243353748,0.999999999999475,0.942760942760448,CACNA1F,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,4/1291,93/10616,0.997527536690032,0.999999999999475,0.942760942760448,CASP8/NFKB2/BIRC3/NOD2,4
R-HSA-6806834,Signaling by MET,3/1291,79/10616,0.997537816423405,0.999999999999475,0.942760942760448,LAMB3/LAMA3/SPINT2,3
R-HSA-167161,HIV Transcription Initiation,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-167162,RNA Polymerase II HIV Promoter Escape,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-73762,RNA Polymerase I Transcription Initiation,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-73776,RNA Polymerase II Promoter Escape,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-75953,RNA Polymerase II Transcription Initiation,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,1/1291,47/10616,0.997775711644222,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-1592230,Mitochondrial biogenesis,4/1291,95/10616,0.997979806052785,0.999999999999475,0.942760942760448,PERM1/CAMK4/ATP5MC1/APOO,4
R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,1/1291,48/10616,0.998047407761859,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-73893,DNA Damage Bypass,1/1291,48/10616,0.998047407761859,0.999999999999475,0.942760942760448,PCLAF,1
R-HSA-163200,Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,6/1291,123/10616,0.998268542479793,0.999999999999475,0.942760942760448,NDUFS5/UCP1/NDUFB2/NDUFC2/ATP5MC1/COX7B,6
R-HSA-166166,MyD88-independent TLR4 cascade ,4/1291,97/10616,0.998351293060802,0.999999999999475,0.942760942760448,CASP8/NFKB2/BIRC3/NOD2,4
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,4/1291,97/10616,0.998351293060802,0.999999999999475,0.942760942760448,CASP8/NFKB2/BIRC3/NOD2,4
R-HSA-204005,COPII-mediated vesicle transport,2/1291,68/10616,0.998492424591966,0.999999999999475,0.942760942760448,COL7A1/LMAN1L,2
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,3/1291,84/10616,0.998565235278413,0.999999999999475,0.942760942760448,TLR10/NFKB2/NOD2,3
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,3/1291,84/10616,0.998565235278413,0.999999999999475,0.942760942760448,TLR10/NFKB2/NOD2,3
R-HSA-975871,MyD88 cascade initiated on plasma membrane,3/1291,84/10616,0.998565235278413,0.999999999999475,0.942760942760448,TLR10/NFKB2/NOD2,3
R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/1291,51/10616,0.998679195149784,0.999999999999475,0.942760942760448,CNGA4,1
R-HSA-611105,Respiratory electron transport,4/1291,100/10616,0.99878703901739,0.999999999999475,0.942760942760448,NDUFS5/NDUFB2/NDUFC2/COX7B,4
R-HSA-72165,mRNA Splicing - Minor Pathway,1/1291,52/10616,0.998840592126748,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-199977,ER to Golgi Anterograde Transport,8/1291,153/10616,0.998890824956164,0.999999999999475,0.942760942760448,COL7A1/ANK1/SPTBN2/LMAN1L/TUBB2A/TUBB4B/TUBA1B/TUBA1C,8
R-HSA-448424,Interleukin-17 signaling,2/1291,71/10616,0.998940049985682,0.999999999999475,0.942760942760448,NOD2/IL17C,2
R-HSA-70171,Glycolysis,2/1291,71/10616,0.998940049985682,0.999999999999475,0.942760942760448,NUP210/HK1,2
R-HSA-191859,snRNP Assembly,1/1291,53/10616,0.998982280461126,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-194441,Metabolism of non-coding RNA,1/1291,53/10616,0.998982280461126,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,1/1291,53/10616,0.998982280461126,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-1169408,ISG15 antiviral mechanism,2/1291,72/10616,0.999057824975179,0.999999999999475,0.942760942760448,NUP210/MX2,2
R-HSA-199992,trans-Golgi Network Vesicle Budding,2/1291,72/10616,0.999057824975179,0.999999999999475,0.942760942760448,AP1M2/FTL,2
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,10/1291,181/10616,0.999193809696338,0.999999999999475,0.942760942760448,CDCA8/NUP210/CDKN2A/NFKB2/NR1H4/BLM/AURKB/TOP2A/BIRC5/PPARG,10
R-HSA-376176,Signaling by ROBO receptors,13/1291,217/10616,0.999246187456251,0.999999999999475,0.942760942760448,CXCR4/SRGAP3/ROBO2/PSMB9/AKAP5/EVL/PSMA8/DCC/PSMD14/PSMD1/PSMB5/PSMC4/FLRT3,13
R-HSA-70326,Glucose metabolism,3/1291,91/10616,0.99933334762313,0.999999999999475,0.942760942760448,NUP210/SLC37A2/HK1,3
R-HSA-5663205,Infectious disease,28/1291,382/10616,0.999340777550339,0.999999999999475,0.942760942760448,LCK/CD247/CD8B/CXCR4/CD28/NUP210/CCR5/DOCK2/HSPA1A/HSPA1B/PSMB9/VAMP1/CD4/B2M/STX1B/PSMA8/SNAP25/HCK/APOBEC3G/PSMD14/PSMD1/POLR2L/TXNRD1/DNAJC3/PSMB5/AP1M2/CALR/PSMC4,28
R-HSA-6784531,tRNA processing in the nucleus,1/1291,57/10616,0.999395858973641,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-2990846,SUMOylation,10/1291,187/10616,0.999512693742792,0.999999999999475,0.942760942760448,CDCA8/NUP210/CDKN2A/NFKB2/NR1H4/BLM/AURKB/TOP2A/BIRC5/PPARG,10
R-HSA-187037,Signaling by NTRK1 (TRKA),2/1291,80/10616,0.999634960373221,0.999999999999475,0.942760942760448,ADORA2A/IRS1,2
R-HSA-450294,MAP kinase activation,1/1291,63/10616,0.999723794851886,0.999999999999475,0.942760942760448,NOD2,1
R-HSA-1268020,Mitochondrial protein import,1/1291,64/10616,0.999757584375834,0.999999999999475,0.942760942760448,ATP5MC1,1
R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,1/1291,64/10616,0.999757584375834,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-168255,Influenza Life Cycle,6/1291,144/10616,0.999765910973493,0.999999999999475,0.942760942760448,NUP210/HSPA1A/HSPA1B/POLR2L/DNAJC3/CALR,6
R-HSA-674695,RNA Polymerase II Pre-transcription Events,2/1291,84/10616,0.999773592959976,0.999999999999475,0.942760942760448,EAF2/POLR2L,2
R-HSA-6782135,Dual incision in TC-NER,1/1291,65/10616,0.999787243072839,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-8951664,Neddylation,13/1291,233/10616,0.999788209338019,0.999999999999475,0.942760942760448,FBXO41/KBTBD8/UBD/PSMB9/ASB2/BIRC5/PSMA8/PSMD14/PSMD1/CISH/UCHL3/PSMB5/PSMC4,13
R-HSA-9006936,Signaling by TGF-beta family members,3/1291,102/10616,0.999804300128266,0.999999999999475,0.942760942760448,PPP1R15A/GREM2/SMAD6,3
R-HSA-2408522,Selenoamino acid metabolism,4/1291,118/10616,0.999816518533513,0.999999999999475,0.942760942760448,AIMP2/GSR/NNMT/TXNRD1,4
R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,8/1291,174/10616,0.999832191722479,0.999999999999475,0.942760942760448,PDK1/NDUFS5/UCP1/ME1/NDUFB2/NDUFC2/ATP5MC1/COX7B,8
R-HSA-5368286,Mitochondrial translation initiation,2/1291,87/10616,0.999841988172248,0.999999999999475,0.942760942760448,MRPS11/MRPL40,2
R-HSA-5389840,Mitochondrial translation elongation,2/1291,87/10616,0.999841988172248,0.999999999999475,0.942760942760448,MRPS11/MRPL40,2
R-HSA-5419276,Mitochondrial translation termination,2/1291,87/10616,0.999841988172248,0.999999999999475,0.942760942760448,MRPS11/MRPL40,2
R-HSA-400253,Circadian Clock,1/1291,69/10616,0.99987378274697,0.999999999999475,0.942760942760448,ARNTL2,1
R-HSA-72306,tRNA processing,3/1291,107/10616,0.999888727010782,0.999999999999475,0.942760942760448,NUP210/METTL1/HSD17B10,3
R-HSA-4551638,SUMOylation of chromatin organization proteins,1/1291,70/10616,0.999889232303589,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-168254,Influenza Infection,6/1291,155/10616,0.999921328581588,0.999999999999475,0.942760942760448,NUP210/HSPA1A/HSPA1B/POLR2L/DNAJC3/CALR,6
R-HSA-5368287,Mitochondrial translation,2/1291,93/10616,0.999923292308313,0.999999999999475,0.942760942760448,MRPS11/MRPL40,2
R-HSA-167172,Transcription of the HIV genome,1/1291,73/10616,0.999925137925775,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/1291,73/10616,0.999925137925775,0.999999999999475,0.942760942760448,PPP1R15A,1
R-HSA-1852241,Organelle biogenesis and maintenance,17/1291,295/10616,0.999936208733085,0.999999999999475,0.942760942760448,PERM1/NEK2/CEP135/PLK4/CAMK4/CNTRL/CDK1/CNGA4/PLK1/SFI1/TUBB2A/TUBB4B/TUBA1B/TUBA1C/B9D1/ATP5MC1/APOO,17
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,7/1291,171/10616,0.999936780409828,0.999999999999475,0.942760942760448,ROBO2/PSMB9/PSMA8/PSMD14/PSMD1/PSMB5/PSMC4,7
R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,1/1291,75/10616,0.99994235004897,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),1/1291,78/10616,0.999961045157994,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-162587,HIV Life Cycle,5/1291,151/10616,0.999973161033683,0.999999999999475,0.942760942760448,CXCR4/NUP210/CCR5/CD4/POLR2L,5
R-HSA-72202,Transport of Mature Transcript to Cytoplasm,1/1291,84/10616,0.999982220027328,0.999999999999475,0.942760942760448,NUP210,1
R-HSA-192823,Viral mRNA Translation,1/1291,89/10616,0.999990754847849,0.999999999999475,0.942760942760448,DNAJC3,1
R-HSA-168273,Influenza Viral RNA Transcription and Replication,3/1291,134/10616,0.999995053807575,0.999999999999475,0.942760942760448,NUP210/POLR2L/DNAJC3,3
R-HSA-9609507,Protein localization,4/1291,163/10616,0.999998740847868,0.999999999999475,0.942760942760448,ABCD2/HSD17B4/CROT/ATP5MC1,4
R-HSA-5696398,Nucleotide Excision Repair,1/1291,110/10616,0.999999409164321,0.999999999999475,0.942760942760448,POLR2L,1
R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1/1291,112/10616,0.999999545455081,0.999999999999475,0.942760942760448,RPN1,1
R-HSA-162599,Late Phase of HIV Life Cycle,2/1291,138/10616,0.999999694986303,0.999999999999475,0.942760942760448,NUP210/POLR2L,2
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,10/1291,307/10616,0.999999994968479,0.999999999999475,0.942760942760448,FBXO41/KBTBD8/PSMB9/ASB2/PSMA8/UBE2C/PSMD14/PSMD1/PSMB5/PSMC4,10
R-HSA-72163,mRNA Splicing - Major Pathway,2/1291,182/10616,0.999999998788828,0.999999999999475,0.942760942760448,PPIL1/POLR2L,2
R-HSA-72172,mRNA Splicing,2/1291,190/10616,0.999999999560957,0.999999999999475,0.942760942760448,PPIL1/POLR2L,2
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,3/1291,243/10616,0.999999999991179,0.999999999999475,0.942760942760448,NUP210/PPIL1/POLR2L,3
R-HSA-72766,Translation,5/1291,291/10616,0.999999999996861,0.999999999999475,0.942760942760448,RPN1/AIMP2/MRPS11/AARS1/MRPL40,5
R-HSA-72312,rRNA processing,1/1291,204/10616,0.999999999997526,0.999999999999475,0.942760942760448,HSD17B10,1
R-HSA-381753,Olfactory Signaling Pathway,10/1291,392/10616,0.999999999999475,0.999999999999475,0.942760942760448,RTP5/OR2B6/OR13A1/OR51I1/OR52N4/OR10AD1/OR2W3/OR2T8/OR2T33/OR51E1,10
